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O presente trabalho teve como objectivos identificar e caracterizar polimorfismos genéticos 
no gene da hormona de crescimento (oGH) em ovinos Serra da Estrela e estabelecer possíveis 
associações entre eles e a produção e composição do leite, de modo a avaliar a aplicabilidade 
do gene da GH em selecção assistida por marcadores genéticos. 
O gene da GH apresentou elevado polimorfismo, tendo sido preditas oito e dez variantes 
proteicas codificadas pelas cópias GH2-N e GH2-Z, respectivamente. 
Verificou-se a ocorrência de associações significativas entre os polimorfismos encontrados e a 
produção e composição do leite (teores e produção de gordura e proteína). O genótipo N2+Z7 
(GH2-N+GH2-Z) produziu mais 39,6 ± 7,5 litros de leite/150 dias, com maior teor em gordura 
e igual teor em proteína que o N5+Z2 (mais 25% da produção média das ovelhas). Resultados 
semelhantes foram observados nas ovelhas com o fenótipo proteico AAN+BBZ. 
Os resultados indicam que os polimorfismos do gene da GH poderão vir a ser utilizados na 
selecção assistida por marcadores genéticos. Estes poderão permitir o melhoramento da 
produção de leite sem afectar a sua qualidade. Contudo, a resposta à selecção dependerá das 
condições de exploração intrínsecas a cada rebanho e nomeadamente do maneio alimentar dos 
animais. 
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The objectives of the present work were the identification and characterisation of nucleotidic 
polymorphisms naturally occurring at the growth hormone gene (oGH) in "Serra da Estrela" 
sheep, and the establishment of associations with milk traits in order to evaluate GH as a 
useful candidate gene for marker assisted selection. 
The oGH gene was found to be highly polymorphic. Polymorphisms found in coding regions 
allowed the prediction of eight protein variants coded by the GH2-N copy and ten by the 
GH2-Z copy. 
Milk yield and milk composition (fat and protein contents and yields) were associated with 
GH polymorphisms by restricted maximum likelihood (REML) through a univariate best 
linear unbiased prediction (BLUP) animal model with repeated measures. 
The N2+Z7 (GH2-N+GH2-Z) genotype produced 39.6 ± 7.5 litres of milk/150 days more than 
N5+Z2 (more 25 % than the mean milk yield of the studied population), with higher milk fat 
content and similar protein content. Moreover, a similar result was obtained for the protein 
phenotype AAN+BBZ ewes. 
The results indicate that using GH polymorphisms as genetic markers could improve milk 
yield potential in “Serra da Estrela” ewes without detrimental impact on milk quality. The 
extent of the response, however, might depend on the environmental conditions within the 
flock, namely on an appropriate feeding management of the animals. 
Key words: Ovis aries; growth hormone gene; polymorphism; PCR-SSCP; genetic markers; 
milk yield. 
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Grb2 growth-factor-bound protein 2  
GS stimulatory guanyl nucleotide-binding protein 
ha hectare 
hGH human growth hormone 
hGHBP human growth hormone binding protein 
hGH-N human growth hormone gene copy N 
hGHRH human growth hormone-releasing hormone 
HMM hidden Markov models 
HWE Hardy-Weinberg equilibrium 
IGF insulin-like growth factor 
IGFBP insulin-like growth factor binding proteins 
INE National Institute of Statistics of Portugal 
JAK Janus tyrosine kinase 
kb kilo base pair(s) 
KCl potassium chloride  
kg kilogram(s) 
l litre(s) 
LCR locus control region 
LPA lysophosphatidic acid 
M molar 
MAP mitogen-activated protein 
MAPK  mitogen-activated protein kinase 
MAS marker assisted selection 
MEK MAP/ERK kinase 
mg milligram 
MgCl2  magnesium chloride 
MGF mammary gland factor; STAT5 
 xv 
min minute(s) 
MKP1 MAPK phosphatase 1 
mm millimetre(s) 
MME mixed model equations 
mRNA messenger ribonucleic acid 
MspI restriction endonuclease MspI 
MTDFREML multiple-trait derivative free restricted maximum likelihood 
MY milk yield 
My Million years 
N North 
NaOH sodium hydroxide 
 
nd no date; not determined 
NEFA non-esterified fatty acids 
NPY neuropeptide Y 
NPY-Y neuropeptide Y receptor 
NRE negative regulatory element 
nt nucleotide(s) 
OB leptin 
ob leptin gene 
ºC degrees Celsius 
oGH ovine growth hormone 
PACAP pituitary adenylate cyclase-activating polypeptide 
PCR  polymerase chain reaction 
PDGF platelet-derived growth factor 
PDO protected denomination of origin 
PDO Protected Denomination of Origin 
PEPCK phosphoenolpyruvate carboxykinase 
pGH pig growth hormone 
PKA protein kinase A 
PKC protein kinase C 
PL placental lactogen 
polyA polyadenylation 
POU Pit-1/Oct-1/Unc-86 
POU1F1 pituitary-specific transcription factor 1 
PRL  prolactin 
PRLR prolactin receptor 
PROP1  prophet of Pou1F1 
QTL  quantitative trait loci 
raf ras oncogene 
RAPD random amplified polymorphic DNA 
RAR  retinoic acid receptor 
ras ras oncogene 
REML Restricted Maximum Likelihood 
Rev reverse 
RFLP restriction fragment length polymorphism 
rGH rat growth hormone 
RNA ribonucleic acid 
s second(s) 
SE Standard error 
SH2 Src homology 2 
 xvi 
Shc SH2-containing protein 
SHP SH2 domain-containing protein tyrosine phosphatases 
SIRP1 signal regulatory protein-1 
SNP single nucleotide polymorphism 
SOCS suppressors of cytokine signalling 
Sos son-of-sevenless 
Sp1 stimulating protein 1 
Spi2.1  serine protease inhibitor 2.1 gene 
SRIF somatotropin release-inhibiting factor; somatostatin 
SSCP single-strand conformation polymorphism 
sst SRIF receptor 
ST somatotropin; used as synonymous of exogenously administrated GH 
STAT signal transducers and activators of transcription 
T thymine residue 
T3 3,5,3’-triiodothyronine; thyroid hormone 
T3R thyroid hormone receptor 
TATA box consensus sequence TATAAAT 
TBE  Tris/borate/EDTA 
TMY total milk yield 
TRE  thyroid hormone response element 
UTR untranslated region 
V Volt(s) 
vs. versus 
W Watt(s); West 
WAP whey acidic protein 
YY1 yin and yang factor 1 
Zn-15 zinc finger protein 
Zn15/Zn16 zinc finger transcription factor 
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One- and three- letter symbols for amino acids: 
 
A Ala Alanine 
C Cys Cysteine 
D Asp Aspartic acid 
E Glu Glutamic acid 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
Y Tyr Tyrosine 
X Xxx undetermined or non-standard aa 
 
 
Notations: 
 
P-7L amino acid residue P (proline) at position -7 of a given protein sequence changed to amino 
acid residue L (leucine) 
G9R amino acid residue G (glycine) at position 9 of a given protein sequence changed to amino 
acid residue R (arginine) 
P89 amino acid residue P (proline) at position 89 of a given protein sequence 
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 “The beginning of knowledge is  
the discovery of something  
we do not understand.” 
 
Frank Herbert (1920-1986) 
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I.1 Introduction 
Powerful molecular biology tools are nowadays available that significantly help in 
fundamental research and much contribute to technical developments in many scientific 
domains. In particular, their impact in animal science has been considerable (Vignal et al., 
2002). These techniques have applications so diverse as fraud control and animal products 
traceability (Botter et al., 2003; Brodman and Moor, 2003), genetic diversity characterization 
(Rendo et al., 2004) or parentage testing (Werner et al., 2004). It is also possible, through 
molecular techniques, to select animals having lower susceptibility to a disease (Brandsma et 
al., 2005), or favourable genotype for productive traits such as growth performance in cattle, 
sheep and pigs (Johnson et al., 2005; Maj et al., 2006; McRae et al., 2005; Taylor et al., 1998; 
Wimmers et al., 2002) or milk production and composition in dairy cattle (Blott et al., 2003; 
Kaminski et al., 2005; Shariflou et al., 2000) and sheep (Barillet et al., 2005; De Vries et al., 
2005; Diez-Tascón et al., 2001). 
The search for polymorphism in candidate genes thought to affect production traits has 
contributed to a better understanding of the basic biology of milk production and composition, 
and to intensify selection for these traits, namely in dairy cattle. Hence, effort has been made to 
identify candidate gene markers for milk selection within the somatotropic axis (Di Stasio et 
al., 2005; Parmentier et al., 1999; Renaville and Portetelle, 1998) with particular emphasis on 
growth hormone gene (GH) (Malveiro et al., 2001; Marques et al., 2003; Lagziel et al., 1999). 
Various studies have shown that administration of GH to lactating animal increases milk 
production and feed conversion efficiency without detrimental effects on milk composition. 
The choice of new selection processes linked to the polymorphism at the GH, a 
hormone that plays an essential role in milk production, is a possibility for a faster genetic 
progress and thus flocks improvement since females can be tested at birth. 
Some initial studies on molecular diversity of somatotropic axis’ genes have been 
performed in the “Serra da Estrela” ovine breed (Barracosa, 1996; Ramos et al., 2002). The use 
of molecular markers to improve milk production could considerably contribute to speed up 
genetic progress in this autochthonous breed. Thus, it could have a major impact on the 
preservation of the breed as it should help in implementing more efficient breeding programs 
leading to increased productivity while maintaining flock size. Breeders would be stimulated to 
maintain autochthonous breeds instead of introducing foreign breeds characterised by higher 
milk productions but non-adapted to traditional Portuguese grazing conditions. The 
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preservation of native breed would thus be promoted and the biodiversity assured while 
providing financial conditions for maintaining farmers in the rural areas. 
 
I.2 Objectives 
Throughout the literature review of this work, the principal regulatory mechanisms of 
GH gene expression and their effects on milk production in lactating ruminants will be looked 
into. Special emphasis will be given to the important roles that GH, or other genes under its 
control, plays in the animal body growth until puberty, in mammary gland development during 
puberty, gestation and possibly in the early lactation period, and in the homeorhetic control of 
female metabolism during gestation and lactation. Some considerations will be made about the 
ethical questions linked to the use of exogenous GH or transgenic animals for milk production. 
The main objectives of the present work were to identify and characterise nucleotidic 
polymorphisms naturally occurring at the oGH gene in "Serra da Estrela" sheep, and associate 
them with milk traits in order to evaluate GH as a useful candidate gene for marker assisted 
selection. To attain those objectives, both copies of the oGH gene were genotyped, putative 
transcription factors binding sites at each copy’s promoter were screened and GH genotypes 
and phenotypes were established. Once the putative GH variants were identified, their 
associations with milk yield and composition were also evaluated. 
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 “Science is the knowledge of consequences and 
dependence of one fact upon another.” 
 
Thomas Hobbes (1588–1679) 
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II.1 Serra da Estrela ovine breed 
The “Serra da Estrela” ovine breed was considered one of the best Portuguese dairy 
breeds in the 40s and one of the best in the world (Alberty cit. by Borrego, 1982). The official 
milk records were initiated in the years 1944/45. The Herd Book of the breed started in 1984 
and is presently at ANCOSE (National Association of the Breeders of the “Serra da Estrela” 
Sheep). The totality of the milk yielded by “Serra da Estrela” ewes is transformed into “Serra 
da Estrela” cheese which has a Protected Denomination of Origin (PDO). This cheese is 
manufactured exclusively with milk from this ovine breed and is the main agricultural product 
of this region, and has a high socio-economical importance for rural populations. 
Despite all the efforts towards genetic improvement of the “Serra da Estrela” breed, the 
milk yield levels have not increased (Table II-1) as in foreign breeds and the breed is 
nowadays considered a low milk yield breed in the Mediterranean context (Boyazoglu, 1991a 
cit by Georgoudis, 1998). Presently, the milk yield potential of the “Serra da Estrela” breed 
(148 l/150 d; Carolino et al., 2003b) is much lower than that of Awassi (506 l/214 d; Pollott 
and Gootwine, 2001, 2004), Assaf (334 l/173 d; Pollot and Gootwine, 2004) or Lacaune 
(270 l/165 d, Barillet et al., 2001; 230 l/145d at the 1st lactation, Rupp et al., 2003) breeds. 
 
Table II-1. Evolution of “Serra da Estrela” total milk yields (TMY; l) and milk yields in 150 
days (MY; l/150 d) between 1944 and 2004. 
Years  n Lactation lenght TMY MY 
No. 
breeders Reference 
White 1989 100 nd 1944/1946 
Black 466 
220 
135 nd 
nd Alberty, 1948 cit. by Borrego, 1982 
1966/1985  6537 220 145.8 112.7 41 Delgado and Martin, 1992 
Single na 136.9 108.6 
Twin na 143.1 114.4 
1986/1990 
Triple na 
220 
144.6 118.9 
71 Gulbenkian, 1993 
Single 51091 140.7 121.5 1993/1997 
Twin 32470 
220 
149.3 128.6 
557 Carolino et al., 1997/1998 
Single 744 180.0 126.9 108.1 
Twin 450 196.0 149.3 124.2 
1997/2004 
Triple 14 229.0 198.5 153.9 
28* ANCOSE, not published 
n – number of lactations; na – non-available; nd – non-determined. 
* 398 Artificial insemination born ewes (paternal grandmother with milk yield higher than 240 l/150 d in at least two lactations; 
Esteves, 1997/1998) 
 
The factors pointed by Borrego (1982), i.e., the production system and the socio-
economic-cultural structure of the shepherds, were responsible for the subsistence of traditional 
flock management practices, which in the end impaired the genetic improvement results of the 
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breed. Indeed, “Serra da Estrela” ovine breeders have seen no substantial improvement on 
flocks´ milk yields via the classical genetic selection programme. Simultaneously, ewes’ milk 
prices have decreased in the Portuguese market (from € 1.00/l in 1995 to € 0.87/l in 2004; INE, 
2006). The joint effect of these two factors could be the loss of economic sustainability of the 
traditional ovine production system based on “Serra da Estrela” ewes and the abandonment of 
this autochthonous breed in favour of higher yielding foreign breeds such as Lacaune, Assaf 
and Manchega. The number of “Serra da Estrela” ewes increased from 1999 to 2000 and has 
remained constant afterwards (Figure II-1). A possible way for the valorisation and genetic 
improvement of the breed is the inclusion of genetic markers in a breeding programme. 
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Figure II-1. Evolution of the 
number of “Serra da Estrela” 
ewes inscribed in the breed Herd 
Book (FAO, 2004). 
 
 
The introduction of genetic markers in animal breeding programmes will allow a more 
rigorous selection, giving an increase of information about the genetic value of an animal. 
Animal identification early in life (in the embryo phase or immediately after parturition) will 
allow reducing the time interval between generations and will be useful for the selection of 
young females before the onset of their productive life, leading to the development of more 
efficient breeding programs. Several candidate genes can be proposed to be introduced into 
marker assisted selection (MAS), depending on the breeding programme objective. In “Serra da 
Estrela”, the objectives are to improve milk yield and to minimize any negative effect on milk 
quality.  
In ewes, results from Kann et al. (1999) suggest that mammogenesis and/or 
lactogenesis are partially controlled by somatotrophic hormones such as ovine growth hormone 
(oGH) and ovine placental lactogen (PL), and that insulin-like growth factor I (IGF-I) could be 
one of the mediators of these hormones. Therefore, the detection of genetic markers at the oGH 
gene associated with milk production and quality might contribute to the establishment of early 
selection criteria.
  	
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II.2 The growth hormone gene 
The GH is a member of a multigene family which includes chorionic 
somatomammotropin, prolactin (PRL) and PL genes as well as several other genes, all of which 
evolved through series of gene duplications. Extensive reviews concerning the evolution, 
structure, function and molecular biology of the growth hormone gene family have been 
published (Bluet-Pajot et al, 1998; Cooke and Liebhaber, 1995; Chappel and Murphy, 2000; 
Forsyth and Wallis, 2002; Miller and Eberhardt, 1983). Thus, the present review will briefly 
focus on domestic animals’ GH, with special emphasis on ovine (whenever information exists), 
its structure, regulation, metabolic effects and impact on animals’ productive traits. 
GH genes have been isolated and characterized in detail in different domestic animals 
species such as ovine (Byrne et al., 1987; Guron et al., 1992; Orian et al., 1988), caprine 
(Kioka et al., 1989; Yamano et al., 1988; Yato et al., 1988), bovine (Miller et al., 1980; 
Woychik et al., 1982), bubaline (Maithal et al., 2001; Verma et al., 1999), porcine (Chen et al., 
1970; Vize and Wells, 1987), equine (Conde et al., 1973), dromedary (Martinat et al., 1990) 
and chicken (Zhvirblis et al., 1987). 
CDS1 CDS3
intron1 intron2 intron3 intron4
polyA signal1
polyA site1TATA signal1
exon1 exon2 exon3 exon4 exon5
 
Figure II-2. Schematic representation of oGH gene structure (2162 bp; Orian et al., 1988). 
 
The oGH gene has been mapped to 11q25 (Hediger et al., 1990) being entirely located 
within a 3.9 kb BamHI/HindIII fragment (Byrne et al., 1987). The oGH coding sequence 
contains five exons with 71, 161, 117, 162 and 198 bp in length (according to Orian et al., 
1988; see Figure II-2) interrupted by four introns (with sizes between 227 and 275 bp). Several 
highly conserved regions were described at the 5’ end of the gene: a TATAAA sequence 
(TATA signal 1) is located at position -30 from the transcription starting point, and a 
CATAAAT sequence at position -84. The AATAAA polyadenylation signal (polyA signal 1 at 
position 2032) and polyA site1 (at position 2055) are present at the 3’-untranslated region 
(3’-UTR) of the gene. 
Signal peptide         Mature peptide 
  
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The oGH predicted amino acid sequence, established by Orian et al. (1988) from an 
ovine pituitary genomic library, consists of a signal peptide composed of 26 amino acids in 
length and a mature peptide of 191 amino acids (Swiss-Prot accession no. P01247). The GH 
amino acid sequence is 99 % identical between ovine, caprine, bovine and bubaline, but differs 
markedly from non ruminant sequences [about 88% identical to pig GH (pGH) and 65% to 
human GH (hGH)]. 
In ovine, the GH family genes are expressed in the anterior pituitary somatotrophs 
(Sartin et al., 1996) and in the trophectoderm and syncytial placenta cells in a temporal-specific 
way (Lacroix et al., 1996; 1999). 
II.2.1 oGH gene duplication 
Two alleles of the GH gene have been described in ovine. The Gh1 allele contains a 
single gene copy (GH1), whereas in the Gh2 allele the gene is duplicated (GH2-N and GH2-Z 
copies) with the two copies being located 3.5 kb apart (Valinsky et al., 1990; Figure II-3). 
Individual animals homozygous for Gh1 or Gh2 alleles have two or four GH-like genes, 
respectively, while heterozygous animals with one allele of Gh1 and one of Gh2 (Gh1/Gh2), 
have three GH-like genes (Wallis et al., 1998). Sequence differences between the GH2-N and 
GH2-Z genes have been demonstrated and polymorphisms have been found in oGH coding and 
noncoding regions (Ofir and Gootwine, 1997). 
 
Figure II-3. oGH gene alleles Gh1 and Gh2 in sheep (based on Valinsky et al., 1990). 
Exons are presented as black boxes. GH1, GH2-N and GH2-Z are the three copies of the oGH gene. Dashed 
arrows indicate the duplicated sequence (Adapted from Wallis et al., 1998). 
 
A similar GH gene duplication has also been described in caprine (Yamano et al., 1991) 
but not in bovine, porcine or rats. In humans, the GH cluster comprises five GH-like genes in 
tandem sharing more than 95% sequence identity (Seeburg et al., 1982 cit. by Bennani-Bäiti et 
al., 1998). GH gene is also duplicated in some species of fish (Yang et al., 1997; Clements et 
al., 2004). 
 
  	
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Sequence differences at the expressed protein level have been demonstrated. Lacroix et 
al. (1996) detected two GH-like proteins in the ovine placenta: one identical to the amino acid 
sequence deduced from the nucleotide sequence published by Orian et al. (1988) which is the 
pituitary product of the oGH gene (copy GH1 or GH2-N); the other, is the product of the 
oGH2-Z copy gene, differs from the first in three amino acids: one at the signal peptide (P-7L), 
a second at the border of helix1 (G9R) of the GH molecule and a third one (G63S) at a loop 
structure of the binding site 1 (described in hGH; de Vos et al., 1992; see II.4).
 
II.3 Transcription regulation of the GH gene 
Within the numerous transcription factors acting upon the anterior pituitary gland 
(Savage et al., 2003), several play a determinant role in somatotroph development and in the 
GH gene regulation. Binding sites to several of those transcription factors were disclosed by 
DNase I footprinting experiments, methylation-interference assays and band-shift analysis 
mainly at hGH, rat GH (rGH) and bovine GH (bGH). Putative binding sites could also be found 
at the oGH gene promoter (Figure II-4). 
 
 -200 AGTGGAGAGG GGATGATGAC GAGCCTGGGG GACATGACCC CAGAGAAGGA 
        TRE 
 -150 ACGGGAACAG GATGAGTGAG AGGAGGTTCT AAATTATCCA TTAGCACAGG 
       Sp1           POU1F1(d) 
             NRE(YY1) 
              Zn-15... 
 -100 CTGCCAGTGG TCCTTGCATA AATGTATAGA GCACACAGGT GGGGGGAAAG 
      ...Zn-15     POU1F1(p) 
           CAT box  
  -50 GGAGAGAGAA GAAGCCAGGG TATAAAAAGG GCCCAGCAGA GACCAATTCC 
             TATA box 
    1 AGGATCCCAG GACCCAGTTC ACCAGACGAC TCAGGGTCCT GCTGACAGCT 
        M   M  A  A 
   51 CACCAGCTAT GATGGCTGCA GGTAAGCTCA CGAAAATCCC CTCCATTAGC  
  101 GTGTCCTAAG GGGGTGATGC GGGGGGCCCT GCCGATGGAT GTGTCCACAG  
  151 CTTTGGGTTT TAGGGCTTCT GAATGTGAAC ATAGGTATCT GCACCCGACA 
  201 TTTGGCCAAG TTTGAAATGT TCTCAGTCCC TGGAGGGAAG GGCAGGCGGG  
        GR 
Figure II-4. Regulatory sequences at the promoter of the oGH gene. 
The sequence of the sense strand of the oGH promotor region (from Orian et al., 1988) is shown together with the 
putative locations of the following transcription factors’ binding sites (boxed bold sequences): TRE (T3 response 
element), Sp1 (stimulating protein 1), POU1F1(d) and POU1F1(p) (distal and proximal pituitary-specific 
transcription factor 1), NRE (negative regulatory element), YY1 (yin and yang factor 1), Zn-15 (zinc finger 
protein) and GR (glucocorticoid receptor). CAT and TATA boxes are also shown. The exon 1 sequence is 
underlined, and the first four NH2-terminal amino acids of the signal peptide are shown in blue. 
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Despite GH promoters’ species-specific organization (Chuzhanova et al., 2000) 
throughout vertebrate evolution, some common features subsist. The following sub-sections 
will briefly focus on the general action of individual transcription factors (with special 
emphasis on POU1F1) and on the synergic action between them that lead to the transcriptional 
control of GH gene expression. 
II.3.1 Pituitary-specific transcription factor (POU1F1) 
Two pituitary-specific transcription factor (POU1F1, also called Pit-1, GHF-1, PUF-1 
or GC-1) binding sites are present in the oGH promoter at position -118 (ATTATCCAT in 
agreement with the consensus sequences; Ingraham et al., 1988; Rhodes and Rosenfeld, 1996) 
and at position -87 [TTGCATAA; differs at 1 nt from hGH (Lemaigre et al., 1990) and at 2 nt 
from rGH (Kim et al., 1996)]. In addition to GH promoter POU1F1 binding sites, the presence 
of at least two POU1F1 binding sites within the chromatin Dnase I hypersensitive sites (HS I, II 
– F14 segment) of the locus control region (LCR; Jones et al., 1995) located -14.5 kb upstream 
of the hGH-N gene seem to be fundamental for the appropriate pituitary hGH-N gene 
expression in transgenic mouse (Shewchuk et al., 1999). Whether this LCR is also important 
for GH expression in transgenic sheep with additional GH copies was not discussed (Adams et 
al., 2002, 2005). 
POU1F1 is a pituitary-specific POU-homeodomain protein (Ingraham et al., 1988) 
essential for thyrotrophs, somatotrophs and lactotrophs differentiation and survival (Li et al., 
1990). It regulates the GH gene expression activation at the somatotrophs and its repression at 
the lactotrophs (Scully et al., 2000). 
In the early embryonic life following the formation of Rathke’s pouch, the primordium 
of the pituitary gland, POU1F1 expression is activated by the Prophet of POU1F1 (PROP1) 
binding to POU1F1 early enhancer (Sornson et al., 1996), possibly not alone but with the 
synergic action of vitamin D receptor and retinoic acid receptor (RAR) binding (Cohen et al., 
1999; DiMattia et al., 1997). As soon as levels of PROP1 decay, POU1F1 expression changes 
to an auto-regulatory pathway (Rhodes et al., 1993 cit by Sornson et al., 1996). 
POU1F1 expression is dependent on its auto-regulation as POU1F1 promoter contains 
several binding sites to POU1F1 at its proximal and distal regions (Rhodes et al., 1993 cit by 
DiMattia et al., 1997) and is age (DiMattia et al., 1997) and gender (Gonzalez-Parra et al., 
1996) dependent. Distinct signal-transduction pathways could thus regulate POU1F1 activity. 
These pathways are mediated by intracellular levels of cyclic adenosine 3’,5’-monophosphate 
  	
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(cAMP) or by mitogen-activated protein kinases (MAPK) and/or protein kinase A (PKA) 
activities in response to the epidermal growth factor (EGF) or insulin and involve a co-
repressor complex containing the nuclear receptor co-repressor N-CoR/SMRT, mSin3A/B and 
histone deacetylases, and a co-activator complex containing cAMP-response element binding 
protein (CREB) and p/CAF (Xu et al., 1998). 
POU1F1 activity depends also on other peptides, e.g. activin inhibits POU1F1 binding 
to GH promoter and consequently GH expression (Struthers et al., 1992). This effect is 
mediated by an increase in POU1F1 phosphorylation which also decreases POU1F1 stability 
(Gaddy-Kurten and Vale, 1995). 
Mutations at the POU1F1 gene interrupt the normal development of the anterior 
pituitary gland (dwarf genotype; Li et al., 1990; Pfäffle et al., 1992; 1993; Aarskog et al., 1997) 
and may lead to combined pituitary hormone deficiency (Cohen et al., 1995; Vallette-Kasic et 
al., 2001). POU1F1 genotypes affect milk yield in humans (Pfäffle et al., 1996), milk yield and 
conformational traits in bovine (Renaville et al., 1997), and plasma GH and PRL levels (Sun et 
al., 2002) and growth and carcass traits in porcine (Stancekova et al., 1999; Yu et al., 1995). 
However, in other studies no associations were found between productive traits and POU1F1 
genotypes, e.g., with meat production traits in Piemontese bovine breed (Di Stasio et al., 2002). 
II.3.2 Thyroid hormone and retinoic acid receptors response elements 
One 3,5,3’-triiodothyronine receptor (T3R) response element (TRE)/ retinoic acid 
receptor (RAR) element is present in the oGH promoter at position -172 (GGGACATGACCC 
identical to bGH; Brent et al., 1988 cit. by Williams et al., 1992). The presence of such an 
element near the POU1F1 binding site is concomitant with the finding in rat, that GH 
transcription is enhanced by straight cooperation between T3R and RAR and POU1F1 via 
direct protein-protein interaction (Palomino et al., 1998). 
II.3.3 Glucocorticoid receptor (GR) 
A glucocorticoid receptor (GR) site is present in the oGH promoter at position +218 
(TGTTCT) within the intron 1 as in the hGH (Moore et al., 1985) and in the goat GH (gGH; 
Kioka et al., 1989) promoters. Several works conducted in rat (reviewed by Theill and Karin, 
1993) and in humans (Isaacs et al., 1987 cit. by Theill and Karin, 1993) reported that the GH 
gene expression was stimulated by glucocorticoids (GCs) and that GCs promote hGH mRNA 
stability (Paek and Axel, 1987 cit. by Theill and Karin, 1993). However, familial GC 
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deficiency has been associated with tall stature in human (Elias et al., 2000 cit. by van der 
Eerden et al., 2003), which is in accordance with findings that GC inhibits GH release in 
pituitary (Allen, 1996 and Luo and Murphy, 1989 cited by van der Eerden et al., 2003). Thus, 
considering the conflicting results obtained in the referred two species and that regulation of 
GH transcription by GR was not investigated in ovine, the real impact of GCs on oGH gene 
remains to be clarified. 
II.3.4 Ubiquitous transcription factors 
II.3.4.1 Stimulating protein 1 (Sp1) 
One stimulating protein 1 (Sp1) binding site is present in the oGH promoter at position 
-134 [TGAGAGG; different in 1 nt from rGH (Kim et al., 1996)]. This site is near to the 
POU1F1 distal binding site and some authors suggested that Sp1 and POU1F1 binding could 
be mutually exclusive (Lemaigre et al., 1990). Nevertheless, Sp1 is thought to positively 
influence GH expression. 
II.3.4.2 Zinc finger protein (Zn15/Zn16) 
A zinc finger protein (Zn15/Zn16) binding site is present in the oGH promoter at 
position -108 (AGCACAGGCTGCCAGTGG; Lipkin et al., 1993 cit by Das et al., 1996). 
Zn15/Zn16 is a member of the Cys/His zinc finger transcription factor superfamily which can 
act synergistically with POU1F1 to enhance GH expression (VanderHeyden et al., 2000). 
II.3.5 Silencer element 
A negative regulatory element (NRE; sequence TCCATTAGC at position -114) with 
sequence similar to the yin and yang factor 1 (YY1) binding site, described in bovine (Park and 
Roe, 1996a, 1996b) and red deer (Lioupis et al., 1997), is present in the oGH promoter. Park 
and Roe’s results (1996b) suggest that bGH expression is negatively regulated by YY1 or by a 
very similar YY1 homolog via NRE binding. 
The joint action of the tissue-specific POU1F1 trans-acting factor and the ubiquitous 
factors referred before (and possibly others) should contribute to the tissue specific 
transcription of oGH gene, as it has been observed in other species. 
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II.4 Neuroendocrine regulation of GH secretion 
Regulatory pathways of GH expression are not straightforward. They involve chain 
reactions whereby a peptide could simultaneously regulate expression of several genes. 
Transcription regulation of GH gene was addressed in the previous section, but many of those 
transcription factors are actively involved in the regulation of other peptides which in turn 
regulate GH expression. An example is POU1F1: it regulates GH-releasing hormone receptor 
(GHRHR) gene expression, and thus indirectly GH secretion by GH-releasing hormone 
(GHRH) signalling (Godfrey et al., 1993 cit by DiMattia et al., 1997). 
Pituitary somatotroph cells possess receptors to GHRH, somatostatin (somatotropin 
release-inhibiting factor, SRIF), pituitary adenylate cyclase-activating polypeptide (PACAP) 
and GH secretagogue (ghrelin) peptides that control the GH expression at those cells. 
Hypothalamic neurons secreting GHRH are located in the arcuate nucleus and those 
secreting SRIF are in the periventricular nucleus and arcuate nucleus (Leshin et al., 1994 cit by 
McMahon et al., 2000). GHRH and SRIF could mutually inhibit each other’s synthesis in the 
arcuate nucleus neurons, but GHRH and SRIF syntheses and consequently GH regulation could 
be modulated also by neuropeptides such as leptin, insulin and IGF-1, dopamine, 
norepinephrine, serotonin, thyrotropin-releasing hormone, acetylcholine, neuropeptide Y 
(NPY) and galanin (see McMahon et al., 2001). Their influence upon GH synthesis and 
secretion of some of those peptides will be briefly discussed. 
II.4.1 Growth hormone-releasing hormone (GHRH) 
GHRH is structurally related to the glucagon superfamily, which include also PACAP, 
glucagons and glucose-dependent insulin-inducing peptide (GIP) (Cummings et al., 2002; for 
review see Mayo et al., 2003). 
GHRH stimulates equally the synthesis and the GH pulse secretion in sheep. Indeed, it 
was observed a significant association between GHRH and GH peaks, but not between SRIF 
and GH peaks in unanesthetized ovariectomized ewes (Frohman et al., 1990). Moreover, other 
studies reported an increase in plasma GH levels when lambs were injected with a GHRH 
analogue with increased feed conversion and leaner carcasses (Godfredson et al., 1990), and 
recently the injection of a myogenic expression GHRH plasmid DNA into Inner Mongolia fuzz 
lambs resulted in higher GH levels and in organomegaly (Meng et al., 2004). 
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The GHRH-stimulated GH release in the somatotrophs is presumably cAMP- and 
Ca2+-dependent in sheep (Sartin et al., 1996). In vitro results suggest that Ca2+ pathway 
presumably acts via calmodulin activation and concomitant/subsequent activation of PKA 
which promotes GH release induced by cAMP (Sartin et al., 1996; for a review see Bluet-Pajot 
et al., 1998). 
II.4.2 Somatostatin (SRIF) 
SRIF is a hypothalamic cyclic polypeptide with two bioactive isoforms (SRIF-14 and 
SRIF-28; Møller et al., 2003) that negatively regulate GH release (Davis, 1975; Kazmer et al., 
2000) by SRIF receptors (sst-1 and sst-2) activation. Besides GH, an extensive list of hormones 
is inhibited by SRIF; among them are PRL, insulin, thyroid-stimulating hormone and almost all 
hormones from the gastrointestinal tract, inhibiting also the nutrient absorption at intestinal 
level (reviewed by Møller et al., 2003). 
SRIF binds to its receptor activating the cAMP and phosphoinositide signal 
transduction pathways (Møller et al., 2003). Specifically and in opposition to what happens 
when GHRH binds to its receptor, when SRIF binds to guanyl nucleotide-binding proteins 
(GI-proteins) linked cell surface receptor, the activity of the adenylate cyclase is reduced 
resulting in lower levels of cAMP and in PKA inhibition. PKA inhibition reduces CREB 
phosphorylation, a key step in POU1F1 transcription regulation. SRIH and GHRH signal 
transduction pathways converge at Ca2+ ion channels with presumably metabolic antagonist 
effect. 
Under insulin hypoglycaemia conditions, SRIF secretion increases and in response, GH 
levels decrease in ewes (Frohaman et al., 1990). However, when lactating ewes were 
immunized against SRIF (Sun et al., 1990), no GH level change was observed yet milk yield 
increased. It was suggested that more nutrients reach the mammary gland in response to the 
blocking of the inhibitory action of SRIF upon the gastrointestinal tract and consequent 
increase in nutrient absorption. In growing cattle also immunized against SRIF, Ingvartsen and 
Sejrsen (1995 cit. by Ingvartsen and Andersen, 2000) observed a somehow similar effect as the 
animals grew faster and, despite a higher feed intake, the feed conversion ratio improved. 
II.4.3 Pituitary adenylate cyclase-activating polypeptide (PACAP) 
PACAP is a neuropeptide expressed in the central nervous system acting 
simultaneously as a neurohormone and a neurotransmitter (Montero et al., 2000). It is also 
  	
 
 17 
expressed within the gonads (reviewed by Moretti et al., 2002) and the adrenal gland (Ghatei et 
al., 1993 cit by Cummings et al., 2002). In ovine, PACAP was found to stimulate the 
accumulation of cAMP in the pituitary cells (Miyata et al., 1989 and 1990 cit. by Cummings et 
al., 2002) similarly to what occurs after GHRH stimulation. Moreover, in meal-fed Holstein 
steers injected with PACAP before feeding, the GH peak levels increased in serum. It was thus 
postulated that PACAP induces GH secretion maybe in association with GHRH (Radcliff et al., 
2001). 
II.4.4 Ghrelin 
Ghrelin (also known as GH secretagogue) is a growth hormone-releasing acylated 
peptide synthesised in the oxyntic glands of the stomach and intestine (Date et al., 2000). It 
stimulates GH secretion in small ruminants (Hayashida et al., 2001; Sugino et al., 2004) by 
activating ghrelin receptor (reviewed by Davenport et al., 2005) in the pituitary. It is thought 
that ghrelin may have a role in feeding regulation in domestic animals and thus in energy 
homeostasis, as it was suggested by the results of studies in ghrelin knockout mice (Wortley et 
al., 2005) and in fat and lean lines of sheep (French et al., 2006). 
Ghrelin and GHRH act synergistically to promote GH release. Moreover, GHRH and 
GH-releasing peptide 2 (GHRP-2; a synthetic secretagogue) were shown to regulate their 
receptor synthesis in a time-dependent way in ovine pituitary cell cultures, playing also an 
important role in GH, GHRHR, POU1F1, sst-1 and sst-2 expression and GH synthesis (Yan et 
al., 2004). Ghrelin regulation of GH secretion could also be mediated by the activation of the 
NPY-Y1 receptor pathway (Shintani et al., 2001). 
The first studies with synthetic secretagogues (GHRP-6 and more recently GHRP-2) 
showed that secretagogues enhance GH secretion by a different via than that used by GHRH. 
GH-release via ghrelin involves inhibition of K+ channels and somatotroph depolarization with 
consequent Ca2+ channel rearrangement. However, GHRH and ghrelin pathways communicate 
trough signalling pathways involving intricate ionic exchanges (Chen et al., 1996 cit. by 
Casanueva et al., 1999). 
II.4.5 Leptin 
Leptin (or OB protein) is the product of the ob gene expression in the adipose tissue 
(Zhang et al., 1994 cit. by Schwartz et al., 1996) and placenta (Anthony et al., 2001). The 
leptin levels are positively correlated with body fat mass (Delavaud et al., 2002), energy intake 
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level (Marie et al., 2001; Reist et al., 2003), β-adrenergic stimulation (Chilliard et al., 2000) 
and negatively correlated with photoperiod in sheep (Marie et al., 2001; Clarke et al., 2003). 
Leptin receptors are expressed in ewe hypothalamus, anterior pituitary and adipose tissues 
(Dyer et al., 1997c), and mammary gland (Laud et al., 1999), and in bovine adrenal medullary 
cells (Yanagihara et al., 2000). Main effects of leptin were reviewed by Chilliard et al. (2001), 
Ingvartsen and Boisclair (2001) and Faggioni et al. (2001). 
A high level of leptin, which could be observed after a meal or in obese animals, was 
shown to physiologically regulate food intake by decreasing appetite (Barb et al., 1998). At the 
same time, high levels of leptin increase energy demands and, to meet those demands, there is 
an increased fatty acid oxidation, i.e., lipolysis at the adipose tissue, or alternatively a decrease 
in insulin-stimulated lipogenesis (Ramsay, 2001). However, in other studies this effect was not 
observed (Newby et al., 2001). Those metabolic events are mediated by modification at 
hormonal levels, namely GH, catecholamines and T3 augment, and insulin and GCs decline 
(see review by Chilliard et al., 2001). 
Leptin acts upon the expression of hypothalamic neuropeptides involved in energy 
homeostasis. It was observed that after leptin injection NPY expression decreased in the 
arcuate nucleus and corticotrophin releasing hormone increased in the paraventricular nucleus 
in normal Long-Evans rats (Schwartz et al., 1996). This could cause GH levels to decrease 
which mimic the observed decrease of the GH levels after meals in sheep (Matsunaga et al., 
1999) or, following another via, could decrease GHRH-stimulated GH expression and at the 
same time increase basal GH as it was observed in vitro in ovine pituitary cells (Roh et al., 
1998) and plasmatic GH in vivo without altered GH pulse frequency (Nagatani et al., 2000). 
Leptin regulates short- and long-term homeostasis, thus some of the opposite effects 
observed concerning GH expression regulation could reflect complex feedback mechanisms 
that support the return to a steady levels of body fat after episodes of mobilization/deposition of 
fat tissue. 
II.4.6 Other GH-Regulating Neuropeptides 
II.4.6.1 Catecholamines 
Two catecholamines are particularly important in GH regulation in domestic animals: 
dopamine and norepinephrine. 
Dopamine has been found to inhibit GH secretion via D1- and D2-like dopamine 
receptors. Stimulation of dopamine D1-receptors and subsequent enhanced activity of 
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periventricular SRIF neurons increases SRIF secretion into hypophysial-portal vessels and 
GHRH-induced release of GH into blood decreases in steers (McMahon et al., 1998; West et 
al., 1997). In addition, dopamine or D2-receptors activation inhibit GHRH-induced GH 
secretion and decrease cAMP levels in sheep pituitary cells culture (Law et al., 1984). 
Norepinephrine effects are mediated by its 1-, 2- and β-adrenergic receptors. It was 
observed that GH secretion is inhibited by 1- and stimulated by 2-adrenergic receptors 
activation in rat (Willoughby et al., 1993). 2-adrenergic receptor activation also stimulated GH 
secretion in ovine (Soyoola et al., 1994 cit. by McMahon et al., 2001) and bovine (Gaynor et 
al., 1993). Furthermore, pulse GH secretion before feeding and basal GH levels post-feeding 
are apparently mediated by 2-adrenergic receptor stimulation in Holstein steers (Gaynor et al., 
1993). β-adrenergic receptors activation was found to inhibit GH secretion hypothetically by 
SRIF-enhanced secretion in ewes (Thomas et al., 1994). 
II.4.6.2 Neuropeptide Y (NPY) 
NPY is an orexigenic peptide from the pancreatic peptide family. In ovine, the 
expression of the NPY-Y1 receptor was seen within the arcuate nucleus and paraventricular 
nucleus of the hypothalamus, the dentate gyrus of the hippocampus and in pancreatic, anterior 
pituitary, and adipose tissues, and the expression of the NPY-Y2 receptor within hippocampus 
and within pancreatic tissue (Dyer et al., 1997a). 
Administration of NPY was shown to strongly increase GH secretion in sheep 
(Morrison et al., 2003) and cattle (Garcia et al., 2004; Thomas et al., 1999). However, the 
effect of NPY on GH secretion was attenuated if cows were primarily injected with leptin 
(Garcia et al., 2004). Furthermore, in a comparative study, underfed ewes presented higher 
number of immunoreactive cells for NPY at the arcuate nucleus and median eminence, higher 
density of NPY terminal fields at arcuate nucleus and pre-optic area, paraventricular nucleus, 
and higher plasma levels of GH than well-fed ewes (Barker-Gibb and Clarke, 1996). Taken 
together, those observations suggest that NPY is a mediator signal reporting overall body 
energy status to the brain, probably within an insulin-leptin-NPY pathway as hypothesised by 
Dyer et al. (1997b), where ghrelin could also be involved (Shintani et al., 2001). 
II.4.6.3 Galanin 
Galanin neurons were found in several regions of the hypothalamus. Galanin has two 
subtypes of receptors: GalR1 and GalR2 (Wang et al., 1998 cit. by McMahon et al., 2001). In 
pituitary slices of young male calves, galanin was shown to have a significant stimulatory effect 
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upon GH secretion (Baratta et al., 1997). This effect was also found in sheep (Saleri et al., 
1999), humans and rat (see Giustina and Veldhuis, 1998). 
Immunization against GHRH inhibits the GH response to galanin, suggesting a galanin-
GHRH interaction (Murakami et al., 1989 cit by Giustina and Veldhuis, 1998). 
II.4.6.4 Neurotransmiters amino acids  
Amino acids influence polarization status of central nervous system cells by exciting 
(depolarizing) or inhibiting (hyperpolarizing) the cells. Cells could be excited by aspartic acid, 
cysteic acid, glutamic acid, and homocysteic acid, and inhibited by -aminobutyric acid 
(GABA), glycine, taurine, and β-alanine, with consequences on GH secretion regulation 
(Cooper et al., 1996 cit by McMahon et al., 2001; Müller et al., 1999). 
For instance, intravenous administration of GABA resulted in a rapid and significant 
increase in plasma GH, however intracerebroventricular administration of GABA changed 
plasma GH levels in a dose dependent manner: 10 mg of GABA increased and 100 mg 
decreased plasma GH levels. Results also point out to the possible existence of a mechanism 
independent from GHRH/SRIF, which could mediate GABA regulating effect upon GH 
secretion in sheep (Spencer et al., 1994).
 
II.5 GH signal transduction regulation 
The three dimensional structures of pig (Abdel-Meguid et al., 1987), bovine (Carlacci 
et al., 1991) and human (Cunnigham et al., 1991; de Vos et al., 1992) GH proteins have  
 
Figure II-5. Rainbow-colored 
ribbon diagram of the hGH 
from the 3HHR crystallogra-
phic structure.  
Adapted from Keeler et al. (2003). 
C – COOH-terminus;  
N – NH2-terminus. 
been described. The oGH, as other members of the family 
of hematopoietic cytokines, is expected to comprise an 
anti-parallel twisted four--helix bundle with “up-up-
down-down” topology, with two long loops, linking 
helices 1 and 2, and 3 and 4 respectively, and a short 
segment connecting helices 2 and 3 (Abdel-Meguid et al., 
1987; Wells and de Vos, 1993). Structure-function results 
obtained for pGH and hGH have no direct application to 
oGH, nevertheless some assumptions can be made. In 
analogy with pGH, the four helices of the oGH are 
localised between residues 7-34, 75-96 (kinked at P89), 
107-128 and 153-183, respectively (Figure II-5). In the 
hGH three short helical segments were also described: two  
N 
C 
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of them between residues K38-N47 and R64-K70, within the first long crossover connection, were 
involved in hormone-receptor contacts; and the third one between residues R94-S100 located 
between helices 2 and 3 (de Vos et al., 1992). 
The pGH presents two disulfide bridges connecting C53 in the first crossover connection 
to C164 in helix 4, and C181 in helix 4 to C189 near the COOH-terminus (Abdel-Meguid et al., 
1987). These connections were also described in hGH (de Vos et al., 1992) along with several 
hydrogen-bonds which contribute to the four helix-bundle at GH hydrophobic core. 
II.5.1 GH binding to cellular GH receptors 
The biological effects of the GH are mediated by numerous second messenger 
pathways, activated in response to GH binding to specific cell surface GH receptors (GHR; 
Allan et al., 1999). In sheep the GHR was characterized by Adam et al. (1990). 
The signal transduction of hGH is only achieved by the formation of the ternary 
complex between hGH and its receptor’s extracellular domain (hGHBP) (X-ray crystal 
structure described by de Vos et al., 1992; Figure II-6) where a single hGH molecule binds 
sequentially to two hGHBP molecules (Cunningham et al., 1991; Wells, 1996), i.e., firstly hGH 
binds site 1 to a hGHBP, and then, binds site 2 to a second hGHBP. GH has also the ability to 
bind functionally to PRL receptors (PRLR; Barash et al., 1988; Cunningham and Wells, 1991; 
Kossiakoff et al., 1994; Somers et al., 1994), thus presenting lactogenic activity in addition to 
the somatogenic activity. 
 
 
 
Figure II-6. The structure of 
the 1:2 complex of the hGH 
with the hGHR extracelular 
domain (hGH/hGHBP2 
complex).  
Adapted from www.expassy.org. 
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The hGH amino acid residues involved in hGH/hGHBP binding sites 1 and 2 have been 
elucidated by Cunningham et al. (1991) and de Vos et al. (1992): site 1 - residues of the helix 
1, of the short helical segment connecting helices 1 and 2 and more than half of the residues of 
the helix 4; site 2 - 13 residues across NH2-terminus, the first residues of helix 1 and some 
residues of helix 3. In a subsequent review of the structure and function of the hGH (Wells and 
de Vos, 1993), the authors reported that only part of the hGH residues involved in 
hGH/hGHBP contact interface are actually functional epitopes, i.e., residues whose substitution 
generate a twofold reduction in binding activity. It has also been emphasised the hypothesis that 
many of the hydrophilic contacts are functionally silent or deleterious. Recently, Kouadio et al. 
(2005) showed by shotgun alanine scanning that minimal binding sites are necessary for 
functional hGH binding to its receptor. The authors also demonstrated that the stability of the 
ternary hGH/hGHBP2 complex depends on the hormone – receptor affinity for binding site 2. 
The extracellular domain of the hGHR covers two partial domains (Figure II-6): the 
NH2-terminal domain I and the COOH-terminal domain II β-sheets. From the crystallographic 
structure of the hGH/hGHBP2 complex, it is clear that the site 1 at hGH is larger than site 2, 
and that hGHBPs’ binding residues are mostly the same, i.e. S145, H150, D152, Y200 and S201, 
showing also, similar structures (de Vos et al., 1992). 
GH mutations might prevent receptor dimerization [e.g. hGH(G120R); Ultsch and de 
Vos, 1993; Clackson et al., 1998] and cause diseases and/or growth disorders such as short 
stature in humans by bio-inactivation of GH (Takahashi et al., 1997). However, mutations have 
been described that do no block GH/GHR binding activity, e.g. the ovine GH molecule with 
deletion of residues 33 through 46 continues to show significant GHR-binding activity (Sami et 
al., 1999). Another GH mutant molecule such as the hGH44-191 has been reported to retain high 
affinity to lactogenic receptors (PRLR) but not to the somatogenic ones (GHR) (Haro et al., 
1996). 
II.5.2 GH-dependent activation of JAK2 
When GH binds to cell surface, it induces GHR homodimerization and consequent 
conformational changes that trigger GHR association with the intracellular Janus tyrosine 
kinase 2 (JAK2; Argetsinger et al., 1993), which phosphorilates both GHR and JAK2 itself, 
creating high-affinity binding sites for several signalling molecules with Src homology 2 (SH2) 
and phosphotyrosine binding sites (Carter-Su et al., 2000). The tyrosine residues of the GHR 
necessary for association and activation of the JAK2 were identified in Chinese hamster ovary 
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cells expressing wild-type or truncated GHR (VanderKuur et al., 1994) and also in humans 
(Hansen et al., 1996) and pigs (Wang et al., 1996) by GHR mutational studies (Figure II-7). 
Activation of JAK2 is the initial event for GHR signal, mediating several biological responses 
in the cells, e.g.: stimulation of tyrosyl phosphorylation of p97, activation of MAPK, protein 
kinase C (PKC) and signal transducer and activator of transcription (STAT) pathways and 
Spi2.1 and c-fos expression, increase of protein synthesis and insulin secretion, and thus 
influencing metabolism and cellular proliferation and differentiation (reviewed by Carter-Su et 
al., 2000). 
 
Figure II-7. Binding sites at the GHR responsive for GH binding and GH-GHR signal 
transduction and their putative biological functions. 
C – extracellular cysteines linked by disulfide bonds; N – potential N-linked glycosylation sites; Y – tyrosines of 
rat GHR cytoplasmic region; Box 1 and Box 2 – intracellular proline rich domains; IRS – insulin receptor 
substrate; MAP kinase – mitogen-activated protein kinase; SHC – Src homologous containing proteins; Spi2.1 –
serine protease inhibitor 2.1; STAT – signal transducer and activator of transcription. Adapted from Argetsinger 
and Carter-Su (1996) and Carter-Su et al. (1996). 
 
II.5.3 Activation of MAPK signalling pathway 
JAK2 activation could be the trigger event for the activation of other tyrosine kinases or 
for the inhibition of tyrosine phosphorylases. One of the pathways affected by such stimuli 
involves MAPK and extracellular-signal-regulated kinases 1 and 2 (ERK1/2) proteins which 
are phosphorylated in reply to GH stimuli, mediating pathways controlling cellular growth, 
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differentiation (Cobb and Goldsmith, 1995 cit. by Argetsinger and Carter-Su, 1996) and Ca2+ 
equilibrium (Olszewska-Pazdrak et al., 2004 cit. by Werry et al., 2005). 
The Ras-MAPK-dependent membrane receptor tyrosine kinase activation is another via 
of GHR signalling mediated by Src homologous containing (Shc), Grb2, son-of-sevenless 
(Sos), ras, raf, and also by MAP/ERK kinase (MEK) (Smit et al., 1999 cit. by Carter-Su et al., 
2000). Additionally, MAPK is a mediator between seven-transmembrane spanning (G-protein-
coupled) receptors and their target effectors ERK1/2, in processes involving feedback 
regulation of the phospholipase A2, phosphodiesterases and cytoskeletal proteins and also 
downregulating MAPK phosphatase 1 (MKP1) (Werry et al., 2005). 
II.5.4 GH signalling through PKC 
The ability of GH to regulate several metabolic pathways is reduced by the inhibition of 
PKC (Argetsinger and Carter-Su, 1996). There are two second messengers that mediate PKC 
activation and translocation to the cytosol: Ca2+ and 1,2-diacylglycerol (DAG). Distinct 
pathways are thought to generate those messengers after GH stimulation depending on cell 
type: the inositol 1,4,5-triphosphate pathway generates Ca2+ and DAG; alternatively, in another 
pathway phospholipase C or D are necessary to hydrolyse the phosphatidylcholine generating 
only DAG (Argetsinger and Carter-Su, 1996). 
II.5.5 GH-dependent activation of the STAT proteins family 
Various signal transducers and activators of transcription (STATs) were identified until 
now (STAT1, 2, 3, 4, 5a, 5b and 6; Wakao et al., 1992, 1994; Liu et al., 1995; Silva et al., 
1996), all of them containing a SH2 domain. Many of the functional roles of STAT family 
proteins were understood after studies in knockout mice (see Akira et al., 1999). 
STATs play an important role in the early embryogenesis, and in the GH-regulated 
somatic growth pathway, by enhancing insulin (Galsgaard et al., 1996), IGF-I (Wang and 
Jiang, 2005), and acid-labile subunit (ALS) of the IGF-binding protein-3 complex (IGFBP-3) 
expression in the liver (namely through STAT5b; Woelfle and Rotwein, 2004). Furthermore, 
STAT5 (also known as mammary gland factor, MGF) identified in sheep mammary gland 
(Wakao et al., 1994), is involved in the milk secretion by regulating the mammary gland 
development (Liu et al., 1995; Matsumoto et al., 1999; Iavnilovitch et al., 2002), and the 
transcription of milk caseins (Inuzuka et al., 1999; Schmitt-Ney et al., 1991; Wakao et al., 
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1992, 1994; Wartmann et al., 1996) and whey acidic proteins (WAP; Li and Rosen, 1995; Jura 
et al., 2005; Mukhopadhyay et al., 2001). 
STATs, activated after GH-induced tyrosine phosphorylation (Xu et al., 1996), could 
form homodimers or heterodimers that, binding to specific sites at different genes, enhance the 
expression of those genes, e.g.: STAT5 homodimer binds to IGF-I intron 2 at the HS7 site 
(Woelfle and Rotwein, 2004), enhancing IGF-1 expression by interacting with the transcription 
factors present at the two IGF-I promoters (Figure II-8). The GH-STAT-IGF-1 axis is the 
main system of GH-transduction signalling in living organisms, mediating many of the GH 
biological function. 
 
Figure II-8. Diagram of the GH-dependent transcription of the insulin-like growth factor I 
(IGF-I) gene pathway. 
GH-GHR binding induces GHR dimerization and association, and activation of the JAK2 tyrosine kinase in the 
cell cytoplasm, with GHR-JAK2 cross-phosphorylation (1). STAT5b is tyrosine phosphorylated at the GHR (2) 
and form homodimers (3) which migrate to the cell nucleus (4). Within the nucleus, STAT5b binds to IGF-I intron 
2 at the HS7 site, and interacting with the transcription factors present at the two IGF-I promoters (large arrows), it 
induces IGF-I gene transcription (angled arrows). Adapted from Woelfle et al. (2005). 
 
II.5.6 GH signalling inhibition 
GH secretion could be regulated by GH-dependent and/or independent negative 
feedback mechanisms. High concentration of GH can negatively regulate GH signalling by 
saturating GHR, inducing a dose dependent response to GH somehow similar to the response 
obtained when GH-antagonists are used (Frank, 2002; Figure II-9). It is thought that, as GHR 
has high affinity for the GH binding site 1, and because binding to sites 1 and 2 occurs 
sequentially (see section I.4.1), low number of GHR will be available for the formation of the 
GHR Cell  
Membrane  
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GH/GHR2 ternary complex, fundamental for the correct GH-signal transduction (reviewed by 
Frank, 2002). 
GH-dependent negative feedback was not observed at somatotrophs in sheep when 
injected intravenously or intracerebroventricularly with human or bovine GH (Spencer, 1997). 
These findings, in association with previous studies from Spencer et al. (1991 cit. by McMahon 
et al., 2001), seem to suggest that the basal secretion of oGH is not influenced by GH feedback. 
GH signalling inhibition could be enhanced by the following factors: prolonged insulin 
treatment via STAT1 and STAT3 inhibition (Xu et al., 2005); SOCS (Adams et al., 1998; 
Cooney et al., 2002; Greenhalgh and Alexander, 2004; Greenhalgh et al., 2005; Ram and 
Waxman, 1999), signal regulatory protein-1 (SIRP1; Stofega et al., 2000), SHP1 and SHP2 
(Ram and Waxman, 1997; Rui et al., 2000b) via decreasing JAK2 activation; platelet-derived 
growth factor (PDGF) and lysophosphatidic acid (LPA) in a PKC-dependent pathway (Rui et 
al., 2000a); Grb-10 with reduced c-fos and Spi2.1 transactivation (Moutoussamy et al., 1998); 
and via ubiquitin/proteasome pathway required for GHR endocytosis/degradation (Strous and 
van Kerkhof, 2002; van Kerkhof and Strous, 2001). 
Detailed information on the mechanisms involved in GH signalling inhibition has been 
reviewed by Frank (2001) and Flores-Morales et al. (2006). 
 
Figure II-9. GHR-expressing cells’ in response to GH or GH plus GH-antagonist treatment. 
Adapted from Frank and Messina (2002).
 
II.6 GH and milk production 
Milk production potential depends on the mammary cell differentiation in puberty, 
pregnancy and early lactation, on the secretory rate of differentiated mammary cells and on cell 
death (apoptosis) throughout lactation (Pollott, 2000, 2002). Daily expression of the animal’s 
dairy potential depends also on the daily nutrient supply to the mammary gland. This complex 
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process is under the control of several genes (Figure II-10), some of them still unknown. 
Among them, GH was shown to be essential for mammary development both in the pubertal 
phase and during pregnancy (Feldman et al., 1993; Purup et al., 1993; Sejrsen et al., 1999). GH 
also coordinates processes involving alterations in the mammary gland that result in greater 
rates of milk synthesis and an improved maintenance of mammary cell numbers (Bauman and 
Vernon, 1993; Etherton and Bauman, 1998; Burton et al., 1994). 
 
Figure II-10. Hormonal regulation of the mammary gland development. 
Growth factors involved in each phase of the mammary gland development with emphasis on GH direct influence (in red) or 
GH indirect influence through IGF-1 stimulation (in green). Adapted from Touraine and Goffin (2005). 
GH – growth hormone; IGF-1 – insulin-like growth factor 1; PTHrP – PTH-related peptide; RANKL – nuclear factor-κB 
receptor activator ligand. 
 
II.6.1 Mammary gland development 
Mammary gland development begins during the embryonic life of the females. 
However at birth the mammary gland is nothing more than a rudimentary organ. Until puberty, 
the ductal network increases, but only with the onset of puberty does the ductal network 
develop completely to fill the entire fat pad in the mature female. The lobulo-alveolar 
morphogenesis takes place during pregnancy, transforming the mammary gland into a 
functional organ where lactogenesis occurs (Figure II-10). After the lactation peak, the last 
phase of mammary development – involution – occurs, and lobulo-alveolar structures enter in 
senescence leading to the end of milk production. The knowledge available today about these 
complex processes and their signalling pathways came from in vitro or in vivo studies with 
knockout mice or studies in which orthologous or paralogous GH was injected into ruminants 
(reviews from Brisken, 2002; Capuco et al., 2003; Hennighausen and Robinson, 2001, 2005; 
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Kelly et al., 2002; Neville et al., 2002 and Touraine and Goffin, 2005). In this review, 
emphasis will be given to the effect of GH during mammary gland development and lactation 
metabolism. 
II.6.1.1 From birth to partum 
The presence of GH is necessary for the formation of normal mammary gland ducts in 
the prepuberal phase (Kelly et al., 2002). During ductal morphogenesis, GH binds to stroma 
GHRs stimulating IGF-1 secretion and influencing the epithelial compartment in a paracrine 
way (Hovey et al., 2002 cit. by Neville et al., 2002). Until recently, it was considered the major 
effect of GH in mammary development. However, 
- the observed increase in mammary parenchymal cell numbers in primigravid ewes 
injected with bovine somatotropin (exogenous bGH, bST) (Stelwagen et al., 1993); 
- the tendency to higher mammary DNA concentration associated with higher levels of 
plasma GH and IGF-1 and higher milk production in ewes artificially induced to lactate 
and injected with hGHRH (Kann, 1997; Kann et al., 1999); and 
- the discovery of GHR in the mammary epithelium as well as in stroma in mice and 
sheep (Gallego et al., 2001; Jammes et al., 1991; Ilkbahar et al., 1999; Chun et al., 
2005),  
suggest that GH may play other direct roles in mammary development during pregnancy and 
lactogenesis. Indeed, mammary GH gene expression induced by endogenous progesterone 
levels across the oestrous cycle was observed in normal human and dog mammary glands 
during the proliferation phase of epithelial cells (Lantinga-van Leeuwen et al., 1999; reviewed 
by van Garderen and Schalken, 2002), and also in sheep induced to lactate after treatment with 
progesterone and estradiol (Kann, 1997). Moreover, higher levels of progesterone in 
twin-bearing ewes (Nanalu and Sumaryadi, 1998 cit. by Manalu et al., 1999) and in 
superovulated Javanese thin-tail ewes were correlated with a higher growth of mammary ductal 
system in the early phase of pregnancy (Manalu et al., 1999) and with higher mammary gland 
synthetic activity (Frimawaty and Manalu, 1999) which consequently increased milk 
production. Whether GH gene is expressed or not in the mammary gland in ovine is still 
unknown. 
GHR and GHBPs were found to increase throughout pregnancy until the onset of 
lactation in Préalpes du Sud ewes mammary cells and their location change over time (Chun et 
al., 2005), similarly to what was previously reported in mice (Ilkbahar et al., 1995). In ovine, 
GHR-like immunoreactivity was found in the epithelial cells from alveoli at the 90th day of 
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pregnancy, in plasma membrane and cytosol of the epithelial cells at the 140th day of 
pregnancy, and in the apical part of the alveolar cells, near the alveolar lumina, at the 3th day of 
lactation (Chun et al., 2005). Furthermore, it was also observed that GH could activate STAT5 
and MAPK pathways in ovine mammary acini. These finding suggest that GH could act 
directly upon mammary growth and lactogenesis through its own receptors, PRLR and/or 
GHR-PRLR heterodimers (Herman et al., 2000). 
II.6.1.2 Throughout lactation 
During lactation, milk is synthesised within the epithelial cells, secreted to the alveolar 
lumen and then sent to the mammary gland cistern by a system of ducts. Milk production 
depends on epithelial cell number and on their activity level. As lactation peak is reached 
around the third week of lactation in ewes (Cardellino and Benson, 2002; Delgado and Martin, 
1992; Ribeiro, 1999; Ruiz et al., 2000), some increase in mammary cell number or in 
mammary cell activity occurs during early lactation (Tucker, 1981), depending on the species. 
For instance, an increase in secretory cell number was observed before the lactation peak in 
goats, which accounts for the increased milk production on that lactation period (Knight and 
Peaker, 1984 cit. by Capuco et al., 2003). But in dairy cows, the increased milk production that 
occurs at the referred lactation phase seems to be the result of the enhanced activity of the cells 
only (Capuco et al., 2001). After the lactation peak, the rapid drop in milk production, and 
consequently reduced lactation persistency, appears to be related with the decline in mammary 
epithelial cell number in cows (Capuco et al., 2001). So, the lactation persistence depends on 
the ratio between cell proliferation and cell death (apoptosis; see Capuco et al., 2001; 2003). 
The administration of ST is one of the factors pointed out to improve lactation 
persistency (Baldi et al., 2002; Bauman et al., 1999; Capuco et al., 2001; Gallo et al., 1997). It 
appears to act via two mechanisms, a direct and/or indirect stimulus upon cell proliferation, and 
an indirect inhibition of cell apoptosis mediated by IGF-1 (Forsyth, 1996) and 
plasminogen/plasmin system (Politis et al., 1990). Indeed, it was observed that IGF-1 promotes 
the ductal system and acini development in mammary cell cultures throughout lactation (Plaut 
et al., 1993; Dallard et al., 2005). However, IGF-1 action is controlled by a loop mechanism 
whereby it could be inhibited (Sejrsen et al., 1999; Berry et al., 2001) or enhanced (Grill and 
Cohick, 2000 cit. by Cohick et al., 2000) by IGF-binding protein type 3 (IGFBP-3) depending 
on the nutritional status of the animal (Vestergaard et al., 1995; Sejrsen et al., 2000) and on the 
lactation stage (Sejrsen et al., 2001) and, together with cAMP, could regulate IGFBP-3 gene 
expression (Vestergaard et al., 1995; Cohick et al., 2000). 
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Table II-2. Biological effects of GH in farm animals during lactation. 
Tissue Physiological process affected a 
Mammary tissue 
(lactation) 
↑ synthesis of milk with normal composition 
↑ synthesis of lactose 
↑ uptake of nutrients used for milk synthesis 
NC GLUT1 mRNA 
↑ activity per secretory cell 
↑ maintenance of secretory cells, i.e. ↓ involution 
↑ blood flow consistent with change in milk synthesis 
Adipose tissue ↓ lipogenesis if in positive energy balance 
↑ lipolysis if in negative energy balance 
↓ glucose and acetate uptake and glucose oxidation 
↓ GLUT4 mRNA 
↓ insulin stimulation of glucose metabolism and lipid synthesis 
↑ catecholamine stimulation of lipolysis 
↓ antilipolytic effects of adenosine and prostaglandins 
Liver ↑ basal rates of gluconeogenesis 
↑ ability to synthesize glucose 
↓ ability of insulin to inhibit gluconeogenesis 
Kidney b ↑ production of 1,25-vitamin D3 
Intestine b ↑ absorption of calcium and phosphorus required for milk (lactation) 
↑ ability of 1,25-vitamin D3 to stimulate calcium binding protein 
↑ calcium binding protein 
Skeletal muscle ↓ glucose uptake 
↑ lactate output 
↓ glucose oxidation (inferred) 
↓ insulin receptor abundance and tyrosine kinase activity b 
↓ GLUT4 mRNA 
Pancreas NC basal or glucose-stimulated secretion of insulin 
NC basal or insulin/glucose-stimulated secretion of glucagon 
Systemic effects ↓ glucose oxidation 
↓ glucose response to insulin tolerance test 
↑ NEFA oxidation if in negative energy balance 
↓ amino acid oxidation and blood urea nitrogen 
↑ circulating IGF-1 and IGFBP-3, and ALS 
↓ circulating IGFBP-2 and IGFBP-5 
↑ cardiac output consistent with increases in milk output 
↑ enhanced immune response 
NC energy expenditure for maintenance 
NC partial efficiency of milk synthesis 
↑ voluntary intake to mach nutrient needs for extra milk synthesis 
↑ productive efficiency (milk/unit of food intake) 
↓ animal waste (faecal and urine output/unit of milk 
a
 Changes (↑– increase; ↓ – decrease; NC – no change) that occur in initial period of bST treatment; 
ALS - acid-labile subunit; GLUT1 – erythrocyte-type glucose transporter; GLUT4 – insulin-responsive 
glucose transporter; IGF-1 - insulin-like growth factor 1; IGFBP – insulin-like growth factor binding 
protein; NEFA - non-esterified fatty acids.  
b
 Demonstrated in non-lactating animals and consistent with observed.  
Adapted from Bauman (1992, 1999), Bauman and Vernon (1993), Bell and Bauman (1997), Chilliard et al. 
(1998a), and Etherton and Bauman (1998). 
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The increased persistency of lactation after treatment with ST could also be related with 
the GH-induced inhibition of the IGFBP-5 levels, since IGFBP-5 has been shown to induce 
mammary cell apoptosis in dairy cows (Accorsi et al., 2002) and in rodents (Allan et al., 2002; 
Tonner et al., 2002). In recent reviews it was postulated that the effects of IGFBP-5 could be 
mediated by IGF-independent pathways involving cross-relationships between some elements 
of the plasminogen/plasmin system and the matrix metallo-proteinases that participate in tissue 
remodelling during involution [reviewed by Allan et al. (2004) and Flint et al. (2005)]. 
The maintenance of mammary cell number and activity has also been shown to be 
related with external physical factors such as increasing milking frequencies/reducing milking 
intervals (Boutinaud et al., 2003; Bryson et al., 1993; Stelwagen et al., 1994; Vetharaniam et 
al., 2003). 
II.6.2 Mechanisms of GH action during lactation 
The somatotrophic axis plays a key role in the coordination of lipid, carbohydrate and 
protein metabolism in mammals, with GH being direct or indirectly involved in it, contributing 
to the homeorhetic control of the metabolism by regulating homeostatic signals (Bauman and 
Currie, 1980). In this section, the effects of GH upon ruminant metabolism during lactation will 
be discussed. Biological effects of GH during lactation are summarised in Table II-2. 
II.6.2.1 Lipid metabolism 
GH has a major impact on lipid metabolism but its effects depend on the nutritional and 
physiological status of the animals. In late pregnancy and early lactation, animals are usually in 
negative energy balance, having high energy needs. During that period, the levels of putative 
homeorhetic hormones change (Figure II-11) in order to adjust body metabolism to overcome 
those needs. 
In early lactation (before peak), when ewes are in negative energy balance, the high 
levels of endogenous GH stimulate lipolysis. This seems to be related to increased response and 
sensitivity to catecholamines via increasing numbers of β-adrenergic receptors, adenylate 
cyclase enhanced activity and increased amounts of Gs-protein -subunits (Vernon et al., 1995), 
with an increase (McDowell et al., 1987; Rose et al., 2005) or no change in non-esterified fatty 
acids (NEFA) levels (Chilliard et al., 1998b). Surprisingly, lactation also increases the response 
to adenosine, an anti-lipolytic factor (Vernon et al., 1991b). After peak, when the animal needs 
for milk production begin to decrease and energy balance becomes zero or positive, 
administration of ST induces metabolic changes in the adipose tissue resulting in increased 
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lipolysis. However, that is presumably due to a decrease in the anti-lipolytic activity of 
adenosine rather than to an increase in β-adrenergic response (Houseknecht and Bauman, 1997; 
Lanna et al., 1995). ST action reflects on adipose tissue response to insulin and in the activity 
of the lipogenic enzymes. 
 
Figure II-11. Changes in blood serum concentrations of putative homeorhetic hormones in cows.  
Adapted from Tucker (1985). 
 
ST treatment is frequently associated with insulin resistance, i.e., a diminished biologic 
response of tissues to insulin (Etherton and Bauman, 1998). GH regulates SOCS mRNA 
expression in 3T3-L1 adipocytes via JAK/STAT-signalling pathways inducing insulin 
resistance (Fasshauer et al., 2004). In the presence of insulin resistance, impaired activation of 
insulin receptor, insulin receptor substrate proteins and phosphatidylinositol 3-kinase has been 
observed, which in the end may result in the disruption of insulin-induced metabolic targets, 
such as glucose uptake (Kahn & Flier, 2000 cit. by Fasshauer et al., 2004). It has been 
demonstrated that GH stimulates SOCS-3 mRNA expression in liver and in 3T3-L1 adipocytes 
(Adams et al., 1998) and that SOCS-1, SOCS-3 and SOCS-6 are strong inhibitors of insulin 
signalling (Emanuelli et al., 2000; Mooney et al., 2001; Rui et al., 2002). 
In studies where ST was administrated to dairy cows, it was observed that increased 
lipolysis was possibly due to a moderate increase in hormone sensitive lipase activity. 
Simultaneously, ST treatment induced lower adipose tissue lipogenesis mediated by a reduction 
in acetyl-coenzyme A and fatty acid synthase enzymatic activities (Beswick and Kennelly, 
1998; Lanna et al., 1995; Vernon et al., 1991a), and to a lesser extent a reduction in 
glucose-6-phosphate dehydrogenease and isocitrate dehydrogenease enzymes activities (Lanna 
et al., 1995). 
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II.6.2.2 Carbohydrate metabolism 
As mentioned in Table II-2, GH influences carbohydrate metabolism in several tissues 
during lactation. Glucose availability at the mammary gland level is a limiting factor in milk 
synthesis, since it is the key precursor for lactose synthesis at the mammary epithelial cells 
(Neville et al., 1983 cit. by Zhao et al., 1996). In ruminants, the main source of glucose is the 
hepatic gluconeogenesis that uses mainly the propionate originated by rumen microbial 
fermentations (Bauman and Elliot, 1983). Indeed, hepatic phosphoenolpyruvate carboxykinase 
(PEPCK) mRNA expression has been shown to be higher in dairy cows receiving ST, 
presumably reflecting a major ability for gluconeogenesis from gluconeogenic precursors, 
namely propionate, than from oxaloacetate under ST treatment (Velez and Donkin, 2004), as it 
was observed that the conversion rate of propionate to glucose increased in cows receiving ST 
without changes on the conversion rate of propionate to succinate, malate, and oxaloacetate 
taken together (Knapp et al., 1992 cit. by Velez and Donkin, 2004). Authors also postulate that 
the increased PEPCK expression could be a sign of hepatic insulin insensitivity that has been 
described in ruminants. 
It has not been unanimously demonstrated that higher extracellular glucose 
concentration could influence glucose mammary uptake in lactating ruminants (Miller et al., 
1991; Peel et al., 1982). Accordingly, a sodium-dependent and a facilitative family of 
tissue-specific glucose transporters have been proposed to regulate glucose uptake in cells 
(Gould and Holman, 1993 cit. by Zhao et al., 1996a). Facilitative glucose transporters family, 
which transport glucose according to its concentration gradient, mediate glucose withdrawal 
from liver, kidney and intestine cells to plasma (reviewed by Hocquette and Abe, 2000). ST 
and GHRH administration favours the repartitioning of glucose to the mammary gland by 
decreasing significantly the expression level of the insulin-responsive glucose transporter gene 
(GLUT4) in skeletal muscle, with the same tendency observed at the omental fat tissue (Zhao et 
al., 1996b). However, no changes were observed upon erythrocyte-type glucose transporter 
(GLUT1), liver-type glucose transporter (GLUT2) and intestinal-type glucose transporter 
(GLUT5) mRNA expression levels in liver or in kidney (Zhao et al., 1996a). GLUT1 mRNA 
expression seems to be dominant in lactating bovine mammary tissue (Zhao et al., 1993 cit. by 
Nielsen et al., 2001). It was thus suggested that glucose uptake in ruminant mammary gland 
occurs by an insulin-independent mechanism in which glucose transport could probably be 
done by GLUT1 (Komatsu et al., 2005; Nielsen et al., 2001). Those results, taken together with 
others suggest that the ST’s effects upon milk production may involve: an increase in 
mammary glucose uptake due to a higher mammary blood flow rather than changes in glucose 
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transporters; and an enhanced lactose synthesis through a more efficient intracellular glucose 
metabolism as proposed in goats by Nielsen et al. (2001). 
II.6.2.3 Protein metabolism 
High levels of endogenous GH observed in late pregnancy/early lactation and ST 
treatment are known to change amino acids and protein metabolism in lactating mammals (Bell 
et al., 1995). Amino acids are fundamental for milk synthesis at the mammary gland during 
lactation (Bauman et al., 1988), being also precursors for hepatic gluconeogenesis along with 
propionate, lactate and, to a lesser extent, glycerol (see Bell and Bauman, 1997). 
The main changes that high levels of GH induce in protein metabolism consist in an 
increase in body protein mobilization, namely skeletal muscle amino acids. This has been 
suggested to be concomitant with a possible decrease in amino acid catabolism and an increase 
in hepatic glucose and protein synthesis, as well as a more efficient mammary gland milk 
protein synthesis (Reynolds et al., 1994). A decrease in amino acid catabolism was associated 
with reduced levels of plasma urea nitrogen (Morris et al., 1992 cit. by Velez and Donkin, 
2004). This was observed in several studies in lactating cows (Sechen et al., 1989), goats 
(Disenhaus et al., 1995) and ewes (Sallam et al., 2005) treated with ST, but was not observed 
in others studies (e.g., Velez and Donkin, 2004). 
The mechanism by which GH promotes amino acid mobilization in skeletal muscle, and 
simultaneously increases milk protein synthesis in mammary gland, appears to involve insulin 
receptor signalling impairment at organs other than mammary gland, and enhanced expression 
of IGF-1 at the mammary gland. 
II.6.3 Recombinant somatotropin and milk production in ewes 
Since the 50’s, ST effects upon ewes’ milk yield have been studied (Dracy and Jordan, 
1954; Jordan and Shaffhausen, 1954). Lactating ewes treated with ST yielded significantly 
more milk (Brozos et al., 1998; Chiofalo et al., 1999; Fernandez et al., 1995, 1997, 2001; 
Leibovich et al., 2001; Min et al., 1997; Sallam et al., 2005; Sandles et al., 1988) (Figure 
II-12). This was also achieved by giving GHRH to ewes in artificially induced lactation (Kann, 
1997). Another way to increase milk yield in ewes is through the immunization of pregnant 
ewes against SRIF (Sun et al., 1990; Westbrook et al., 1993). Accordingly, milk production in 
ewes seems to be regulated by genes from the somatotrophic axis as it was also demonstrated 
in dairy cows (Bauman, 1999; Chilliard et al., 1998a; Etherton and Bauman, 1998; Rose et al., 
2005) and goats (Boutinaud et al., 2003; Gallo et al., 1997). 
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Figure II-12. Milk production in lactating ewes submitted to recombinant bovine ST (rbsT) 
treatment. Adapted from Sallam et al. (2005). 
 
Factors such as lactation number and stage, flocks’ average milk production, animals’ 
body condition score and weight at the beginning of the treatment influence the ST dose that 
should be given to the ewes (Fernandez et al., 1997) and at which time intervals (Fernandez et 
al., 2001). 
In general, the use of recombinant ST for ewes’ milk production allows to obtain higher 
productions with no detrimental effects on milk gross composition and coagulating properties 
(except in the advanced stage of lactation; Baldi, 1999), which is of great importance for cheese 
manufacture. Nevertheless, as far as the application of this technology to dairy cows is 
concerned, 79 % of the UK dairy farmers and 65.4 % of the UK consumers did not consider 
bST ‘ethically acceptable’ (Millar et al., 1999 cit. by Mepham, 2000). These acceptability 
problems are expected to arise in respect to dairy sheep industry. The immunization of pregnant 
ewes against SRIF as proposed by Westbrook et al. (1993) has the advantage of obtaining more 
milk without injecting the animals during the lactation period, and thus without the negative 
impact on consumer’s opinion. 
With regard to animals’ health, ST treatment did not change hematological parameters 
(Sallam et al., 2005), mastitis incidence or milk somatic cell count (Fernandez et al., 1995). 
However, in dairy cows some increase in milk somatic cells count was attributed to the higher 
milk production (see Chilliard et al., 1998a). It was also reported a higher occurrence of foot 
and leg disorders in cows subjected to long-term treatment with ST (Zhao et al., 1992; Collier 
et al., 2001), which may also occur in ewes since GH axis has been seen to promote bone 
growth (Braithwaite, 1975). The above mentioned health effects upon females injected with 
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bST resulted in increasing culling rates in multiparous cows (European Commission, 1999a cit. 
by Mepham et al., 2000), thus increasing milk production costs. This correlates with studies 
that reported that GH deficiency due to GH gene deletion or to combined pituitary hormone 
deficiencies - as observed in Ames dwarf mice (PROP1 mutation; Bartke and Brown-Borg, 
2004), in Snell dwarf mice (POU1F1 mutations; Lin et al., 1994) - or deficient transduction of 
GH signal - as in Laron mice (GHR knock-out; Coschigano et al., 2003), which usually result 
in lower body weight and decreased insulin and IGF-I levels. As a consequence, the GH 
deficiency improves lifespan.
 
II.7 Transgenic animals expressing an additional GH copy 
Due to its effects on animal metabolism and its proved efficiency in increasing 
productivity in animal husbandry, GH is a natural target for genetic manipulation in livestock. 
Experiments in this field were performed in sheep (Adams et al., 2002; Adams and Briegel, 
2005). The authors reported that, when expressed, the impact of the transgene depends on age, 
breed and sex of the transgenic animal. Nevertheless, animals expressing an additional GH 
gene presented a plasma GH level twofold higher that the non-transgenic animals, but GH 
expression was continuous. Transgenic animals were leaner, grew faster and had similar wool 
productions (Adams et al., 2002). Ewes had greater ovulation and foetal death rates (Adams 
and Briegel, 2005). In addition, health problems such as higher parasite faecal egg count and 
foot problems (swollen metatarsal and metacarpal joints) were present in transgenic animals 
(Adams et al., 2002; Adams and Briegel, 2005). Skeletal malformations had been observed 
before in transgenic sheep (Ward et al., 1990), and foot problems observed in dairy cows 
injected with bST, accounting for the reduced lifespan of those animals (Zhao et al., 1992; 
Collier et al., 2001). 
 
II.8 Impact of GH polymorphisms on productive traits 
In the 90’s, with the huge development of the molecular biology techniques, scientists 
begun to search more actively for polymorphisms at the DNA level that might be responsible 
for alterations of gene functions leading to changes that could be involved in a disease situation 
or impair/enhance a production trait. Several techniques were developed and refinements are 
proposed every day, and applied to domestic animals to look for polymorphisms at candidate 
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genes that are suspected to influence a particular production trait. Examples of these techniques 
are: restriction fragment length polymorphism (RFLP; Beckmann and Soller, 1983 cit. by 
Valinsky et al., 1990), SSCP (Orita et al., 1989) and single nucleotide polymorphism (SNP; 
reviewed by Kwok and Chen, 2003); or in genomic regions that might be close to a gene that 
regulates a production trait (quantitative trait loci; QTL), e.g. microsatellites (Weber and May, 
1989), random amplified polymorphic DNA (RAPD; Williams et al., 1990) and amplified 
fragment length polymorphism (AFLP; Vos et al., 1995). 
GH gene polymorphisms were shown to be a possible selection criterion for milk 
production traits of high merit animals, mostly in dairy cattle (Lucy et al., 1993; Falaki et al., 
1996b; Lagziel et al., 1996). Small ruminant species have been much less studied. 
Polymorphisms at the GH gene were identified in bovine: two insertion/deletion in the 
promoter region (ins/del AAG - Rodrigues et al., 1998; ins/del TGC – Yao et al., 1996); a 
MspI-RFLP at the intron 3 (Zhang et al., 1993; Lagziel et al., 2000; Khatami et al., 2005); two 
SNPs detected by SSCP in intron 4 (Lee et al., 1994b); an AluI-RFLP at the exon 5 (Lucy et al., 
1991; Zhang et al., 1993; Chrenek et al., 1998b); a HaeIII-RFLP at the exon 5 (Unanian et al., 
1994); and GH gene haplotypes established by SSCP (Lagziel and Soller, 1999). It was also 
described a splicing variant of the bGH gene which results from nonsplicing of the intron 4 
(Hampson and Rottman, 1987). Some of the polymorphisms were identified in several breeds 
and associations with meat and milk production traits, metabolic parameters and reproduction 
traits were established (Table II-3), sometimes reaching contradictory conclusions. 
 
Table II-3. Polymorphisms at the GH gene significantly associated with production traits and 
metabolic parameters in bovines. 
Site Polymor-phisms Breed Effect References 
L127V 
(exon 5) 
AluI-RFLP 
 
Holstein, 
Brown 
Swiss, 
Guernsey, 
Jersey, and 
Ayrshire 
Estimates of transmitting ability for milk 
production tended to be: 
• greater for LL Holstein cows;  
• greater for VV Jersey cows; 
• no differences for Holstein sires. 
Lucy et al., 1993 
L127V 
(exon 5) 
AluI-RFLP 
 
Holstein AluI(+/-), i.e., the presence of V allele: 
• ↓ 170 kg of EBV-milk and  
• ↓ 240 kg of AYD-milk  
Lee et al., 1996 
L127V 
(exon 5) 
AluI-RFLP 
 
Simmental VV genotypes: 
• ↓ body weight; 
• ↓ average daily gain. 
Chrenek et al., 1998a 
L127V 
(exon 5) 
AluI-RFLP 
 
Simmental LV genotypes: 
• ↑ carcass gain. 
Schlee et al., 1994a 
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Table II-3. Polymorphisms at the GH gene significantly associated with production traits in 
bovines and metabolic parameters (cont.). 
Site Polymor-phisms Breed Effect References 
L127V 
(exon 5) 
AluI-RFLP 
 
Black and 
White 
LL genotypes: 
• ↑ concentration of GH; 
• ↓ concentration of  IGF-1. 
Schlee et al., 1994b 
L127V 
(exon 5) 
AluI-RFLP 
 
Holstein LV genotype: 
• More frequent in top ETA bulls. 
Sabour et al., 1997 
L127V 
(exon 5) 
AluI-RFLP 
 
Polish 
Friesian 
No significant effect on overall 
parameters of GH release. 
VV genotypes: 
• ↑ GH baseline in heifers and bulls; 
• ↑ GH peak amplitude in bulls.  
Grochowska et al., 
1999 
L127V 
(exon 5) 
AluI-RFLP 
 
German 
Black and 
White, 
Yaroslavl 
LV genotypes: 
• ↑ milk fat content. 
Khatami et al., 2005 
L127V 
(exon 5) 
AluI-RFLP 
 
Several VV bulls tendency: 
• ↑ ejaculate volume; 
• ↑ day 60 non-return rates. 
Lechniak et al., 1999 
Intron 3 
and 3’ 
region 
MspI-RFLP 
and/or 
ins/del in 3’ 
region  
Holstein Milk fat yield Lee et al., 1994a 
Exon5  HaeIII-
RFLP 
Holstein Linked to a QTL for milk protein 
content 
Vukasinovic et al., 
1999 
Gene 
haplotypes 
SSCP Israel 
Holstein 
Milk protein content Lagziel et al., 1996 
GH gene TaqI-RFLP Double 
muscled 
Belgium 
White Blue 
AA genotype:  
• ↑ weight at 7 and 13 months 
Renaville et al., 1994; 
Sneyers et al., 1994 
GH gene TaqI-RFLP Holstein 
Simmental 
Milk yield traits  Falaki et al., 1994 
GH gene TaqI-RFLP Italian 
Simmental 
• Not significant in milk yield traits 
• EBVmilk yield of BB bulls > AA bulls 
in with more 382±185 kg 
• EBVprotein content of BB > (AA =AB) 
Falaki et al., 1997 
GH gene TaqI-RFLP Italian 
Holstein-
Friesian 
(AA = AB) >AE for milk, fat and 
protein yield 
Falaki et al., 1996b 
Intron3 
and 
GH gene 
MspI- and 
TaqI-RFLP  
Italian 
Holstein-
Friesian 
No effect milk traits  Falaki et al., 1996a 
Intron 3, 
and 3' 
region 
MspI-RFLP 
and ins/del at 
3’ region 
Red Danish, 
Norwegian 
Red 
MspI(-) allele/Del allele more frequents 
in high milkfat line 
Hoj et al., 1993 
Intron 3 MspI-RFLP Israel 
Holstein 
MspI(+/-) vs MspI(+/+) genotype: 
• ↑ milk protein content and yield 
• ↓ Somatic cell count 
Lagziel et al., 1999 
Promoter 
region 
Three SNPs Angus • Serum IGF-I concentration on day 
42 post-weaning; 
• mean IGF-I concentration. 
Ge et al., 2003 
AYD – Average yield deviation; EBV – estimated breeding value; ETA – estimated transmitting ability for milk traits.  
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Some polymorphisms were identified at the oGH gene: TaqI- and PvuII-RFLP 
(Gootwine et al., 1993, 1996; Parsons et al., 1992) and EcoRI-RFLP (Barracosa, 1996; 
Gootwine et al., 1998), and PCR-SSCP polymorphisms (Bastos et al., 2001; Santos et al., 
2004) have been reported. 
Recent studies conducted on dairy goats have shown associations between PCR-SSCP 
at the GH gene and milk production traits: polymorphisms at exons 4 and 5 were significantly 
associated to milk yield in “Algarvia” goats (Malveiro et al., 2001). In another study, it was 
observed that goats with SSCP pattern A/B at the GH exon 2 yielded more milk than the other 
goats from the “Serrana Jarmelista” ecotype; goats with SSCP pattern A/B at the GH exon 4 
yielded more milk than the other goats from “Serrana Ribatejano” ecotype; in the “Serrana 
Ribatejano” ecotype, goats with patterns A/B at the GH exon 1 and B/B at the GH exon 2 had 
higher milk protein content than the other goats (Marques et al., 2003). 
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“I am among those who think that 
science has great beauty. 
A scientist in his laboratory is not 
only a technician: he is also a child 
placed before natural phenomena 
which impress him like a fairy tale.” 
 
Marie Curie (1867-1934) 
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III.1 Serra da Estrela sheep production system  
III.1.1 Geographical area 
The animals that are the object of the present study came from commercial farms 
located in the geographical area of milk production for “Serra da Estrela” cheese (PDO) known 
as “Demarcated Region of Serra da Estrela Cheese” (DRSEG; Figure III-1). The DRSEG 
includes all the municipalities of Carregal do Sal, Celorico da Beira, Fornos de Algodres, 
Gouveia, Mangualde, Manteigas, Nelas, Oliveira do Hospital, Penalva do Castelo and Seia; and 
some parishes in the municipality of Aguiar da Beira, Arganil, Covilhã, Guarda, Tábua, 
Tondela, Trancoso and Viseu (decrees No. 42/85 and D06/94 Reg EC 12/06). 
 
 
 
 
Figure III-1. Municipalities of the geographical area of the Demarcated Region of the ”Serra 
da Estrela” Cheese (DRSEG). 
 
III.1.2 Topography and soil types 
The DRSEG is located in ”Serra da Estrela” mountain region (40º 20’ N, 7º 35’ W) 
which is characterized by plateaus of various altitudes and wide valleys (Vieira et al., 2006), 
presenting glacial landscapes. 
Geologically, the “Serra da Estrela” is mainly a granite region (Hercynian granites – 
300 My; Vieira et al., 2006) with large areas of large rocky outcrops. It has also areas of schist-
metagreywackes (650-500 My; Vieira et al., 2006). The soils are predominantly from types D 
and E, and present low fertility and profundity (Gulbenkian et al., 1993). They are suitable for 
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forest and pastoral activities. Viera et al. (2006) and Natura 2000 report 
(http://www.eco.science.ru.nl/expploec/Estrela/natura2K.html) reviewed the information 
concerning topography, geomorphology and vegetation distribution in the “Serra da Estrela” 
mountain. 
III.1.3 Climate 
This region has a temperate and humid Mediterranean climate (Le Houerou, 2004), with 
cold temperatures in winter (often below 0ºC) and hot temperatures in summer (often over 
30°C from June to August) with more than 1000 mm of annual rainfall, mainly distributed 
from October to May and with a high number of rainy days in the western side of the “Serra da 
Estrela” mountain where a large part of the DRSEG is located. 
III.1.4 Sheep production system 
In this study a brief characterisation of the “Serra da Estrela” sheep production system 
was made based on the answers by farmers to the questionnaire presented in Appendix 1. An 
extensive characterization of the “Serra da Estrela” sheep production system had been 
conducted by Gulbenkian (1993). The questionnaire was answered in 1998 by 36 sheep farmers 
from municipalities of Oliveira do Hospital, Carregal do Sal and Gouveia. Only farmers who 
owned brucellosis free flocks (B4) were requested to answer. 
Three main aspects were considered: 
III.1.4.1 Land utilization 
Farms had on average 30 ha (owned and mainly rented land). The foremost occupation 
of land was the natural (some of them under olive trees) and sown pastures. The forage 
production practised by the farmers was based upon annual crops. The principal species sown 
in autumn were rye-grass, rye, oat, and some legumes as clovers and alfalfa and, in spring, 
sorghum and corn forage (“Milharada”). Pastures were fertilized in all the farms and spring 
crops were irrigated. Pasture lands were divided in parcels with fences. Generally, the distance 
between pasture and pen house was covered in less than 30 minutes. Only 15% of the inquired 
farmers used to graze their sheep in communitary barren lands. 
III.1.4.2 Feeding system 
One of the most important factors affecting milk production is ewes’ nutrition. 
Throughout the year, feeding regime changes to accommodate the evolution of grass 
production and the availability of other feeding products in the farm: 
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- From September to March (autumn/winter): 90% of the flocks graze natural pastures, rye-
grass and rye and/or oat, and some legumes. A small percentage of flocks graze shrubs, 
crops and vineyard remains, and sown pastures. 
- From April to August (autumn/winter): ewes graze the remaining of the natural pastures, 
some communitary pastures in June and above all corn forage (“Milharada”) and sorghum. 
The ewes receive a feed supplement during milking: a commercial mix in 80% of the 
flocks with some corn, or rye or oat (250 g to 400 g/ewe). Other flocks receive corn and/or 
potatoes or a mixture of potatoes and cabbages. Inside the pen overnight, the animals have also 
rye-grass, oat or natural pasture hay (alfalfa in a very small number of flocks) or oat, rye or corn 
straw. 
Forty percent of the farmers separate the lactating ewes in order to adequate their 
feeding level to the nutritional needs of the lactation period. 
III.1.4.3 Flocks management 
Sheep production in the region is mostly a familial activity, with more than 75% of the 
farmers shepherding their own ewes with the help of a family member. Only less than 25% of 
the farmers had a shepherd to conduct their ewes to the pastures and to do the milking. 
Mating season is in April/May. The lambing season begins in August/September and 
more than 50% of the multiparous ewes lamb in October. Ewes nurse their lambs 8 to 30 days 
whereas they are to be sold to be slaughter (“Canastra” lambs). Lambs for flock replacement 
are weaned at 45-60 days. Ewes are replaced with ewes that are born in the flock, and rams are 
brought from outside the flock. 
III.1.4.4 Milk production and utilization 
Milking begins in September/October and ends in June. Ewes are machine (20%) or 
manually (80%) milked in the morning and evening. The higher milk yield is obtained in 
October and November. Average milk yields of the inquired flocks are shown in Appendix 2. 
Most farmers (65%) produce milk for sale. “Serra da Estrela” cheese producers need 5.5 to 6 l 
of milk to manufacture 1 kg of cheese during winter and approximately 5 l of milk during 
spring. “Serra da Estrela” cheese is a mature cheese prepared by traditional methods from raw 
milk, and curdled with Cynara cardunculus. It has a soft consistency, buttery texture and clean, 
smooth and slightly acid flavour. 
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III.2 Animals and milk records 
In the present work, 556 “Serra da Estrela” sheep were genotyped. Blood samples 
(9 ml) were obtained by jugular venipuncture on potassium-ethylenediaminetetracetic acid 
(EDTA; final concentration of 1.6 mg/ml blood). DNA extraction was performed using a 
phenol/chloroform free method (Puregene DNA Isolation Kit, Gentra Systems, Minneapolis, 
USA). 
The 556 sheep were registered on the “Serra da Estrela” Herdbook. They belong to 
seven breeders associated in National Association of the Breeders of the “Serra da Estrela” 
Sheep (ANCOSE) and to ANCOSE Male Testing Center. Pedigree information and official 
milk records (milk yield and milk quality data) were kindly provided by ANCOSE. Milk yield 
per lactation was estimated from A4 milking records (ICAR, 2001) using the Fleischmann 
method and was adjusted for milking length on a reference period of 150 days. 
 
Table III-1. Flocks’ mean milk yield (l/150 days) in the period 1995-2000. 
Flock n Variety Milk yield ± SE 
FL1 59 White 92.8 ± 1.7 
FL2 71 Black 129.4 ± 1.9 
FL3 71 Black 228.2 ± 4.7 
FL4 72 Black 90.2 ± 1.4 
FL5 116 White 136.9 ± 2.1 
FL6 82 White 217.2 ± 3.6 
FL7 52 White 218.3 ± 4.1 
n – Number of ewes; SE – standard error. 
 
The seven flocks were chosen considering the number of ewes (more than 50), breed 
variety (white or black) and milk yield level (<100 l/150 days – low; ~130 l/150 days – 
medium; and >200 l/150 days – high). Number of ewes with milk records within flocks, ewes’ 
variety and flocks’ mean milk yield from 1995 to 2000 (1704 valid lactations) are shown in 
Table III-1. Flocks’ milk yield; fat and protein content; fat, protein and fat + protein yields in 
1998 (the only year with milk composition records – 294 valid lactations) are shown in table 
Table III-2. 
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Table III-2. Flocks’ mean milk yield (l/150 d), fat content (g/kg), protein content (g/kg), fat 
yield (kg/150 d, protein yield (kg/150 d) and fat plus protein yield (kg/150 d) in 1998. 
Flock n 
Milk yield  
± SE 
Fat content 
± SE 
Protein 
content ± SE 
Fat yield  
± SE 
Protein 
yield ± SE 
Fat + Protein 
Yield ± SE 
FL1 46 93.4 ± 3.9 73.2 ± 1.3 67.5 ± 1.0 6.9 ± 0.3 6.3 ± 0.3 13.2 ± 0.6 
FL2 57 152.3 ± 3.6 81.9 ± 1.2 67.2 ± 0.9 12.6 ± 0.4 10.2 ± 0.3 22.8 ± 0.7 
FL3 43 227.0 ± 9.1 78.7 ± 1.6 68.9 ± 1.0 17.9 ± 0.8 15.5 ± 0.6 33.5 ± 1.4 
FL4 54 98.9 ± 2.8 76.6 ± 1.4 66.7 ± 0.8 7.6 ± 0.3 6.6 ± 0.2 14.2 ± 0.5 
FL6 54 238.0 ± 8.0 82.8 ± 2.0 63.2 ± 0.8 19.5 ± 0.7 15.0 ± 0.5 34.5 ± 1.1 
FL7 40 239.3 ± 8.7 83.7 ± 1.8 58.6 ± 1.0 20.1 ± 0.9 14.1 ± 0.6 34.2 ± 1.4 
n – Number of ewes; SE – standard error.
 
III.3 oGH gene copy number genotypes 
To determine the copy number genotype of the oGH gene, a total of 89 “Serra da 
Estrela” sheep (56 ewes and 33 rams) from the white (61%) and the black (39%) varieties were 
analysed by Southern blotting. 
A 2055 bp DNA probe containing the oGH gene was amplified by PCR with the 
primers GHT-Fwd (5’ CCA GAG AAG GAA CGG GAA CAG GAT GAG 3’) and GHT-Rev 
(5’ ATA GAG CCC ACA GCA CCC CTG CTA TTG 3’) designed according to the published 
oGH gene sequence (GenBank accession number: X12546, Orian et al., 1988). The PCR 
reaction was performed in a final volume of 50 µl according to the following conditions: 
500 ng of genomic DNA; 6 pmoles of each primer; 2.0 unit of TaKaRa LA TaqTM (TAKARA 
SHUZO CO., Ltd, Japan); 1x of 2x GC Buffer I with 2.5 mM MgCl2 and 400 µM of each 
dNTP. Amplification cycles included an initial denaturation at 94ºC for 1 min followed by 
30 cycles of denaturation at 98ºC for 20 s, annealing from 62ºC for 12 min, and a final 
extension at 72ºC for 10 min. The 2055 bp DNA probe was digoxigenin (DIG)-labelled with 
the PCR DIG Probe Synthesis Kit (Roche Diagnostics GmbH, Indianapolis, USA) according to 
the instruction manual. 
Fifteen µg of genomic DNA were digested overnight, separately, with EcoRI, BamHI 
and HindIII restriction endonucleases (Invitrogen Life Technologies; Carlsbad, CA, USA). The 
digested fragments were separated on a 0.8% agarose gel (2 V/cm) with 0.5x TBE buffer 
(0.045 M borate, 0.001 M EDTA) for 13 h, denatured in 0.5 M NaOH for 30 min, transferred 
by capillarity to a positively charged nylon membrane (HybondTM-N+, Amersham Pharmacia 
	
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Biotech, Ireland), and UV-cross linked to the membrane. The blots were hybridized with the 
2055 bp DIG-labelled probe at 45ºC in DIG Easy Hyb solution (Roche Diagnostics GmbH, 
Indianapolis, USA) for 16 h. The probe-target hybrids were immunodetected on the blots with 
an alkaline phosphatase-conjugated anti-DIG antibody from sheep (Anti-Digoxigenin-AP, Fab 
fragments; Roche Diagnostics GmbH, Indianapolis, USA) and visualized with the 
chemiluminescent alkaline phosphatase substrate CSPD (Roche Diagnostics GmbH, 
Indianapolis, USA). Then the blots were exposed to X-ray film (Kodak BioMax MS1, Eastman 
Kodak Company, Rochester, NY, USA) for 45 min according to the standard DIG 
chemiluminescent detection procedure. 
The Hardy-Weinberg equilibrium (HWE) for the oGH copy number genotypes was 
tested by 2 analysis (Statistica software, StatSoft, Inc., Tulsa, OK, USA). 
 
III.4 oGH gene analysis by PCR-SSCP 
Five hundred and twenty three “Serra da Estrela” ewes from white (64%) and black 
(36%) varieties were analysed by SSCP to determine oGH polymorphisms. 
Seven DNA fragments (I to VII) of the oGH gene comprising the five exons (including 
intron-exon junctions), and the 5’-UTR and 3’-UTR regions, were amplified by PCR with 
copy-unspecific primer pairs (Invitrogen Life Technologies, Barcelona, Spain) shown in Table 
III-3. Sizes of amplified fragments ranged from 112 to 289 bp. PCR reactions of the fragments 
II to VI were performed in a final volume of 25 µl using Ready-To-Go PCR Beads (Amersham 
Biosciences, Buckinghamshire, England) according to the following conditions: 25 to 50 ng of 
genomic DNA; 0.16 to 0.64 µM of each primer; 1.5 units of Taq DNA polymerase; 10 mM 
Tris-HCl (pH 9); 50 mM KCl; 1.5 or 2.5 mM MgCl2; 200 µM of each dNTP and stabilisers 
including BSA. PCR reactions of the fragments I and VII were performed in a final volume of 
25 µl according to the following conditions: 50 ng of genomic DNA; 12 pmoles of each primer; 
1.0 unit of Taq DNA polymerase (Roche Diagnostics GmbH, Indianopolis, USA); 10 mM 
Tris-HCl (pH 9); 50 mM KCl; 3.5 mM or 4.5 mM MgCl2; and 200 µM of each dNTP. 
Amplification cycles included an initial denaturation at 95ºC for 5 min followed by 30 cycles of 
denaturation at 95ºC for 30 s, annealing from 57ºC to 68ºC for 30 s (Table III-3), extension at 
72ºC for 30 s and a final extension at 72ºC for 5 min. Amplification products were analysed by 
electrophoresis on ethidium bromide stained 2% agarose gels (5 V/cm), with 1x TBE buffer 
(0.09 M borate, 0.002 M EDTA).
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Table III-3. Length and localisation of PCR-SSCP fragments of the oGH gene and primers used for the PCR analysis† 
Fragment    Primer  
Name Type Length Localisation (bp) Name Sequence 
Annealing 
temperature (ºC) 
I 5’-UTR, E1 125 205 to 329 
GH5’-Fwd: 
GH5’-Rev: 
5’
 GGG AAA GGG AGA GAG AAG AAG CCA G 3’ 
5’
 CAG CCA TCA TAG CTG GTG AGC TGT C 3’ 
68 
II 5’-UTR, E1, I1 112 248 to 359 
GH1-Fwd: 
GH1-Rev: 
5’
 CAG AGA CCA ATT CCA GGA TC 3’ 
5’
 TAA TGG AGG GGA TTT TCG TG 3’ 
57 
III I1, E2, I2 198 569 to 766 
GH2-Fwd: 
GH2-Rev: 
5’
 CTC TCC CTA GGG CCC CGG AC 3’ 
5’
 TCT AGG ACA CAT CTC TGG GG 3’ 
65 
IV I2, E3, I3 154 967 to 1110 
GH3-Fwd: 
GH3-Rev: 
5’ CTC CCC CCA GGA GCG CAC CT 3’ 
5’ GCT CCT CGG TCC TAG GTG GC 3’ 
60 
V I3, E4, I4 200 1303 to 1502 
GH4-Fwd: 
GH4-Rev: 
5’
 CTG CCA GCA GGA CTT GGA GC 3’ 
5’
 GGA AGG GAC CCA ACA ATG CCA 3’ 
60 
VI I4, E5, 3’-UTR 289 1740 to 2028 
GH5-Fwd: 
GH5-Rev: 
5’
 CCC TTG GCA GGA GCT GGA AG 3’ 
5’
 AAA GGA CAG TGG GCA CTG GA 3’ 
67 
VII E5, 3’-UTR 150 1943 to 2092 
GH3’-Fwd: 
GH3’-Rev: 
5’
 CCT TCT AGT TGC CAG CCA TCT GTT G 3’ 
5’
 CCA CCC CCT AGA ATA GAA TGA CAC CTA C 3’ 
64.5 
†
 According to the published oGH gene sequence GenBank accession number X12546 (Orian et al., 1988).
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For SSCP analysis, 4 µl or 5 µl of each amplification product were added to 12 µl or 
15 µl of stop solution (95% formamide, 10 mM NaOH, 0.05% xylene cyanol and 0.05% 
bromophenol blue). The samples were heat-denatured at 95ºC for 5 min, immediately chilled 
on ice, and loaded onto native 8-12% polyacrylamide gels, with 2.5% crosslinking and 0.5 or 
1x TBE buffer. Gels were run at constant power (25 or 40 W) and temperature (8 to 20ºC), for 
an optimized time (4 to 9 h) in a DCode Universal Mutation Detection System (BIO-RAD, 
Hercules, USA), coupled to a refrigeration system. After the run, gels were silver stained 
(PlusOne DNA Silver Staining Kit, Amersham Biosciences, Uppsala, Sweden). SSCP 
patterns were identified and assigned a capital letter. 
After cloning and sequencing the oGH gene copies and the inter-copy region (see 
section III.5), PCR-SSCP analyses were further carried out on each oGH gene copy separately 
using the previously described conditions. PCR amplicons of the oGH copies as well as cloned 
oGH copies were used as DNA templates. Genotypes were assigned to each amplified fragment 
(I through VII) produced from each gene copy.
 
III.5 Cloning and sequencing of the oGH gene copies and of the 
inter-copy region 
In order to specifically assign the SSCP bands to the GH2-N (or GH1) or the GH2-Z 
gene copies, cloning and sequencing of the inter-copy region was performed. A DNA fragment 
4527 pb long (ranging from the exon 5 of the GH2-N copy to the exon 3 of the GH2-Z copy; 
Figure III-2) of a Gh2/Gh2 animal was amplified with primers GH5-Fwd and GH3-Rev 
(Table III-3). The PCR reaction was performed in a final volume of 50 µl according to the 
following conditions: 250 ng of genomic DNA; 3 pmoles of each primer; 1.0 unit of TaKaRa 
LA TaqTM (TAKARA SHUZO CO., Ltd, Japan); 1x of 2x GC Buffer I with 2.5 mM MgCl2 and 
400 µM of each dNTP. Amplification cycles included an initial denaturation at 94ºC for 1 min 
followed by 30 cycles of denaturation at 98ºC for 20 s, annealing from 60ºC for 12 min, and a 
final extension at 72ºC for 10 min. The PCR products were column purified, cloned into the 
pCR®-XL-TOPO® vector according to the instructions of the TOPO XL PCR Cloning Kit 
(Invitrogen Life Technologies; Carlsbad, CA, USA) and transformed into competent E. coli 
One Shot® TOP10 cells. Recombinant plasmids DNA were purified using the QIAGEN® 
Plasmid Midi Kit (QIAGEN GmbH, Hilden, Germany) following manufacturer 
recommendations. The 4527 pb long DNA fragment was sequenced from both ends (GenBank 
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accession number: DQ238053; Appendix 3). Sequencing reactions were performed according 
to the protocol from the ABI Prism® BigDyeTM Terminator Cycle Sequencing Ready Reaction 
Kit (PE Biosystems, Warrington, England) and repeated for confirmation. The DNA was 
purified using ethanol precipitation and analysed using an Automatic Sequencer 3730xI. 
 
Figure III-2. Gh2 allele in sheep (following Valinsky et al., 1990) containing the GH2-N and 
GH2-Z copies in tandem. 
The black boxes represent the exons. The dashed arrows indicate the supposed duplicated region. The blue box 
indicates the amplified 4527 pb fragment containing the inter-copies region. Adapted from Wallis et al. (1998). 
 
Alignment of the sequences of GH2-N and GH2-Z gene copies with the inter-copy 
region sequence using Vector NTI® Suite software (InforMax®, Bethesda, MD, USA) revealed 
nucleotide variations (see section IV.2.3) that allowed the design of primers specific for the 
GH2-Z copy and showed that the GHT-Fwd primer was specific for the GH1 and GH2-N 
copies. The oGH copies of 20 animals, representative of all SSCP patterns, were subsequently 
sequenced. GH1 and GH2-N copies were PCR amplified using the GHT-Fwd and GHT-Rev 
primers. The GH2-Z copy was amplified using primers GHZ-Fwd (5’ GAG GAG TAA ATG 
AAA TGA GGT C 3’) and GHZ-Rev (5’ CCT CTG TGC TAT GTC CTT CAC AAG C 3’) 
designed according to GenBank accession numbers: DQ238053 (our results; Appendix 3) and 
M37310 (Byrne et al., 1987), respectively. The PCR of the GH1 and GH2-N copies was 
performed as described previously (see section III.3). The PCR of the GH2-Z copy was 
performed as described above for the inter-copy region using annealing temperature of 50°C. 
The PCR products of the oGH gene copies were cloned and sequenced as described above 
and/or directly sequenced after purification using the QIAquick Gel Extraction Kit (QIAGEN 
GmbH, Hilden, Germany). 
All sequences were submitted to the GenBank data base: 
- GH1 copy: GenBank accession numbers DQ450146-DQ450147; 
- GH2-N copy: GenBank accession numbers DQ461644-DQ461681; 
Gh2 
0                    2                     4                     6                    8                    10 kpb    
   
  GH2-N                                        GH2-Z 
4527 pb fragment 
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- GH2-Z copy: GenBank accession numbers DQ461615-DQ461643. 
After alignment of the sequencing data (Vector NTI Suite software, InforMax, 
Bethesda, MD, USA), GH2-N, GH2-Z and associated GH2-N and GH2-Z genotypes were 
established. Haplotypes and their frequencies were inferred using the Family-Based 
Association Tests software (FBAT; Horvath et al., 2004). 
The HWE of the SSCP alleles of GH2-N and GH2-Z copies was tested with the 
population genetic software package GENEPOP v3.4 (http://wbiomed.curtin.edu.au/genepop/; 
Garnier-Gere and Dillmann, 1992; Raymond and Rousset, 1995a, b). Estimation of exact 
P-values was performed by the Markov chain method. Markov chain parameters for all tests 
were: dememorization – 10000; batches – 100; and iterations per batch – 5000.
 
III.6 Statistical analysis 
III.6.1 oGH copy number genotypes 
Two different statistical analyses were performed considering two data sets: 
- Data set 1 – milk yield records of the genotyped ewes; 
- Data set 2 – milk yield records of the genotyped animals (ewes and rams) progeny. 
III.6.1.1 Data set 1 – Milk yield in the genotyped ewes 
Data set 1 was statistically analysed to test possible associations between milk yield 
adjusted to 150 lactation days and copy number genotypes. Data was analysed by restricted 
maximum likelihood (REML) through univariate analyses with repeated measures using the 
BLUP - Animal Model and multiple-trait derivative free restricted maximum likelihood 
analysis (MTDFREML; Boldman et al., 1993). The following model was used: 
y = Xβ + Zaa + Zpp + e 
where,  y is the vector of milk records; β is the vector of fixed effects which included 
the effect of year-flock (year 1992 flock 1, year 1997 flock 1, …, year 2001 flock 7), of month 
of lambing (August, September, …, December), type of lambing (simple or multiple), variety 
(white or black), the linear and quadratic effect of the ewes’ lambing age, and the effect 
associated with the genotypes studied; a is the vector of random additive genetic effects; p is 
the vector of random permanent environmental effects; e is the vector of random residual 
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effects. X, Za and Zp are the incidence matrixes which relate the fixed (X) and random (Za and 
Zp) effects with the vector of milk records, y. In the relationship matrix A 750 animals were 
considered. 
To solve the mixed model equations (MME; 1) it was assumed that =2.4, which 
corresponds to milk production heritability of 0.25 and that γ=4, which corresponds to a 
repeatability of 0.40.  
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In the mixed model equations, A is the relationship matrix between all animals 
(genotyped ewes with milk records and their pedigrees: 750 animals); I is the identity matrix; 
b is the solution for fixed effects; a is the solution for genetic effects and p is the solution for 
permanent environmental effects, where: 
2
2
a
e
σ
σ
=α  and 2
2
pe
e
σ
σ
=γ  
Solutions for the effects of the analysed genotypes upon milk yield, contrasts between 
the analysed genotypes and the corresponding significance test were obtained through option 4 
of the subroot MTDFRUN (solutions for MME then sampling variances) from the 
MTDFREML program (Boldman et al., 1993), using estimates of genetic additive ( 2aσ ), 
permanent environmental ( 2peσ ) and residual ( 2eσ ) variances of the "Serra da Estrela" ovine 
population (Department of "Genética e Melhoramento Animal" of the EZN, personnal 
communication). 
Only genotypes Gh1/Gh2 and Gh2/Gh2 were considered, as genotype Gh1/Gh1 was 
only found in one ewe. 
III.6.1.2 Data set 2 – Milk yield in the genotyped animals’ progeny 
Data set 2 was statistically analysed to test possible associations between milk yield 
adjusted to 150 lactation days and the probability of a ewe to receive allele Gh2 from its 
genotyped progenitor (dam or sire). The probability values were 0, 0.5 or 1 depending on 
whether the progenitor genotype was Gh1/Gh1, Gh1/Gh2 or Gh2/Gh2. Data was analysed 
following two models. 
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Model 1 was similar to the model described in section III.6.1.1, considering the 
probability of a ewe to receive allele Gh2 from its genotyped progenitor (dam or sire) as a fixed 
effect. The fixed effect of the genotyped progenitor was added to the model. . Thus the vector 
of fixed effects (β) included the effect of year-flock (year 1995 flock 1, year 1997 flock 1, …, 
year 2005 flock 30), of month of lambing (August, September, …, February), type of lambing 
(simple or multiple), variety (white or black), the linear and quadratic effect of the ewes’ 
lambing age, and the effect of the probability of a ewe to receive allele Gh2 from its genotyped 
progenitor (dam or sire). In the relationship matrix A 1113 animals were considered. 
Model 2 was similar to model 1, but the probability of a ewe to receive allele Gh2 from 
its genotyped progenitor (dam or sire) was analysed as a covariate. A regression coefficient (b1) 
was obtained for the Gh2 allele, which corresponds to the milk yield deviation observed for 
each additional Gh2 allele received from the progenitor. Regression coefficient was considered 
significant (P<0.05) when b1 absolute value was higher than twice its respective standard error 
(SE) (if b1– 2×SE > 0, then P<0.05; Boldman et al., 1995). 
III.6.2 Polymorphism at the oGH copies 
Data was statistically analysed to test possible associations between milk, fat and 
protein yields adjusted to 150 lactation days, fat and protein contents and oGH2-N and GH2-Z 
copies genotypes and phenotypes taken separately or associated. Data was analysed as 
described in section III.6.1.1. The vector of fixed effects (β) included the effect of year-flock 
(year 1996 flock 1, year 1997 flock 1, …, year 2000 flock 7), of month of lambing (August, 
September, …, December), type of lambing (simple or multiple), variety (white or black), the 
linear and quadratic effect of the ewes’ lambing age, and the effect associated with the 
genotypes and phenotypes studied. In the relationship matrix A 750 animals were considered. 
Milk fat and protein contents and milk fat and protein yield were only available from 
1998 and in six flocks. Thus, the effect of year-flock was replaced by the effect of the flock 
only. To solve the mixed model equations (1, see section III.6.1.1) a heritability of 0.40 was 
considered for milk fat and protein contents and of 0.25 for milk fat and protein yields. 
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III.7 Bioinformatics 
The sequences obtained were analysed using specific bioinformatics tools. 
III.7.1 Gene finding 
Gene finding were performed both by homology and ab initio methods. The homology 
method used was BLASTN (Altschul et al., 1997; http://www.ncbi.nlm.nih.gov/BLASTN/), a 
standard pairwise comparison method which indicates the rough position of exons. The ab 
initio methods used were: 
- NetGene2 v2.4 (Brunak et al., 1991; Hebsgaard et al., 1996; http://www.cbs.dtu.dk/ 
services/NetGene2/) uses artificial neural networks to predict splice sites location. 
- GENSCAN 1.0 (Burge and Karlin, 1997; http://genes.mit.edu/GENSCAN.html). It 
uses generalized hidden Markov models (GHMM) to predict complete gene 
structures. 
- Eukaryotic GeneMark.hmm v2.2a (Lomsadze et al., 2005; http://exon.gatech.edu/ 
GeneMark/eukhmm.cgi) with Homo sapiens matrix. It uses explicit state duration 
hidden Markov models (HMMs). The optimal gene candidates, selected by HMM 
and dynamic programming are further processed by a ribosomal binding site 
recognition algorithm. 
The combined results of the referred methods led to a consensus in exon prediction and 
allowed sequences annotation and subsequently protein inference. 
III.7.2 Transcription factors binding sites 
Sequencing results showed that the 5’ region of the oGH gene is identical in the GH1 
and GH2-N copies and different from the GH2-Z copy. Thus, a characterization of the 
regulatory factors involved in the oGH gene copies transcription control (~1 kb upstream of the 
exon 1) was performed. Putative transcription factors binding sites were identified using the 
PATCH public 1.0 pattern search for transcription factor binding sites (http://www.gene-
regulation.com/cgi-bin/pub/programs/patch/bin/patch.cgi) using TRANSFAC® 6.0 public sites 
(BIOBASE Biological Databases/ Biologische Datenbanken GmbH, Wolfenbüttel, Germany; 
Matys et al., 2003). The TRANSPLORER® site prediction tool uses position weight matrix 
(Chen et al., 1995) and matrices derived from the TRANSFAC® database 
(http://www.biobase.de/pages/ products/databases.html). 
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III.7.3 Protein analysis 
Conceptual translation of each haplotype was done with Vector NTI Suite software 
(InforMax, Bethesda, MD, USA). Protein motif search was run under PROSITE 
(http://www.expasy.org/prosite/). 
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“Perfect as the wing of a bird may be,  
 it will never enable the bird to fly if 
unsupported by the air. 
Facts are the air of science.” 
 
Ivan Pavlov (1849 - 1936) 
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IV.1 oGH copy number genotypes 
IV.1.1 Probe preparation 
A 2055 bp DNA probe containing the oGH gene was amplified and digoxigenin 
(DIG)-labelled as described in section III.3. The evaluation of probe labelling efficiency 
was performed through the analysis of PCR-labelled probe by agarose gel electrophoresis 
(Figure IV-1), as labelled product has a significant greater molecular weight than the unlabeled 
product, due to DIG incorporation into the product.
  
 
Figure IV-1. Evaluation of PCR DIG labelling efficiency of 
the 2055 bp probe in agarose gel electrophoresis. 
The unlabeled PCR product (1) and the corresponding DIG-labelled PCR 
product (2) were separated by electrophoresis in a 0.8% agarose gel.  
M: molecular weight marker
.
IV.1.2 oGH copy number genotyping 
Sheep can be homozygous for one copy (GH1, Gh1 allele), homozygous for the two 
copies (GH2-N and GH2-Z, Gh2 allele) or heterozygous for the copy number (Gh1 and Gh2 
alleles) (Wallis et al., 1998). Southern blotting analysis of the genomic DNA of the 89 “Serra 
da Estrela” sheep digested with EcoRI showed the three oGH genotypes Gh1/Gh1, Gh1/Gh2 
and Gh2/Gh2 (Figure IV-2) previously described (Gootwine et al., 1998). The Gh1/Gh1 
genotypes were confirmed by BamHI- and HindIII-RFLP analysis. 
The observed genotypic and allelic frequencies are shown in Figure IV-3. The studied 
population was found in Hard-Weinberg equilibrium (χ2=0.123; df=2; P>0.10). 
Considering only the 56 ewes genotyped for the oGH copy number, with available milk 
yield records, the observed genotypic frequencies were 1.14%, 15.91% and 82.95% for 
Gh1/Gh1, Gh1/Gh2 and Gh2/Gh2 genotypes, respectively. Allele frequencies were 9.09% for 
the Gh1 allele and 90.91% for the Gh2 allele. These animals were also found in 
Hardy-Weinberg equilibrium (χ2=0.508; df=2; P>0.10). 
 2 Kbp 
M    1    2 
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Figure IV-2. EcoRI-restriction fragment length polymorphism at the growth hormone locus in 
“Serra da Estrela” sheep. 
Ovine genomic DNA was digested with EcoRI, separated on a 0.8% agarose gel, and blotted onto positively 
charged nylon membranes. The blots were hybridized with 50 ng/mL of a DIG-labeled oGH gene DNA probe. 
Chemiluminescent detection was according to the standard DIG chemiluminescent detection procedure using 
CSPD at 0.25 mM final concentration and exposure of the blot to X-ray film for 30 min. 
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Figure IV-3. oGH copy number genotypic and allelic frequencies in the “Serra da Estrela” 
sheep. 
 
IV.1.3 Statistical analysis 
IV.1.3.1 Milk yield in the genotyped ewes 
The impact of the oGH copy number genotype on milk yield adjusted to 150 lactation 
days was statistically analysed as described section III.6.1.1. The number of records used in 
univariate analyses was 259 lactations from the 56 oGH copy number genotyped ewes. The 
mean milk yield adjusted to 150 lactation days (± SD) was 180.8 ± 90.6 l.  
Ewes with Gh2/Gh2 genotype produced 4.9 ± 8.6 l/150 d more than ewes with 
Gh1/Gh2 genotype (P>0.05). Only one ewe of the genotyped population presented the 
Gh1/Gh1 genotype, so this genotype was not considered in the analysis. 
IV.1.3.2 Milk yield in the genotyped ewes animals’ progeny 
The impact of the probability of a ewe to receive the Gh2 allele from either progenitor 
on milk yield adjusted to 150 lactation days was statistically analysed as described in 
12 kb 
6 kb 
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section III.6.1.2. The mean milk yield adjusted to 150 lactation days (± SD) was 141.8 ± 60.3 l 
and the mean daily milk yield (± SD) was 0.94 ± 0.40 l. 
The probability of a ewe to receive allele Gh2 was tested as a covariate and as a fixed 
effect (Figure IV-4). The first analysis (model 1) showed that the ewes which received allele 
Gh2 yielded on average 26.4 ± 7.2 l/150 d more than ewes which received allele Gh1 (P<0.01), 
and 3.0 ± 8.3 l/150 d more than ewes which could have received either Gh1 or Gh2 alleles 
(P>0.05). The second analysis (model 2) showed that ewes which received allele Gh2 yielded 
on average 21.9 ± 7.5 l/150 d more than ewes that received allele Gh1 (P<0.05). These results 
suggest that the Gh2 allele has a strong positive effect upon milk production in “Serra da 
Estrela” ewes. 
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Figure IV-4. Effect of the probability of a ewe to receive alleles Gh1, Gh2 or either from their 
progenitor on milk yield adjusted to 150 lactation days (± SE). 
Model 1 – probability of receiving one of the alleles analysed as a fixed effect; Model 2 - probability of receiving 
one of the alleles analysed as a covariate; ns - P>0.05; * - P<0.05; ** - P<0.01.
 
IV.2 oGH gene SSCPs’ detection, charaterization and influence on 
milk traits 
IV.2.1 PCR-SSCP analysis 
Seven PCR fragments (I to VII) containing the five oGH exons, the 5’-UTR and the 
3’-UTR analysed by PCR-SSCP were found to be highly polymorphic (Figure IV-5). Except 
for the 5’-UTR, the primers used in the amplification were not copy-specific due to the high 
homology of sequences in the 3’-UTR, and in exons and adjacent intronic regions. PCR-SSCP 
revealed four SSCP patterns in the fragment I, two in fragment II, 17 in fragment III, eight in 
fragment IV, two in fragment V, five in fragment VI, and seven in fragment VII. SSCP pattern 
frequencies (total and by flock) are shown in Table IV-1 and Table IV-2. The most frequent 
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SSCP pattern was denoted as A for all the fragments. Its frequency was found to be 91.88% in 
fragment I, 93.12% in fragment II, 22.41% in fragment III, 57.36% in fragment IV, 84.70% in 
fragment V, 48.18% in fragment VI and 36.82% in fragment VII. However, considering each 
flock separately, the SSCP pattern A was not found to be the most frequent one for some 
fragments. 
 
 
Figure IV-5. PCR-SSCP patterns for fragments I (5’-UTR, exon 1), II (5’-UTR, exon 1, 
intron 1), III (intron 1, exon 2, intron 2), IV (intron 2, exon 3, intron 3), V (intron 3, exon 4, 
intron 4), VI (intron 4, exon 5, 3’-UTR) and VII (exon 5, 3’-UTR) of “Serra da Estrela”  
oGH gene separated by native PAGE under non-denaturing conditions. The horizontal line is a schematic 
representation of the oGH gene. Exons are represented by black boxes and UTRs by striped boxes. Boundaries of 
these fragments are indicated in base pairs according to the published oGH gene sequence (exons following Orian 
et al., 1988; GenBank accession number X12546; 3’-UTR following UTR accession number: 3OAR000234). 
Different PCR-SSCP patterns within each fragment were randomly identified with a capital letter. 
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Table IV-1. SSCP patterns found at the oGH fragments I, II, III and IV, the corresponding 
genotypes (in italic figures) and frequencies (%) in “Serra da Estrela” sheep population (SE) 
and in each of the seven flocks (FL1 to FL7). 
Flock 
Fragment 
SSCP 
pattern 
Genotype* 
SE 
(523) FL1 
(58) 
FL2 
(71) 
FL3 
(71) 
FL4 
(73) 
FL5 
(116) 
FL6 
(82) 
FL7 
(52) 
(IN)/(IZ)** A (1/1)/(na) 91.88 98.28 66.67 88.57 91.55 97.41 98.77 100.00 
 B (2/3)/(na) 6.77 0.00 28.99 11.43 7.04 1.72 0.00 0.00 
 C,D nd  1.35 1.72 4.35 0.00 1.41 0.86 1.23 0.00 
(IIN)/(IIZ) A (1/1)/(1/1) 93.12 87.93 95.77 100.00 65.75 100.00 98.78 100.00 
 
B 
(1/2)/(1/1) or 
(2/2)/(1/1) 6.88 12.07 4.23 0.00 34.25 0.00 1.22 0.00 
(IIIN)/(IIIZ) A (1/4)/(3/3) 22.41 29.31 26.76 1.41 27.40 18.97 34.57 19.23 
 B (1/5)/(1/1) 18.01 6.90 23.94 46.48 16.44 7.76 13.58 15.38 
 C (1/1)/(1/1) 16.09 10.34 15.49 11.27 23.29 14.66 19.75 17.31 
 D (1/1)/(2/3) 11.11 13.79 1.41 1.41 6.85 27.59 6.17 11.54 
 E (1/1)/(1/1) 7.47 8.62 14.08 2.82 16.44 1.72 1.23 13.46 
 F (1/1)/(2/2) 4.98 3.45 0.00 9.86 2.74 8.62 1.23 7.69 
 G (1/1)/(2/4) 4.41 5.17 2.82 4.23 4.11 5.17 7.41 0.00 
 H (1/1)/(1/5) 3.64 1.72 8.45 4.23 2.74 1.72 3.70 3.85 
 I (1/3)/(2/2) 3.26 3.45 1.41 4.23 0.00 6.90 1.23 3.85 
 J (1/2)/(1/2) 2.30 1.72 0.00 7.04 0.00 2.59 1.23 3.85 
 K (1/1)/(1/4) 1.92 0.00 0.00 2.82 0.00 2.59 4.94 1.92 
 L (1/6)/(4/4) 1.72 5.17 2.82 1.41 0.00 0.00 2.47 1.92 
 M (1/1)/(nd) 1.53 6.90 1.41 0.00 0.00 1.72 1.23 0.00 
 O (1/1)/(-/-) 0.38 0.00 0.00 1.41 0.00 0.00 0.00 0.00 
 N,P,Q nd  0.77 3.45 1.41 1.41 0.00 0.00 1.23 0.00 
(IVN)/(IVZ) A (1/2)/(1/1) 57.55 74.14 61.97 22.54 87.67 48.28 70.73 38.46 
 B (1/1)/(1/2) 19.69 3.45 28.17 46.48 8.22 17.24 10.98 25.00 
 C (1/1)/(1/3) 8.60 1.72 0.00 19.72 1.37 12.07 6.10 19.23 
 D (1/2)/(1/3) 5.54 12.07 1.41 0.00 1.37 12.07 2.44 7.69 
 E (1/3)/(3/3) 4.59 3.45 2.82 5.63 0.00 9.48 0.00 9.62 
 F (1/4)/(3/4) 2.10 5.17 2.82 2.82 1.37 0.00 3.66 0.00 
 G (1/1)/(5/5) 1.72 0.00 2.82 1.41 0.00 0.86 6.10 0.00 
 H (1/2)/(-/-) 0.38 0.00 1.41 1.41 0.00 0.00 0.00 0.00 
* - Genotypes were determined by copy specific fragment sequencing (for individual fragment allele details see 
Table IV-4); (1/1)/(1/1) – GH2-N/GH2-Z homozygous genotype at both oGH copies; (1/2)/(1/2) – GH2-N/GH2-Z 
heterozygous genotype at both oGH copies; (1/2)/(1/1) - GH2-N/GH2-Z heterozygous genotype at GH2-N copy; 
(1/1)/(1/2) – GH2-N/GH2-Z heterozygous genotype at GH2-Z copy; (1/1)/(-/-) – GH1 homozygous genotype 
(GH2-Z copy absent) etc.; (n) - number of animals; na – not analysed by SSCP; nd - genotype not determined. 
** - SSCP analysis performed either at the GH1 copy or at the GH2-N copy of the oGH gene 
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Table IV-2. SSCP patterns found at the oGH fragments V, VI and VII, the corresponding 
genotypes (in italic figures) and frequencies (%) in “Serra da Estrela” sheep population (SE) 
and in each of the seven flocks (FL1 to FL7). 
Flock 
Fragment 
SSCP 
pattern 
Genotype* 
SE 
(523) FL1 
(58) 
FL2 
(71) 
FL3 
(71) 
FL4 
(73) 
FL5 
(116) 
FL6 
(82) 
FL7 
(52) 
(VN)/(VZ) A 
(1/1)/(1/1) or 
(1/1)/(-/-) 84.70 58.62 77.46 91.55 75.34 93.97 93.90 92.31 
 B (1/1)/(1/1) 15.30 41.38 22.54 8.45 24.66 6.03 6.10 7.69 
(VIN)/(VIZ) A (1/1)/(1/2) 48.18 15.52 64.79 84.51 35.62 41.38 43.90 51.92 
 
B 
(1/1)/(1/1) or 
(1/1)/(-/-) 31.74 29.31 14.08 7.04 15.07 53.45 50.00 38.46 
 C (2/3)/(1/2) 13.58 36.21 21.13 8.45 19.18 5.17 4.88 9.62 
 D (4/5)/(1/3) 5.35 13.79 0.00 0.00 27.40 0.00 0.00 0.00 
 E (6/7)/(3/3) 1.15 5.17 0.00 0.00 2.74 0.00 1.22 0.00 
(VIIN)/(VIIZ) A (1/1)/(1/3) 36.82 13.79 21.43 57.35 13.70 64.91 35.80 28.85 
 B (1/5)/(2/3) 25.19 15.52 45.71 32.35 31.51 6.14 19.75 40.38 
 C (1/1)/(1/1) 12.79 13.79 10.00 0.00 5.48 16.67 25.93 13.46 
 D (2/2)/(2/3) 9.69 24.14 14.29 7.35 10.96 4.39 3.70 9.62 
 E (3/3)/(4/4) 5.81 10.34 0.00 0.00 5.48 7.02 11.11 5.77 
 F (6/7)/(3/3) 5.43 17.24 7.14 0.00 10.96 0.88 3.70 1.92 
 G (2/2)/(2/4) 4.26 5.17 1.43 2.94 21.92 0.00 0.00 0.00 
* - Genotypes were determined by copy specific fragment sequencing (for individual fragment allele details see 
Table IV-4); (1/1)/(1/1) – GH2-N/GH2-Z homozygous genotype at both oGH copies; (1/2)/(1/2) – GH2-N/GH2-Z 
heterozygous genotype at both oGH copies; (1/2)/(1/1) - GH2-N/GH2-Z heterozygous genotype at GH2-N copy; 
(1/1)/(1/2) – GH2-N/GH2-Z heterozygous genotype at GH2-Z copy; (1/1)/(-/-) – GH1 homozygous genotype 
(GH2-Z copy absent) etc.; (n) - number of animals. 
 
In fragment (IN)/(IZ), the SSCP pattern A was found to be the most frequent in all flocks 
(Table IV-1). SSCP pattern B, the second most frequent in the overall population (6.77%), is 
present in 15.82% of the black variety FL2, FL3 and FL4 flocks, is absent in the white variety 
FL1, FL6 and FL7 flocks or rare (FL5 – 1.72%). Patterns C and D are absent in FL3 and FL7 
flocks (high milk yielding flocks). 
SSCP pattern A of fragment (IIN)/(IIZ) is the most frequent in all flocks. SSCP pattern B 
was not found in FL3, FL5 and FL7 flocks, being quite rare in FL6 (1.23%) and having some 
expression in low milk yielding FL1 (12.07%) and FL4 (34.25%) flocks. 
oGH fragment (IIIN)/(IIIZ) is the most polymorphic with eleven SSCP patterns or more, 
in all flocks except in FL4, which is the less polymorphic flock with eight SSCP patterns 
(Table IV-1). SSCP pattern A is the most frequent in all but in FL3 and FL5. The most 
frequent SSCP pattern is pattern B in FL3 (46.48%) and pattern D in FL5 (27.59%). Some 
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SSCP patterns are relatively frequent in particular flocks, and were found at low frequencies or 
not found at all in other flocks, e.g., pattern A with 1.41% in FL3 and with 18 to 35% in the 
other flocks; pattern D with 1.41% in FL2 and FL3 and with 27.59% in FL5; pattern O was 
only found in FL3, but at a very low frequency (1.41%). 
In fragment (IVN)/(IVZ), the SSCP pattern A was found to be the most frequent in all 
flocks except in FL3. The most frequent SSCP pattern in FL3 is pattern B (46.48%). The 
frequency distribution between flocks was found to be quite wide in patterns A (ranging from 
22.54% in FL3 to 87.67% in FL4) and B (ranging from 3.45% in FL1 to 46.48% in FL3) 
(Table IV-1). 
In fragment (VN)/(VZ), the SSCP pattern A was found to be the most frequent in all 
flocks (ranging from 58.62% in FL1 to almost 94% in FL5 and FL6). Pattern B, the less 
frequent one, was found more often in the low milk yielding FL1 (41.38%) and F4 (24.66%) 
flocks and also in FL2 (22.54%), a medium milk yielding flock (Table IV-2). 
In fragment (VIN)/(VIZ), the most frequent SSCP patterns are pattern A in FL2 
(64.79%), FL3 (84.51%), FL4 (35.62%) and FL7 (51.92%); pattern B in FL5 (53.45%) and FL6 
(50.00%); and pattern C in FL1 (36.21%). Pattern D was only found in the low milk yielding 
flocks FL1 (13.79%) and FL4 (27.40%), being FL4 the second more frequent pattern. 
In fragment (VIIN)/(VIIZ), the most frequent SSCP patterns are pattern A in FL3 
(57.35%), FL5 (64.91%) and FL6 (35.80%); pattern B in FL2 (45.71%), FL4 (31.51%) and FL7 
(40.38%); and pattern D in FL1 (24.14%). 
FL7 flock presents a smaller number of SSCP patterns in all but in fragment (VN)/(VZ) 
(Table IV-1 and Table IV-2). 
IV.2.2 Hardy-Weinberg equilibrium test 
HWE tests were performed in each flock and in the overall population considering each 
of the oGH copy gene fragments as an individual locus and SSCP alleles as the loci’ alleles, 
(Table IV-3). Tests were also made to assess heterozygote deficit or excess, as heterozygote 
disequilibrium could reflect the influence of factors such as selection, inbreeding or the 
existence of null alleles. 
HWE was found in fragment IIN and IIIN in all flocks and in fragment IVN in FL3 and 
fragment IVZ in FL4. The total population was not in HWE (χ2=∞; df=84; P<0.001). 
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Heterozygote deficit was found in fragments IN in flock FL5; in fragment VIIN in all but 
FL3; in fragment IIIZ in all flocks; in fragment IVZ in FL2, FL3, FL5 and FL6; in fragment VIZ 
in FL6 and in fragment VIIZ in all flocks. Heterozygote excess was found in fragment IIIN in all 
flocks; in fragment IVN in all but FL3; and in fragment VIZ in FL2, FL3, FL4, FL5 and FL7. 
 
Table IV-3. Hardy-Weinberg equilibrium, heterozygote deficit and excess tests’ significance 
levels for the oGH copy gene fragments IN to IVN, VIN, VIIN, IIIZ, IVZ, VIZ and VIIZ. 
Flock P-value IN IIN IIIN IIIZ IVN IVZ VIN VIZ VIIN VIIZ 
FL1 PHWE - ns ns *** *** ** *** *** *** *** 
 PD - ns ns *** ns † ns ns *** *** 
 PE - ns ** ns *** ns ns ns ns ns 
FL2 PHWE *** ns ns *** *** *** *** *** *** *** 
 PD ns ns ns *** ns *** ns ns *** *** 
 PE ns ns ** ns *** ns ns *** ns ns 
FL3 PHWE *** - † *** ns *** *** *** *** *** 
 PD ns - ns *** ns * ns ns ns ** 
 PE ns - *** ns † ns ns *** ns ns 
FL4 PHWE *** ns ns *** *** † *** *** *** *** 
 PD ns ns ns *** ns ns ns ns *** *** 
 PE ns † ** ns *** ns ns *** ns ns 
FL5 PHWE *** - ns *** *** *** *** *** *** *** 
 PD ** - ns ** ns *** ns ns ** *** 
 PE ns - ** ns *** ns ns *** ns ns 
FL6 PHWE - - ns *** *** *** *** *** *** *** 
 PD - - ns *** ns ** ns ** ** *** 
 PE - - *** ns *** ns ns ns ns ns 
FL7 PHWE - - ns *** * * *** ** *** *** 
 PD - - ns *** ns ns ns ns * *** 
 PE - - * ns ** ns ns *** ns ns 
ALL1 χ2 223.9 4.4 15.8 ∞ 221.0 ∞ ∞ 234.7 ∞ 628.3 
 Df 8 6 14 14 14 14 14 14 14 14 
 Sign. *** ns ns *** *** *** *** *** *** *** 
1
 – Detemined by Fisher's method for the seven flocks; PHWE – significance level for HWE test; PD - significance 
level for heterozygote deficit; - PE - significance level for heterozygote excess. 
ns – P>0.10; † - P>0.05; * - P<0.05; ** - P<0.01; *** - P<0.001. 
 
IV.2.3 Sequencing of the inter-copy region and separate PCR-SSCP fragment 
analysis of each oGH gene copy 
The duplication of the GH gene in Ovis aries causes the PCR-SSCP analysis to be 
complex. A minimum of one and a maximum of four alleles can be differentiated by the SSCP 
analysis depending on the copy number genotype and on the zygotic condition (homo or hetero) 
of the animal for the analysed DNA fragment. In order to specifically assign the SSCP bands to 
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each copy the following strategy was followed. The inter-copy region was PCR amplified, 
cloned and sequenced (GenBank accession number: DQ238053). Sequence analysis disclosed 
major differences in the 5’ regions of the oGH copies (Figure IV-6) allowing the design of 
primers for the specific amplification of each copy. 
 
3520 3530 3540 3550 3560 3570 3580(3520)
TTTTTGAATTTTCATACTGTTCATGGGATTCTCAAGGCAAGAATACAGAAGTGGTTTACCATTGCCTTCTDQ238053(3517)
CCTGGGGGACATGACCCCAGAGAAGGAACGGGAACAGGATGAGTG-AGAGGAGGTTCTAAATTA-----TX12546 (85)
CCTGGGGGACATGACCCCAGAGAAGGAACGGGAACAGGATGAGTG-AGAGGAGGTTCTAAATTA-----TM37310 (785)
----------------CCAGAGAAGGAACGGGAACAGGATGAG---------------------------GHT-Fwd (1)
CCTGGGGGACATGACCCCAGAGAAGGAACGGGAACAGGATGAGTG AGAGGAGGTTCTAAATTA     TConsensus(3520)
 
Figure IV-6. Alignment of the sequence of a fragment of the inter-copy region DQ238053 (our 
results) containing the 5’-UTR of the GH2-Z copy with previously published sequences of 
fragments containing the 5’-UTR of the GH2-N copy (M37310; Byrne et al., 1987) and GH1 
copy (X12546; Orian et al., 1988) and with primer GHT-Fwd specific for GH1 copy (or 
GH2-N) amplification. 
Note: Aligned sequences present any non-similar (N), identical (N) or conservative (N) nucleotides in each 
position. 
 
The products of these specific amplifications were used as templates for separate 
PCR-SSCP fragment analysis. Superimposition of the SSSP patterns from each copy generated 
the patterns obtained with the non-specific copy fragment amplification performed on genomic 
DNA (Figure IV-7). 
 
 
 
 
Figure IV-7. PCR-SSCP analysis of the fragment IV of the oGH gene. 
IV – PCR-SSCP pattern C of the fragment IV [(1/1)/(1/3) genotype (for individual 
fragment allele details see Table IV-4)]: amplification from genomic DNA was not 
copy specific. 
IVN – PCR-SSCP pattern B of the fragment IVN, a DNA specifically PCR amplified 
from the GH2-N copy was used as a template for fragment IV amplification. 
IVZ – PCR-SSCP pattern B of the fragment IVZ, a DNA specifically PCR amplified 
from the GH2-Z copy was used as a template for fragment IV amplification. 
 
For instance, SSCP pattern B of fragment VI has two bands suggesting that animals 
exhibiting this pattern are homozygous for the copy number and/or for the exon 5 containing 
fragment (Figure IV-5, Table IV-2). This was confirmed by Southern blotting analysis which 
showed that one animal presenting this pattern had the Gh1/Gh1 genotype. In addition, 
sequencing showed that the remaining animals with Gh2/Gh2 genotype were homozygous for 
fragment VI. The more complex pattern C in fragment IV exhibits six bands suggesting that 
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animals presenting this pattern have the Gh2/Gh2 genotype and are heterozygous for the 
fragment IV in one copy and homozygous in the other, or alternatively have the Gh1/Gh2 
genotype and are heterozygous for the GH2-N copy. Southern blotting analysis and sequencing 
showed that the first hypothesis applies (Table IV-2 and Figure IV-7). 
IV.2.4 Molecular characterization of the SSCP patterns 
Twenty sheep carrying each of the SSCP patterns shown in Figure IV-5 were selected 
and genotyped for the copy number. One of these animals had the Gh1/Gh1 genotype, two the 
Gh1/Gh2 genotype and 17 the Gh2/Gh2 genotype. The nucleotide sequence of each oGH gene 
copy fragment was established for the selected animals. SSCP alleles at each fragment were 
molecularly characterized and denoted by an italic figure (Table IV-1 and Table IV-4): e.g., 
allele 1 of fragment IIN [at GH2-N (or GH1) copy] carries bases T301 (T at position 301, 
according to sequence GenBank accession number X12546; Orian et al., 1988) and G305; 
allele 1 of fragment IIIZ (at GH2-Z copy) carries bases G644, C649, C668, C704 and G712. For 
each fragment’s SSCP patterns, a fragment genotype was thus established (Table IV-1 and 
Table IV-2). 
A total of 2055 bp were sequenced at the GH2-N (or GH1) copy and of 2100 bp at 
GH2-Z copy in each of the selected animals. Twenty-four polymorphic sites were found at the 
GH2-N (or GH1) copy and 14 at the GH2-Z copy. Some of these polymorphisms were 
previously reported (Table IV-4). Comparing with the GH1 sequence firstly reported by Orian 
et al. (1988) the GH2-N (or GH1) copy presented a total of 16 transitions, six transversions and 
two insertions/deletions of one nucleotide each. Comparing with the GH2-Z sequence reported 
by Ofir and Gootwine (1997) the GH2-Z copy showed a total of 11 transitions and three 
transversions. Nucleotide polymorphisms were found in all of the studied fragments of the 
GH2-N (or GH1) copy but in fragment VN and in fragments IIIZ, IVZ, VIZ and VIIZ of the 
GH2-Z copy. Although two SCCP patterns were found in the fragments VN and VZ no 
polymorphisms were identified. 
The polymorphic sites were distributed as follows at the GH2-N (or GH1) copy: two in 
fragment IN, two in fragment IIN, seven in fragment IIIN, three in fragment IVN, four in 
fragment VIN and seven in fragment VIIN; at the GH2-Z copy: five in fragment IIIZ, five in 
fragment IZ, two in fragment VZ and two in fragment VIZ. The GH2-N copy was found to be 
more polymorphic than the GH2-Z copy. The number of alleles ranged from two in fragment IN 
to seven in fragment VN and fragment VIN.
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Table IV-4. Nucleotide sequence characterisation of SSCP alleles of each amplified fragment 
at the GH2-N (or GH1) and GH2-Z copies. 
oGH Fragment  GH2-N (or GH1) alleles1 oGH Fragment GH2-Z alleles 2 
(Type)  Site 3 1 2 3 4 5 6 7  (Type) Site 3 1 2 3 4 5 
IN  5UN288 C T T             
(5’-UTR, E1)  5UN293 C C A             
IIN  E1N301 T A              
(5’-UTR, E1, I1)  E1N305 G A              
IIIN   E2N597 T T C T T T   IIIZ E2Z644 G G G A G 
(I1, E2, I2)  E2N651 C C C C C T   (I1, E2, I2) E2Z649 C C C C G 
  E2N666 C T C C C C    E2Z668 C T C C C 
  E2N708 A A A A G A    E2Z704 C C C C G 
  E2N717 C C C C C T    E2Z712 G A A** A G 
  E2N733 A A A G A A          
  E2N738 T T C T T T          
IVN   E3N973 A A T A     IVZ E3Z1035 T C T C C 
(I2, E3, I3)  E3N1024 T T C C     (I2, E3, I3) E3Z1047 A A G G G 
  E3N1047 A G* A A      E3Z1057 A G A G G 
            E3Z1062 G G G G C 
            I3Z1100 A G G G G 
VIN   E5N1872 G A G G G G G  VIZ E5Z1852 G G A   
(I4, E5, 3’-UTR)  E5N1938 C C C C C C T  (I4, E5, 3’-UTR) 3UZ1965 T** C C   
  3UN1980 - T T C T T T         
  3UN2024 - - - - - T T         
VIIN   3UN1980 - T T C - - -  VIIZ 3UZ1965 T T C C  
(E5, 3’-UTR)  3UN2024 - - T - - - -  (E5, 3’-UTR) 3UZ2030 T C C T  
  3UN2036 A A A A A A G         
  3UN2039 C C C C T C C         
  3UN2050 C C C C G C C         
  3UN2059 G G G G G T T         
  3UN2069 G G G G G C C         
1
 Underlined: variants from the GH1 copy sequence reported by Orian et al. (1988; GenBank accession number X12546); * Australian Merino 
breed GH sequence reported by Byrne et al. (1987; GenBank accession number M37310). 
2
 Underlined: variants from the Awassi breed GH2-Z copy sequence reported by Ofir and Gootwine (1997; GenBank accession number 
AF002124 to AF002129); ** Romanov breed GH2-Z copy sequence reported by Ofir and Gootwine (1997; GenBank accession no. 
AF002118 and AF002120). 
3
 Site: U – UTR; E – Exon; I – intron; N – GH2-N (or GH1) copy; Z – GH2-Z copy; e.g., 5UN288 – 5’-UTR at GH2-N (or GH1) copy, position 
288 (According to the published oGH gene sequence (Orian et al. 1988; GenBank accession no. X12546).
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Table IV-5. Polymorphisms found in the coding regions of the oGH gene copies, predicted amino acid changes and protein variants. 
 
oGH GH1 or GH2-N Variants GH2-Z Variants 
Fragment Site* nt aa no. aa a b c d e Site* nt aa no. aa a b c 
III E2N597 TC -16 LeuPro L L P L L E2Z644 GA -1 Gly G G G 
(E2) E2N651 CT 3 ProLeu P P P P L E2Z649 CG 2 PheLeu F F L 
 E2N666 CT 8 SerPhe S F S S S E2Z668 CT 9 ArgCys R C R 
 E2N708 AG 22 HisArg H H H R H E2Z704 CG 21 LeuVal L L V 
 E2N717 CT 25 AlaVal A A A A V E2Z712 GA 23 Gln G G G 
 E2N733 AG 30 Lys K K K K K         
 E2N738 TC 32 PheSer F F S F F        
IV E3N973 AT 35 ThrSer T S T   E3Z1035 TC 55 Ser S S S 
(E3) E3N1024 TC 52 PheLeu F L L   E3Z1047 AG 59 Pro P P P 
 E3N1047 AG 59 Pro P P P   E3Z1057 AG 63 SerGly S G G 
          E3Z1062 GC 64 AsnLys K K N 
VI E5N1872 GA 166 Arg R     E5Z1852 GA 160 GlySer G S  
(E5) E5N1938 CT 188 Ser S            
* According to the published oGH gene sequence (Orian et al., 1988; GenBank accession number X12546). E – exon. 
nt – nucleotide; aa no. – amino acid number of the mature protein (considering N-terminal alanine as amino acid 1 which corresponds to amino acid 
27 of the published oGH sequence with GenPept accession number CAA31063) (Orian et al., 1988). 
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IV.2.4.1 oGH haplotypes 
A total of 86 haplotypes at the GH2-N copy and 32 at the GH2-Z copy were 
inferred from SSCP allele composition, and the DNA sequences of the SSCP alleles shown in 
Table IV-4. Haplotypes were constructed by joining together, separated by a comma, the 
alleles of the analysed fragments, e.g. a GH2-N haplotype composed by allele 1 at fragments I 
to VII is denominated (1,1,1,1,1,1,1). Whenever phase was determine, the haplotypes of a 
genotype were separated by /, e.g. the N1 genotype of the GH2-N copy is 
(1,1,1,1,1,1,1)/(1,1,1,2,1,1,1). Fragment genotypes were separated by a comma whenever phase 
could not be determined. For example, an animal with genotype (1/1) at fragments I, II and III, 
genotype (1/2) at fragment IV, genotype (1/1) at fragments V and VI, and genotype (1/5) at 
fragment VII has a genotype denominated (1/1,1/1,1/1,1/2,1/1,1/1,1/5). The three most frequent 
haplotypes were Hn1 (1,1,1,1,1,1,1 - 42.67%), Hn2 (1,1,1,1,1,1,5 - 11.60%) and 
Hn3 (1,1,1,2,1,1,1 - 5.04%) for the GH2-N copy; and Hz1 (1,1,1,1,2,3 - 14.74%), 
Hz2 (1,2,3,1,1,2 - 11.16%), and Hz3 (1,1,1,1,1,1 - 7.87%), Hz4 (1,1,1,1,1,2 - 7.87%) and 
Hz5 (1,3,1,1,1,1 - 7.87%) for the GH2-Z copy. 
IV.2.4.2 oGH protein variants 
Synonymous and non-synonymous substitutions were found in the exons 2, 3 and 5 of 
the oGH copies (Table IV-5). Eight non-synonymous substitutions were predicted in the 
GH2-N copy and six in the GH2-Z copy. 
Eight GH2-N protein variants (A-F, H and I) are predicted considering non-synonymous 
substitutions. The variant A (VNA) of the GH2-N copy with amino acid partial sequence 
L-16,P3,S8,H22,A25,F32,T35,F52 corresponds to the published oGH sequence with GenPept 
accession number CAA31063 (Orian et al., 1988). The remaining variants differ from A at the 
following residues: var. B - S35,L52; var. C - L52; var. D - R22; var. E - P-16,S32; var. F - F8; var. 
H – P-16,S32,S35,L52; var. I - L3,V25. Synonymous substitutions were found at residues K30 in 
exon 2, P59 in exon 3, R166 and S188 in exon 5. Protein variants A (91.98%) and D (4.69%) were 
found to be the most frequent ones at the GH2-N copy (Table IV-6). 
Ten GH2-Z protein variants (A-J) are predicted considering non-synonymous 
substitutions. The variant A (VZA) of the GH2-Z copy with amino acid partial sequence 
F2,R9,L21,S63,K64,G160 corresponds to the published oGH sequence number Q95205 (Lacroix et 
al., 1996). The remaining variants differ from A at the following amino acids: var. B - C9; var. 
C - S160; var. D - C9,G63; var. E - G63; var. F - L2,V21,G63; var. G - C9,S160; var. H - L2,V21,S160; 
var. I - L2,V21 and var. J – G63,N64. Synonymous substitutions were found at residues G-1 and 
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G23 in exon 2, and S55 and P59 in exon 3. Protein variants A (71.89%), B (13.29%) and E 
(7.68%) were found to be the most frequent ones at the GH2-Z copy (Table IV-6). 
 
Table IV-6. Predicted protein variants’ frequencies (%) at the GH2-N and GH2-Z copies. 
VN GH2-N (%) VZ GH2-Z (%) 
A L-16,P3,S8,H22,A25,F32,T35,F52 91.98 A F2,R9,L21,S63,K64,G160 71.89 
B L-16,P3,S8,H22,A25,F32,S35,L52 0.69 B F2,C9,L21,S63,K64,G160 13.29 
C L-16,P3,S8,H22,A25,F32,T35,L52 0.57 C F2,R9,L21,S63,K64,S160 3.90 
D L-16,P3,S8,R22,A25,F32,T35,F52 4.69 D F2,C9,L21,G63,K64,G160 0.86 
E P-16,P3,S8,H22,A25,S32,T35,F52 0.46 E F2,R9,L21,G63,K64,G160 7.68 
F L-16,P3,F8,H22,A25,F32,T35,F52 0.58 F L2,R9,V21,G63,K64,G160 0.20 
H P-16,P3,S8,H22,A25,S32,S35,L52 0.57 G F2, C9,L21,S63,K64,S160 0.40 
I L-16,L3,S8,H22,V25,F32,T35,F52 0.46 H L2,R9,V21,S63,K64,S160 0.20 
 
  I L2,R9,V21,S63,K64,G160 1.49 
 
  J F2,R9,L21,G63,N64,G160 0.09 
VN – predicted protein variant at the GH2-N copy; VZ – predicted protein variant at the GH2-Z copy. 
 
In all the genotyped sheep exhibiting the two oGH copies (seventeen Gh2/Gh2 and two 
Gh1/Gh2 animals) two amino acid changes were always found between GH2-N and GH2-Z 
copies: aa-7 (P → L) and aa9 (G → R or C). Aa63 differs also between copies (G → S), except 
in animals carrying VZD, VZE, VZF and VZJ protein variants as they present a G63 in both 
copies. 
 
IV.2.5 Statistical analysis 
IV.2.5.1 Milk yield 
The influence of oGH copies genotypes and phenotypes on milk yield adjusted to 150 
lactation days was statistical analysed as described in section III.6.2. Data concerning 1704 
valid lactations from 513 ewes’ official milk records between 1996 and 2000 were used in the 
univarieted analysis. The mean milk yield adjusted to 150 lactation days (± SD) was 
159.5 ± 72.2 l. 
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The statistical analyses were performed considering the GH2-N and GH2-Z copies 
genotypes (Table IV-7 and Table IV-8) and phenotypes (Table IV-10 and Table IV-11) taken 
separately or associated (Table IV-9 and Table IV-12) in the overall population and also by 
flock. Contrasts were performed considering the differences of milk yield adjusted to 
150 lactation days between the different genotypes or phenotypes and the most frequent 
homozygous genotype or phenotypes (whenever it was possible) in each oGH gene copy or 
associated GH2-N and GH2-Z genotype or phenotypes. Genotypes and phenotypes with 
frequencies lower than 2% were excluded from the analysis. The different genotypes and 
phenotypes found in the GH2-N and GH2-Z copies were found to have significant influence on 
milk yield in “Serra da Estrela” ewes (P<0.05). The analyses of the influence of oGH genotypes 
and phenotypes upon milk production within each flock showed that they influence milk yield 
differently depending presumably on flocks’ management, namely at nutritional level, and on 
particular environmental factors of the regions where animals are reared. 
Within GH2-N genotypes a milk yield differential of 21.4 ± 5.9 l/150 d (P<0.01) was 
found between the most (N7) and the least (N5) productive one (Table IV-7). The ewes with 
N7 genotype produced respectively 6.3 ± 5.3 l/150 d and 10.5 ± 5.6 l/150 d more milk than 
ewes with genotypes N1 and N2 which were the most abundant in the studied population 
(13.0% each), however this values were not statistically significant (P>0.05). By flock, the 
major significant differences found in milk yield of animals with different GH2-N genotypes 
were as follows: N11 ewes from FL2 yielded 27.2 ± 11.9 l/150 d more milk than N1 ewes 
(P<0.05); N1 ewes from FL3 yielded 79.2 ± 12.9 l/150 d more milk than N8 ewes (P<0.001); 
N18 ewes from FL5 yielded 52.3 ± 16.3 l/150 d more milk than N10 ewes (P<0.05); N4, N7 
and N8 ewes from FL6 yielded respectively 47.6 ± 9.3 l/150 d, 66.7 ± 11.8 l/150 d and  
62.2 ± 11.9 l/150 d more milk than N2 ewes (P<0.001), with no significant differences in milk 
yield between them (P>0.05); N18 ewes from FL7 yielded 83.7 ± 16.5 l/150 d more milk than 
N2 ewes (P<0.001). No significant milk yield differences were found between GH2-N 
genotypes at FL1+FL4 flock. Increasing the number of N7 and N18 genotypes might contribute 
to the improvement of milk yield in “Serra da Estrela” flocks. Ewes with the N5 genotype, the 
worst in the total population, were not the worst in any particular flock; nevertheless, their milk 
yield was always found to be low. Ewes with the N2 genotype were found to be the lowest 
producing ones in FL6 and FL7 high producing flocks, but in the other flocks they were within 
the best milk producing animals.
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Table IV-7. GH2-N genotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the most frequent 
homozygous GH2-N genotype in all flocks but FL1+FL4 (deviation from the most frequent genotype within the flock). 
GH2-N All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 
 Genotypes 
Freq.  
(%)  (N=1150)  
Freq.  
(%)  (N=281) 
Freq.  
(%)  (N=178) 
Freq.  
(%)  (N=161) 
Freq.  
(%)  (N=294) 
Freq.  
(%)  (N=214) 
Freq.  
(%)  (N=143) 
N1 (1,1,1,1,1,1,1)/(1,1,1,2,1,1,1) 13.0 4.2 ± 4.2 bc 4.2 -6.2 ± 9.4 12.8 -13.9 ± 10.1 a 7.9 27.2 ± 12.4 d 33.2 2.5 ± 6.4 cd 12.3 24.6 ± 9.7 b 8.5 39.4 ± 14.5 bc 
N2 (1,1,1,1,1,1,1)/(1,1,1,1,1,1,1) 13.0 0 bc    3.8 0 ab 13.9 0 c 19.0 0 bc 9.9 0 a 10.7 0 a 
N3 (1/1,1/1,1/5,1/1,1/1,1/1,2/4) 8.4 -3.8 ± 5.0 ab 4.0 8.0 ± 9.9 16.1 -2.5 ± 9.8 ab 25.5 -46.5 ± 9.3 a 3.0 15.6 ± 13.5 cd   13.0 59.2 ± 13.0 cd 
N4 (1/1,1/1,1/4,1/2,1/1,1/1,1/1) 8.2 4.3 ± 4.9 bc 5.7 4.4 ± 7.8 11.4 6.3 ± 10.2 ab   6.9 -2.0 ± 9.9 abcd 18.3 47.6 ± 9.3 c 6.2 11.0 ± 15.0 ab 
N5 (1/1,1/1,1/1,1/2,1/1,1/1,2/4) 6.2 -10.9 ± 5.3 a 3.5 -5.8 ± 9.0       20.4 13.2 ± 9.6 ab 13.0 21.8 ± 12.5 ab 
N6 (1/1,1/1,1/1,1/2,1/1,2/3,1/5) 5.4 -3.3 ± 5.7 ab 13.4 0 3.3 -6.2 ± 17.4 ab 3.2  -13.8 ± 16.0 bc 3.0 -10.8 ± 13.9 abc   7.9 23.7 ± 14.5 ab 
N7 (1/1,1/1,1/4,1/2,1/1,1/1,6/7) 5.0 10.5 ± 5.6 c 7.0 11.6 ± 7.6     6.9 6.4 ± 9.6 cd 7.4 66.7 ± 11.8 c 7.9 40.3 ± 15.9 bc 
N8 (1,1,1,1,1,1,1)/(1,1,5,1,1,1,1) 3.5 -4.2 ± 6.4 ab      11.6 -52.0 ± 11.1 a 4.5 -1.0 ± 11.7 abcd 7.0 62.2 ± 11.9 c   
N9 (1/1,1/1,1/4,1/2,1/1,2/3,3/3) 3.2 8.3 ± 6.6 bc 7.2 3.8 ± 7.1 5.2 0.8 ± 13.9 ab         
N10 (1,1,1,1,1,1,1)/(1,1,2,1,1,1,1) 2.2 -0.1 ± 7.3 abc      6.5 0.2 ± 12.1 cd 3.6 -28.5 ± 13.6 a     
N11 (1/1,1/1,1/4,1/2,1/1,2/3,1/5) 2.0 4.3 ± 7.9 abc    9.5 13.3 ± 10.2 b         
N12 (2/3,1/1,1/1,1/2,1/1,1/1,2/4) 1.9 7.2 ± 8.1 bc    10.9 0.6 ± 10.6 ab         
N13 (1,1,1,1,1,1,2)/(1,1,1,1,1,1,4)              9.0 57.3 ± 13.6 cd 
N14 (1/1,1/2,1/1,1/2,1/1,4/5,2/2)   5.7 2.2 ± 7.9           
N15 (1/1,1/2,1/1,1/2,1/1,4/5,2/4)   6.0 4.0 ± 8.1           
N16 (2,1,1,1,1,1,1)/(3,1,1,1,1,1,1)        6.0  -30.8 ± 13.1 ab       
N17 (2/3,1/1,1/5,1/1,1/1,1/1,2/4)      8.5 0.5 ± 10.9 ab         
N18 (1,1,1,1,1,1,1)/(1,1,1,3,1,1,1)          4.5 23.8 ± 11.5 d   4.5 83.7 ± 16.5 d 
N19 (1,1,1,1,1,1,1)/(1,1,1,4,1,1,1)   2.5 -8.9 ± 10.8           
N20 (1/1,1/1,1/3,1/3,1/1,1/1,1/1)          3.9 -21.7 ± 11.9 ab     
N21 (1/1,1/1,1/4,1/2,1/1,1/1,2/2)   4.0 -3.0 ± 9.2           
N22 (1/1,1/2,1/1,1/2,1/1,6/7,3/3)   3.0 6.2 ± 10.5           
N23 (1/1,1/2,1/5,1/2,1/1,4/5,2/4)   3.7 -4.4 ± 9.5           
N24 (2/3,1/1,1/1,1/2,1/1,1/1,1/1)     2.8 -16.5 ± 17.0 ab         
Note: Genotypes with less than 2% of the total lactations are not shown. 
Genotype notation: e.g. N1 - seven phase genotype of the GH2-N copy composed of haplotypes (1,1,1,1,1,1,1) and (1,1,1,2,1,1,1) separated by /; individual fragment (I to VII) 
alleles are represented by an italic figure and are separated by a comma; N3 - (1/1,1/1,1/5,1/1,1/1,1/1,2/4) unphased genotype of the GH2-N with individual fragment (I to VII) 
genotypes separated by a comma. For individual fragment allele details see Table IV-4. 
N = number of lactations. 
a, b, c, d – values in the same column with different letters are significantly different (P<0.05).
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Table IV-8. GH2-Z genotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the most frequent 
homozygous GH2-Z genotype. 
GH2-Z All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 
 Genotypes 
Freq.  
(%)  (N=1007)  
Freq.  
(%)  (N=288) 
Freq.  
(%)  (N=183) 
Freq.  
(%)  (N=163) 
Freq.  
(%)  (N=218) 
Freq.  
(%)  (N=185) 
Freq.  
(%)  (N=93) 
Z1 (1,1,1,1,1,2)/(1,1,1,1,2,2) 5.1 8.0 ± 5.3 abcd 2.7 5.4 ± 10.0 6.9 -5.4 ± 12.0  3.8 64.4 ± 15.5 d 10.0 0 bcd 5.5 -21.8 ± 11.4 a   
Z2 (1/1,1/1,1/1,1/1,1/2,2/3) 13.3 0 a 14.1 0 18.0 0  9.5 0 b   21.8 0 a 19.2 0 a 
Z3 (1,1,1,1,1,4)/(1,1,1,1,3,4) 2.2 7.2 ± 7.8 abcd 8.7 2.9 ± 6.6           
Z4 (1/1,1/1,1/2,1/1,1/2,2/2) 4.3 14.9 ± 5.7 bcd     15.2 -27.1 ± 11.2 a 4.8 20.1 ± 12.0 cd 3.8 52.1 ± 13.4 bc   
Z5 (1/1,1/1,1/2,1/1,1/2,2/3) 10.7 3.8 ± 4.4 ab 5.0 5.1 ± 8.9 25.3 0.9 ± 8.3  27.0 -28.8 ± 10.3 a 3.0 15.0 ± 14.3 bcd   15.8 34.1 ± 10.3 b 
Z6 (1/1,1/5,1/1,1/1,1/2,2/2) 2.3 6.3 ± 7.3 abcd   7.8 -10.4 ± 12.4  5.2 23.5 ± 15.6 bc       
Z7 (1/1,2/2,1/3,1/1,1/2,2/2) 3.2 21.6 ± 6.7 d     10.0 30.2 ± 12.4 c 7.0 -8.7 ± 11.2 ab   4.5 2.1 ± 14.9 ab 
Z8 (1/1,2/3,1/1,1/1,1/2,2/3) 2.1 0.9 ± 7.5 abc 5.0 -5.5 ± 7.8     3.3 -11.4 ± 14.4 abc     
Z9 (1,3,1,1,1,1)/(1,3,1,1,1,1) 6.1 2.0 ± 5.0 ab 3.5 -9.5 ± 9.5 11.1 10.6 ± 11.2      16.6 26.1 ± 8.0 b 5.1 5.3 ± 16.8 ab 
Z10 (1,3,1,1,1,3)/(1,3,1,1,1,3) 5.0 16.2 ± 5.3 cd 5.9 5.6 ± 7.8     7.0 1.8 ± 11.2 bcd 7.3 49.6 ± 10.3 c 7.9 23.0 ± 13.6 ab 
Z11 (1/1,3/3,1/1,1/1,1/2,2/3) 2.4 0.5 ± 6.9 abc   8.8 12.2 ± 11.2          
Z12 (1,3,1,1,1,4)/(1,3,1,1,2,4) 5.0 8.7 ± 5.3 abcd 12.1 0.4 ± 6.0 6.5 -0.6 ± 12.1          
Z13 (1/1,1/1,1/1,1/1,1/3,2/3)   7.4 0.3 ± 7.1           
Z14 (1/1,1/2,1/3,1/1,1/2,2/2)       6.6 12.6 ± 13.2 bc       
Z15 (1,2,1,1,1,2)/(1,3,1,1,1,2)         7.6 -2.1 ± 10.4 abcd     
Z16 (1,1,1,1,3,4)/(1,1,1,1,3,4)   4.5 0.2 ± 8.8           
Z17 (1/1,2/4,3/4,1/1,1/1,2/2)   2.5 -10.3 ± 10.6           
Z18 (1/1,2/3,1/3,1/1,1/1,1/1)         4.5 -2.5 ± 12.8 abcd     
Z19 (1/1,2/3,1/3,1/1,1/1,2/2)         4.5 -7.2 ± 12.9 abcd     
Z20 (1,2,3,1,1,2)/(1,3,3,1,1,2)         4.2 24.1 ± 13.0 d     
Z21 (1,2,3,1,1,2)/(1,2,3,1,1,2)         3.9 -26.5 ± 13.0 a     
Z22 (1/1,2/4,1/2,1/1,1/2,2/2)         3.6 12.1 ± 14.4 bcd     
Z23 (1,3,1,1,1,2)/(1,3,1,1,1,2)         2.4 -12 ± 14.6 abc     
Z24 (1,2,1,1,1,1)/(1,3,1,1,1,1)           4.8 0.9 ± 11.5 a   
Z25 (1/1,2/4,1/3,1/1,1/2,2/2)           4.2 -21.4 ± 14.1 a   
Note: Genotypes with less than 2% of the total lactations are not shown. 
Genotype notation: e.g. Z1 - six phase genotype of the GH2-Z copy composed of haplotypes (1,1,1,1,1,2) and (1,1,1,1,2,2) separated by /; individual fragment (II to VII) alleles are 
represented by an italic figure and are separated by a comma; Z2 - (1/1,1/1,1/1,1/1,1/2,2/3) unphased genotype of the GH2-Z with individual fragment (II to VII) genotypes separated 
by a comma. For individual fragment allele details see Table IV-4. 
N = number of lactations. 
a, b, c, d – values in the same column with different letters are significantly different (P<0.05).
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Within GH2-Z genotypes a milk yield differential of 21.6 ± 6.7 l/150 d (P<0.01) was 
found between the most (Z7) and the least (Z2) productive one (Table IV-8). The ewes with Z2 
genotype were found to be, simultaneously, the most abundant and less productive in the 
studied population (13.3%). By flock, the major significant differences in milk yield of animals 
with different GH2-Z genotypes are as follows: Z1 ewes from FL3 yielded respectively 93.2 ± 
13.9 l/150 d and 91.6 ± 14.7 l/150 d more milk than Z5 and Z4 ewes (P<0.001); Z20 ewes from 
FL5 yielded 50.6 ± 15.7 l/150 d more milk than Z21 ewes (P<0.01); Z10 ewes from FL6 
yielded respectively 71.4 ± 13.5 l/150 d and 71.0 ± 15.9 l/150 d more milk than Z1 and Z25 
ewes (P<0.001); and Z5 ewes from FL7 yielded 34.1 ± 10.3 l/150 d more milk than Z2 ewes 
(P<0.01). No significant milk yield differences were found between GH2-Z genotypes at 
FL1+FL4 and FL2 flocks. Some contradictory results arise from Table IV-8, namely between 
results from FL3 versus all the other flocks; i.e., ewes with genotype Z1 are the best producing 
ewes from FL3, but the worst from FL6; and similarly ewes with Z5 are the best producing 
ewes from the flock FL7, but are ones of the worst from FL3. 
The effect of associated GH2-N and GH2-Z genotypes revealed a milk yield differential of 
39.6 ± 7.5 l/150 d of milk (P<0.001) between the most (N2+Z7) and the least (N5+Z2) productive 
one (Table IV-9). The ewes with N2+Z7 genotype yielded 24.7 ± 6.9 l/150 d more milk 
(P<0.001) than ewes with N3+Z5 genotype which were found to be the most abundant in the 
studied population (9.0%). By flock, the major significant differences in milk yield of animals 
with different associated GH2-N and GH2-Z genotypes were as follows: N2+Z7 ewes from FL3 
yielded respectively 84.2 ± 12.7 l/150 d and 78.2 ± 11.0 l/150 d more milk than N8+Z4 and 
N3+Z5 ewes (P<0.001); N18+Z20 ewes from FL5 yielded 48.6 ± 15.7 l/150 d more milk than 
N20+Z21 ewes (P<0.01); N4+Z9, N7+Z10 and N8+Z4 ewes from FL6 yielded significantly more 
milk (P<0.05) than N1+Z24, N2+Z25 and N5+Z2 ewes, with N8+Z4 ewes yielding 74.1 ± 17.2 
l/150 d more milk than N2+Z25 ewes (P<0.001); N3+Z5 ewes from FL7 yielded respectively 
32.6 ± 16.1 l/150 d, 34.8 ± 11.8 l/150 d and 38.4 ± 15.2 l/150 d more milk than N2+Z7, N5+Z2 
and N6+Z2 ewes (P<0.05). No significant milk yield differences were found between the 
associated GH2-N and GH2-Z genotypes at FL1+FL4 and FL2 flocks. The ewes from F3 with 
the N2+Z7 genotype were found to be the best producing ones only in this flock; but not in flocks 
FL5 and FL7 where N2+Z7 ewes presented quite low milk yields. The N3+Z5 genotype seems to 
be a quite consensual high producing genotype, being the highest producing one from FL1+FL4 
and FL7, and one of the highest from FL5; however it was one of the worst genotypes from FL3. 
Thus, the contradictory results shown above also appear to occur with the associated GH2-N and 
GH2-Z genotypes. 
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Table IV-9. Associated GH2-N+GH2-Z genotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the most 
frequent GH2-N+GH2-Z genotype. 
All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 GH2-N + 
GH2-Z  
Freq.  
(%)  (N=818)  
Freq.  
(%)  (N=216) 
Freq.  
(%)  (N=159) 
Freq.  
(%)  (N=124) 
Freq.  
(%)  (N=190) 
Freq.  
(%) (N=164) 
Freq.  
(%) (N=88) 
N1+Z1 3.5 6.5 ± 6.9 b   5.8 -12.4 ± 14.0    10.1 -14.0 ± 14.3 abc     
N1+Z6 2.0 9.9 ± 8.2 bc   5.3 -10.6 ± 16.8  5.2 46.6 ± 14.4 b       
N1+Z15          7.6 -17.4 ± 14.9 abc     
N1+Z18          4.6 -14.2 ± 16.5 abc     
N1+Z19          3.7 -13.9 ± 17.8 abc     
N1+Z24            5.0 8.3 ± 11.6 a   
N2+Z7 3.1 24.7 ± 6.9 c     9.0 78.2 ± 11.0 c 7.0 -22.2 ± 15.2 ab   4.5 -32.6 ± 16.1 a 
N2+Z22          3.7 -3.8 ± 18.2 bc     
N2+Z25            4.3 -18.6 ± 14.3 a   
N3+Z5 9.0 0 b 4.1 0.0 16.4 0  26.1 0 a 3.1 0 bc   13.0 0 b 
N4+Z9 6.3 -1.5 ± 6.0 b 3.6 -18.8 ± 12.2 11.6 9.8 ± 11.2      17.1 35.1 ± 8.4 b 5.1 -32.3 ± 17.6 ab 
N5+Z2 6.6 -14.9 ± 5.8 a 3.6 -18.1 ± 11.8       20.7 0 a 13.0 -34.8 ± 11.8 a 
N6+Z2 3.3 -2.1 ± 6.7 ab 6.4 -4.8 ± 10.7 3.4 0.0 ± 16.8        6.2 -38.4 ± 15.2 a 
N6+Z8    4.6 -18.0 ± 11.8           
N7+Z10 5.1 11.3 ± 6.2 bc 6.2 -5.7 ± 11.8     7.0 -11.1 ± 15.2 bc 7.5 54.9 ± 10.4 b 7.9 -14.0 ± 14.5 ab 
N8+Z4 3.0 -0.3 ± 6.8 ab     11.8 -6.0 ± 9.9 a 3.1 -14.3 ± 17.6 abc 3.9 55.5 ± 13.5 b   
N9+Z12 3.4 8.2 ± 6.9 bc 7.4 -7.0 ± 10.6 5.3 0.9 ± 14.0          
N10+Z14 1.9 12.5 ± 8.2 bc     6.6 49.3 ± 11.5 b       
N11+Z11 2.1 0.9 ± 8.3 ab   9.2 11.9 ± 11.2          
N12+Z2 1.9 11.9 ± 8.3 bc   11.1 1.3 ± 11.2          
N14+Z3   5.9 -7.3 ± 11.0           
N17+Z5     8.7 2.2 ± 11.2          
N18+Z20         4.3 8.9 ± 16.8 c     
N19+Z17   2.6 -21.5 ± 13.4           
N20+Z21         4.0 -39.7 ± 16.6 a     
N21+Z12   4.1 -11.8 ± 11.2           
N22+Z16   3.1 -3.5 ± 13.1           
N23+Z13   3.8 -12.7 ± 12.0           
Note: Genotypes with less than 2% of the total lactations are not shown. For GH2-N and GH2-Z genotype codes details see Table IV-7 and Table IV-8. 
N = number of lactations.  
a, b, c – values in the same column with different letters are significantly different (P<0.05).
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Seven GH2-N phenotypes were established in “Serra da Estrela” ewes (Table IV-10). 
The most frequent phenotypes were AAN (70.0%) and ADN (18.2%). More phenotypes do 
exist, but they could not be clearly established as they were found in animals carrying 
ambiguous haplotypes to which correspond two possible phenotypes; e.g. AHN and/or BEN 
(2.4%). Within GH2-N phenotypes there was a milk yield differential of 22.6 ± 6.8 l/150 d 
(P<0.01) to 31.4 ± 9.0 l/150 d (P<0.001) between the most producing one (ABN) and all the 
others, i.e., AAN, ACN, ADN, AFN and AHN and/or BEN. By flock, the major significant 
differences in milk yield of animals with different GH2-N phenotypes were as follows: AFN 
and AAN ewes from FL3 yielded respectively 28.9 ± 10.7 l/150 d and 21.1 ± 5.7 l/150 d more 
milk than ADN ewes (P<0.001); ABN ewes from FL5 yielded respectively 48.1 ± 15.8 l/150 d 
and 44.8 ± 13.4 l/150 d more milk than AFN ewes and AHN and/or BEN ewes (P<0.05); ABN 
and ADNewes from FL7 yielded respectively 49.4 ± 12.0 l/150 d (P<0.001) and 31.1 ± 8.3 
l/150 d more milk than AAN ewes (P<0.001). No significant milk yield differences were found 
between GH2-N phenotypes at FL1+FL4, FL2 and FL6 flocks. Conflicting results were 
observed again between FL3 flock and all the others: ewes from FL3 flock with ADN phenotype 
produce low levels of milk; ewes from FL7 flock with the same phenotype produce medium 
levels and ewes from FL1+Fl4, FL2 and FL6 flocks carrying this phenotype were the best milk 
producers. 
Ten GH2-Z phenotypes were established in “Serra da Estrela” ewes (Table IV-11). The 
more frequent phenotypes were AAZ (45.5%), AEZ (17.1%) and ABZ (13.6%). More phenotypes 
exist, but they could not be clearly established as they were found in animals carrying ambiguous 
haplotypes to which correspond two possible phenotypes; e.g. ADZ and/or BEZ (3.4%). Within 
GH2-Z phenotypes there was a milk yield differential of 16.6 ± 8.3 l/150 d (P<0.05) between the 
most (BDZ) and the least (ADZ and/or BEZ) producing one, with BDZ having similar production 
levels to AAZ and AEZ phenotypes (P>0.05). By flock, the major significant differences in milk 
yield of animals with different GH2-Z phenotypes were as follows: AHZ and/or CIZ ewes from 
FL1+FL4 yielded 26.5 ± 12.6 l/150 d more milk than ADZ and/or BEZ (P<0.05); AIZ ewes from 
FL3 yielded 53.5 ± 13.0 l/150 d more milk than AEZ ewes (P<0.001); AEZ ewes from FL5 
yielded respectively 29.9 ± 10.1 l/150 d and 33.4 ± 12.9 l/150 d more milk than BBZ and BDZ 
ewes (P<0.05); BDZ ewes from FL6 yielded 71.7 ± 16.8 l/150 d more milk than ADZ and/or BEZ 
(P<0.001); ABZ and AEZ ewes from FL7 yielded respectively 46.1 ± 13.3 l/150 d (P<0.05) and 
54.2 ± 12.7 l/150 d (P<0.01) more milk than BBZ ewes. No significant milk yield differences 
were found between GH2-Z phenotypes at FL2 flock. AEZ, AIZ and BDZ were the best 
producing genotypes for milk in some flocks and the worst in other; again, results from FL3 flock 
largely contributed to these conflicting results. 
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Table IV-10. GH2-N phenotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the most frequent 
homozygous GH2-N phenotype. 
GH2-N All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 
 Phenotypes 
Freq.  
(%)  (N=1634)  
Freq.  
(%)  (N=480) 
Freq.  
(%)  (N=212) 
Freq.  
(%)  (N=217) 
Freq.  
(%)  (N=340) 
Freq.  
(%)  (N=277) 
Freq.  
(%)  (N=161) 
AAN (a,a,a,a,a)/(a,a,a,a,a) 70.0 0 a 78.66 0 68.0 0 39.6 0 b 75.9 0 b  77.5 0 67.8 0 a 
ABN (a,a,a,a,a)/(a,a,b,a,a) 2.0 22.6 ± 6.8 b        5.3 21.5 ± 9.7 c   6.2 49.4 ± 12.0 b 
ACN (a,a,a,a,a)/(a,a,c,a,a) 2.1 -6.8 ± 7.0 a 3.1 -8.5 ± 8.7        5.1 -20.4 ± 11.7   
ADN (a,a,a,a,a)/(a,d,a,a,a) 18.2 -1.2 ± 2.7 a 13.9 1.4 ± 4.6 25.0 2.3 ± 6.4 44.5 -21.1 ± 5.7 a 7.4 4.8 ± 8.5 bc 11.9 3.2 ± 7.1 16.9 31.1 ± 8.3 b 
AFN (a,a,a,a,a)/(a,b,a,a,a) 2.4 -4.0 ± 6.4 a     6.2 7.8 ± 11.5 b 3.5 -26.6 ± 12.9 a     
AHN 
or 
BEN 
(a/a,a/c,a/b,a/a,a/a) 2.4 -8.8 ± 6.4 a     5.3 -21.1 ± 14.4 ab 5.3 -23.2 ± 10.1 a     
AEN (a,a,a,a,a)/(a,c,a,a,a)         2.6 3.5 ± 13.3 abc     
AIN (a,a,a,a,a)/(a,e,a,a,a)   2.2 -1.5 ± 10.7           
Note: Phenotypes with less than 2% of the total lactations are not shown.  
Phenotypes notation: phenotypes were defined as the product of the gene and denoted by capital letters corresponding to protein variants whenever they could be predicted, e.g. AAN 
– five phase phenotype of the GH2-N copy composed of two protein variants VNA (a,a,a,a,a) separated by /; individual fragments (II to VI) of protein variants were represented by a 
regular letter and were separated by a comma; it corresponds to a homozygous animal for VNA. When an unique phenotype could not be predicted, unphased phenotypes were 
presented with individual fragment (II to VI) variants separated by a comma, e.g phenotype (a/a,a/c,a/b,a/a,a/a) where two combinations were possible: AHN or BEN. For individual 
fragments of protein variant details see Table IV-5 and Table IV-6. 
N = number of lactations. 
a, b, c – values in the same column with different letters are significantly different (P<0.05).
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Table IV-11. GH2-Z phenotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the most frequent 
homozygous GH2-Z phenotype. 
GH2-Z All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 
 Phenotypes 
Freq.  
(%)  (N=1554)  
Freq.  
(%)  (N=395) 
Freq.  
(%)  (N=206) 
Freq.  
(%)  (N=213) 
Freq.  
(%)  (N=322) 
Freq.  
(%)  (N=274) 
Freq.  
(%)  (N=165) 
AAZ (a,a,a,a,a)/(a,a,a,a,a) 45.5 0 b 47.0 0 ab 54.8 0  22.5 0 b 34.8 0 ab 62.6 0 bc 52.0 0 b 
ABZ (a,a,a,a,a)/(a,b,a,a,a) 13.6 -1.8 ± 3.0 ab 11.6 -6.6 ± 5.0 ab   9.0 -5.5 ± 10.1 b 29.8 -0.8 ± 5.3 ab 10.4 -6.5 ± 7.9 bc 15.3 19.0 ± 8.8 c 
ACZ (a,a,a,a,a)/(a,a,a,a,b) 4.2 -1.4 ± 5.4 ab 17.3 0.5 ± 4.5 ab           
AEZ (a,a,a,a,a)/(a,a,b,a,a) 17.1 0.1 ± 2.9 b 7.4 4.5 ± 6.4 ab 30.8 -0.3 ± 6.3  45.0 -27.7 ± 6.9 a 7.7 16.1 ± 8.6 b 8.7 10.7 ± 9.1 cd 18.6 27.1 ± 8.1 c 
ADZ 
or 
BEZ 
(a/a,a/b,a/b,a/a,a/a) 3.4 -13.1 ± 5.4 a 3.5 -12.9 ± 8.9 a     5.4 -2.7 ± 10.7 ab 4.5 -35.7 ± 12.6 a   
AIZ (a,a,a,a,a)/(a,c,a,a,a) 2.3 -0.8 ± 6.4 ab   7.7 -18.4 ± 11  5.4 25.8 ± 12.8 c       
BBZ (a,b,a,a,a)/(a,b,a,a,a) 6.1 -0.2 ± 4.3 ab     14.9 13.3 ± 9.2 bc 13.4 -13.8 ± 7.3 a   7.3 -27.1 ± 11.4 a 
BDZ (a,b,a,a,a)/(a,b,b,a,a) 2.0 3.6 ± 6.4 b       4.8 -17.3 ± 10.8 a 3.8 36.0 ± 11.7 d   
CCZ (a,a,a,a,b)/(a,a,a,a,b)   4.5 -2.2 ± 8.2 ab           
BGZ (a,b,a,a,a)/(a,b,a,a,b)   3.2 -7.2 ± 9.0 ab           
AHZ 
or 
CIZ 
(a/a,a/c,a/a,a/a,a/b)   3.2 13.6 ± 9.3 b           
JJZ (a,a,c,a,a)/(a,a,c,a,a)           4.8 -21.4 ± 11.2 ab   
Note: Phenotypes with less than 2% of the total lactations are not shown. 
Phenotypes notation: phenotypes were defined as the product of the gene and denoted by capital letters corresponding to protein variants whenever they could be predicted, e.g. AAZ 
– five phase phenotype of the GH2-Z copy composed of two protein variants VZA (a,a,a,a,a) separated by /; individual fragments (II to VI) of protein variants were represented by a 
regular letter and were separated with a comma; it corresponds to an homozygous animals for VZA. When an unique phenotype could not be predicted, unphased phenotypes were 
presented with individual fragment (II to VI) variants separated with a comma, e.g phenotype (a/a,a/c,a/a,a/a,a/b) where two combinations were possible: AHZ or CIZ. For individual 
fragments of protein variant details see Table IV-5 and Table IV-6. 
N = number of lactations. 
a, b, c, d – values in the same column with different letters are significantly different (P<0.05).
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Table IV-12. Associated GH2-N+GH2-Z phenotypes, their respective frequencies (%) and milk yield deviation (l/150 d) ± standard error from the 
most frequent homozygous GH2-N+GH2-Z phenotype. 
All flocks FL1+FL4 FL2 FL3 FL5 FL6 FL7 GH2-N + 
GH2-Z  
Freq.  
(%)  (N=1369)  
Freq.  
(%)  (N=377) 
Freq.  
(%)  (N=194) 
Freq.  
(%)  (N=199) 
Freq.  
(%)  (N=292) 
Freq.  
(%) (N=235) 
Freq.  
(%) (N=138) 
AAN+AAZ 42.1 0 ab 43.1 0 ab 54.3 0  17.1 0 a 33.9 0 b 56.7 0 b 47.5 0 ab 
AAN+ABZ 10.0 -4.6 ± 3.5 ab 10.6 -8.1 ± 5.2 a     22.6 -3.6 ± 5.7 ab 10.4 -12.6 ± 8.0 ab 7.3 22.7 ± 12.5 bc 
AAN+ACZ 2.4 2.2 ± 7.1 ab 9.6 3.9 ± 5.7 ab           
AAN+AIZ 2.3 1.3 ± 6.8 ab   7.7 -17.8 ± 11.1  5.4 49.6 ± 13.6 cd       
AAN+BBZ 3.3 7.9 ± 5.8 b     9.5 45.8 ± 11.0 cd 6.8 -9.5 ± 9.4 ab   6.2 -22.8 ± 12.4 a 
ADN+AAZ 2.0 3.6 ± 6.8 ab 4.0 -4.0 ± 8.2 ab   5.4 62.6 ± 12.5 d   5.9 -26.1 ± 9.6 a   
ADN+ACZ   7. 7 -4.7 ± 6.3 ab           
ADN+AEZ 14.2 0.1 ± 3.4 ab 5.0 11.2 ± 7.9 b 25.8 0.4 ± 6.8  41.4 -15.1 ± 7.8 a 6.0 5.2 ± 9.5 bc 5.2 23.9 ± 10.9 c 16.9 32.5 ± 8.7 c 
AFN+ABZ 2.1 0.7 ± 7.2 ab     6.3 26.7 ± 12.0 bc       
(AHN or 
BEN)+BBZ 2.5 -8.3 ± 6.6 a     5.4 -1.7 ± 14.2 ab 5.4 -24.9 ± 10.4 a     
AAN+(ADZ 
or BEZ) 2.1 -5.7 ± 7.1 ab       4.5 7.9 ± 11.6 bc     
AAN+CCZ   4.5 -2.5 ± 8.3 ab           
AAN+BGZ   3.2 -7.9 ± 9.1 ab           
AAN+BDZ         3.3 -20.8 ± 13.4 ab     
AAN+(AHZ 
or CIZ)   3.2 13.1 ± 9.4 b           
ABN+ABZ         4.5 22.1 ± 10.9 c     
ACN+(ADZ 
or BEZ)   2.5 -11.8 ± 10.2 ab           
ADN+JJZ           3.1 8.8 ± 13.9 bc   
Note: Phenotypes with less than 2% of the total lactations are not shown. For GH2-N and GH2-Z phenotypes codes details see Table IV-10 and Table IV-11. 
N = number of lactations. 
a, b, c, d – values in the same column with different letters are significantly different (P<0.05).
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The effect of associated GH2-N and GH2-Z phenotypes revealed a milk yield 
differential of 16.2 ± 8.1 l/150 d of milk (P<0.05) between the most (AAN+BBZ) and the least 
[(AHN and/or BEN)+BBZ] producing phenotype (Table IV-12). The ewes with AAN+BBZ 
phenotype yielded 7.9 ± 5.8 l/150 d more milk (P>0.05) than ewes with AAN+AAZ (42.1%) 
and ADN+AEZ (14.19%) phenotypes which were the two most abundant in the studied 
population and presented similar milk yields between them (P>0.05). By flock, the major 
significant differences in milk yield were as follows: ADN+AEZ and [AAN+(AHZ and/or CIZ)] 
ewes from FL1+FL4 yielded respectively 19.3 ± 8.9 l/150 d and 21.2 ± 10.3 l/150 d more milk 
than AAN+ABZ ewes (P<0.05); ADN+AAZ ewes from FL3 yielded respectively 62.6 ± 12.5 
l/150 d and 77.7 ± 11.6 l/150 d more milk than ADN+AEZ ewes (P<0.001); ABN+ABZ ewes 
from FL5 yielded 47.0 ± 14.0 l/150 d more milk than [(AHN and/or BEN)+BBZ] ewes (P<0.01); 
ADN+AEZ ewes from FL6 yielded 50.0 ± 13.5 l/150 d more milk than ADN+AAZ ewes 
(P<0.01); ADN+AEZ ewes from FL7 yielded 56.3 ± 13.9 l/150 d more milk than AAN+BBZ 
ewes (P<0.01). No significant milk yield differences were found between the associated GH2-
N and GH2-Z phenotypes at FL2 flock. Ewes with ADN+AEZ phenotype were the best 
producing ones in FL6 and FL7 flocks, one of the best in FL1+FL4 and the worst in FL3. 
IV.2.5.2 Milk composition 
The records of milk fat and protein contents and yields were available for 294 ewes for 
one year (1998) and their mean milk production adjusted to 150 lactation days (± SD) on that 
year was 171.4 ± 75.9 l with 79.5 ± 11.8 g of fat/kg of milk and 65.5 ± 7.2 g of protein/kg of 
milk. Mean fat yield was 13.8 ± 6.7 kg, mean protein yield was 11.1 ± 4.7 kg and mean 
fat+protein yield was 25.0 ± 11.3 kg. The statistical analyses were performed considering the 
GH2-N and GH2-Z copies genotypes (Table IV-13) and phenotypes (Table IV-15) taken 
separately or associated (Table IV-14 and Table IV-15) in the population. Contrasts were 
performed considering the differences between the different genotypes or phenotypes for each 
parameter and the most frequent homozygous genotype or phenotypes in each oGH gene copy, 
or associated GH2-N and GH2-Z genotypes or phenotypes. Genotypes and phenotypes with 
frequencies lower than 2% were excluded from the analysis. The genotypes and phenotypes 
found in the GH2-N and GH2-Z copies had significant influence on milk yield traits and on 
milk fat and protein contents in “Serra da Estrela” ewes (P<0.05). Exceptions were found for 
GH2-N genotype effects on protein content and for GH2-N phenotype effects on milk yield, fat 
and protein content, and fat+protein yield and for GH2-Z phenotype effects on fat content 
(P>0.05). The major significant effects are described below. 
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Table IV-13. GH2-N and GH2-Z genotypes, their respective frequencies (%) and deviation of milk yield (l/150 d), fat and protein contents (g/kg), and fat, 
protein and fat+protein yields (kg/150 d) at 150 days of lactation ± standard error for the most frequent homozygous GH2-N and GH2-Z genotype. 
GH2-N genotype (N=193) Freq. (%) 
Milk yield 
(l/150 d) 
Fat content 
(g/kg) 
Protein content 
(g/kg) 
Fat yield 
(kg/150 d) 
Protein yield 
(kg/150 d) 
Fat+Protein yield 
(kg/150 d) 
N1 (1,1,1,1,1,1,1)/(1,1,1,2,1,1,1) 7.8 -20.3 ± 9.5 a -3.89 ± 3.25 abc -0.68 ± 3.17 -2.92 ± 0.66 a -1.78 ± 0.60 ab -4.69 ± 1.33 a 
N2 (1,1,1,1,1,1,1)/(1,1,1,1,1,1,1) 5.8 0 bc 0 b 0 0 c 0 d 0 c 
N3 (1/1,1/1,1/5,1/1,1/1,1/1,2/4) 9.5 -7.8 ± 9.1 abc -3.51 ± 3.11 abc -2.20 ± 3.04 -1.99 ± 0.63 abc -1.29 ± 0.57 abc -3.31 ± 1.27 ab 
N4 (1/1,1/1,1/4,1/2,1/1,1/1,1/1) 8.2 -10.6 ± 9.6 abc -4.15 ± 3.30 abc -3.25 ± 3.21 -2.07 ± 0.67 abc -1.28 ± 0.61 abc -3.39 ± 1.35 ab 
N5 (1/1,1/1,1/1,1/2,1/1,1/1,2/4) 7.5 -17.0 ± 9.7 ab -3.22 ± 3.33 abc -2.81 ± 3.24 -2.26 ± 0.68 abc -1.61 ± 0.61 abc -3.90 ± 1.36 ab 
N6 (1/1,1/1,1/1,1/2,1/1,2/3,1/5) 5.4 3.3 ± 11.1 bc -7.98 ± 3.82 a -4.46 ± 3.72 -1.33 ± 0.77 bcd -0.68 ± 0.70 bcd -2.08 ± 1.55 abc 
N7 (1/1,1/1,1/4,1/2,1/1,1/1,6/7) 4.4 5.4 ± 11.6 c -6.79 ± 4.00 ab -2.90 ± 3.90 -1.29 ± 0.81 bcd -0.27 ± 0.73 cd -1.62 ± 1.62 bc 
N8 (1,1,1,1,1,1,1)/(1,1,5,1,1,1,1) 2.7 -18.2 ± 13.4 abc 3.16 ± 4.61 c -4.46 ± 4.49 -1.41 ± 0.93 abcd -2.08 ± 0.84 ab -3.40 ± 1.88 abc 
N9 (1/1,1/1,1/4,1/2,1/1,2/3,3/3) 4.4 3.9 ± 11.4 c -4.15 ± 3.91 abc -3.89 ± 3.81 -0.88 ± 0.79 cd -0.63 ± 0.71 bcd -1.55 ± 1.59 bc 
N11 (1/1,1/1,1/4,1/2,1/1,2/3,1/5) 2.0 0.1 ± 14.5 abc -1.12 ± 5.02 abc -3.71 ± 4.90 -0.93 ± 1.01 bcd -0.85 ± 0.91 abcd -1.85 ± 2.03 abc 
N12 (2/3,1/1,1/1,1/2,1/1,1/1,2/4) 3.1 9.1 ± 12.9 c -2.59 ± 4.47 abc -8.44 ± 4.36 0.19 ± 0.90 c -0.97 ± 0.81 abcd -0.83 ± 1.80 bc 
N14 (1/1,1/2,1/1,1/2,1/1,4/5,2/2) 2.4 -1.6 ± 14.5 abc -8.07 ± 4.96 abc -4.36 ± 4.84 -1.45 ± 1.01 abcd -0.76 ± 0.91 abcd -2.24 ± 2.02 abc 
N18 (1,1,1,1,1,1,1)/(1,1,1,3,1,1,1) 2.4 -17.4 ± 13.5 abc -7.59 ± 4.61 abc -6.91 ± 4.49 -3.20 ± 0.94 ab -2.46 ± 0.85 a -5.73 ± 1.89 a 
GH2-Z genotype (N=202)        
Z1 (1/1,1/1,1/1,1/1,1/2,2/3) 4.1 -7.3 ± 13.2 b 3.18 ± 4.53 ab 1.99 ± 4.42 ab -0.56 ± 0.92 bc -0.38 ± 0.83 abc -0.90 ± 1.84 b 
Z2 (1/1,1/1,1/2,1/1,1/2,2/3) 14.6 -0.4 ± 10.8 b 0.88 ± 3.72 a -0.32 ± 3.62 a -0.03 ± 0.75 bc -0.2 ± 0.68 abc -0.24 ± 1.51 b 
Z3 (1,3,1,1,1,1)/(1,3,1,1,1,1) 3.4 0 b 0 a 0 ab 0 bc 0 abc 0 b 
Z4 (1,1,1,1,1,2)/(1,1,1,1,2,2) 4.1 8.5 ± 14.1 b 4.81 ± 4.85 ab -0.54 ± 4.73 ab 0.97 ± 0.98 c 0.21 ± 0.89 abc 1.23 ± 1.97 bc 
Z5 (1,3,1,1,1,3)/(1,3,1,1,1,3) 12.2 -1.5 ± 11.7 b 1.56 ± 4.05 ab 1.96 ± 3.95 ab -0.48 ± 0.82 b -0.24 ± 0.74 abc -0.72 ± 1.64 b 
Z6 (1,3,1,1,1,4)/(1,3,1,1,2,4) 2.7 -37.6 ± 15.0 a 0.14 ± 5.15 a 8.67 ± 5.03 b -3.59 ± 1.04 a -1.51 ± 0.94 a -5.09 ± 2.09 a 
Z7 (1/1,1/1,1/2,1/1,1/2,2/2) 2.4 16.6 ± 15.9 b 11.37 ± 5.49 b 2.19 ± 5.35 ab 3.60 ± 1.11 d 1.31 ± 1 b 4.93 ± 2.23 c 
Z8 (1/1,2/2,1/3,1/1,1/2,2/2) 2.4 -4.1 ± 14.6 b 0.31 ± 4.99 ab -2.62 ± 4.87 a -0.51 ± 1.01 bc -0.71 ± 0.92 ab -1.22 ± 2.03 ab 
Z9 (1/1,3/3,1/1,1/1,1/2,2/3) 6.8 -9.6 ± 12.4 b 1.59 ± 4.24 a 1.31 ± 4.13 ab -0.97 ± 0.86 b -0.57 ± 0.78 ab -1.53 ± 1.73 b 
Z10 (1/1,1/5,1/1,1/1,1/2,2/2) 4.1 10.0 ± 13.1 b -2.23 ± 4.48 a 0.72 ± 4.37 ab 0.05 ± 0.91 bc 0.61 ± 0.82 bc 0.62 ± 1.82 b 
Z11 (1,1,1,1,1,4)/(1,1,1,1,3,4) 2.7 -5.0 ± 14.6 b 6.53 ± 5.03 ab 2.29 ± 4.9 ab 0.27 ± 1.02 bc -0.11 ± 0.92 abc 0.13 ± 2.04 b 
Z12 (1/1,2/3,1/1,1/1,1/2,2/3) 6.5 0.2 ± 11.5 b 4.04 ± 3.94 ab 1.89 ± 3.84 ab 0.17 ± 0.80 bc 0.02 ± 0.72 abc 0.20 ± 1.61 b 
Z13 (1/1,1/1,1/1,1/1,1/3,2/3) 2.7 0.3 ± 13.6 b -0.56 ± 4.67 a 0.42 ± 4.56 ab -0.26 ± 0.95 bc -0.06 ± 0.85 abc -0.31 ± 1.90 b 
Note: Genotypes with less than 2% of the total lactations are not shown. For details of GH2-N and GH2-Z genotype codes see Table IV-4. 
N = number of lactations. 
a, b, c, d – values in the same column with different letters are significantly different (P<0.05). 
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Table IV-14. Associated GH2-N+GH2-Z genotypes, their respective frequencies (%) and deviation of milk yield (l/150 d), fat and protein contents 
(g/kg), and fat, protein and fat+protein yields (kg/150 d) at 150 days of lactation ± standard error for the most frequent homozygous associated 
GH2-N+GH2-Z genotype. 
GH2-N+GH2-Z 
genotypes (N=150) 
Freq. 
(%) 
Milk yield 
(l/150 d) 
Fat content 
(g/kg) 
Protein content 
(g/kg) 
Fat yield 
(kg/150 d) 
Protein yield 
(kg/150 d) 
Fat+Protein yield 
(kg/150 d) 
N3+Z5 9.5 0 cd 0 a 0 ab 0 bc 0 ab 0 bc 
N5+Z2 7.5 -19.7 ± 9.6 ab 0.29 ± 3.30 ab 0.52 ± 3.21 ab -1.05 ± 0.67 b -0.77 ± 0.60 a -1.82 ± 1.34 ab 
N4+Z9 6.8 -11.3 ± 9.7 abc 0.15 ± 3.35 ab 0.47 ± 3.26 ab -0.57 ± 0.67 bc -0.31 ± 0.61 ab -0.88 ± 1.35 abc 
N9+Z12 4.4 2.0 ± 10.6 cd -0.33 ± 3.67 abc -0.50 ± 3.58 ab 0.43 ± 0.74 cd 0.25 ± 0.67 ab 0.68 ± 1.48 bc 
N7+Z10 4.1 7.4 ± 11.0 cd -3.66 ± 3.80 a 0.13 ± 3.71 ab 0.28 ± 0.77 bcd 0.83 ± 0.69 b 1.09 ± 1.54 bc 
N6+Z2 2.7 8.8 ± 12.7 cde -4.14 ± 4.39 a -0.94 ± 4.28 ab 0.60 ± 0.88 bcd 0.74 ± 0.80 ab 1.32 ± 1.77 bc 
N8+Z4 2.7 -11.8 ± 12.6 abcd 9.55 ± 4.36 bc -1.95 ± 4.25 ab 1.11 ± 0.88 cd -0.74 ± 0.79 ab 0.50 ± 1.76 bc 
N12+Z2 2.7 18.0 ± 12.3 de 0.26 ± 4.27 abc -6.54 ± 4.16 a 2.17 ± 0.86 d 0.31 ± 0.77 ab 2.47 ± 1.72 c 
N14+Z3 2.4 -0.1 ± 14.4 abcd -3.77 ± 4.93 a -1.22 ± 4.81 ab 0.20 ± 1.00 bcd 0.33 ± 0.90 ab 0.53 ± 2.01 abc 
N2+Z7 2.0 40.1 ± 13.3 de 10.47 ± 4.59 c 0.98 ± 4.48 ab 6.13 ± 0.93 e 3.21 ± 0.84 c 9.36 ± 1.86 d 
N1+Z6 2.0 -36.0 ± 13.3 a -2.11 ± 4.60 a 6.73 ± 4.49 b -3.14 ± 0.93 a -1.18 ± 0.84 a -4.26 ± 1.86 a 
N6+Z8 2.0 -2.6 ± 14.5 abcd -2.31 ± 4.99 abc -3.10 ± 4.87 ab -0.15 ± 1.01 bcd -0.28 ± 0.91 ab -0.44 ± 2.03 abc 
N11+Z11 2.0 1.4 ± 14.5 bcd 2.44 ± 5.03 abc 0.26 ± 4.90 ab 0.56 ± 1.01 bcd 0.28 ± 0.91 ab 0.81 ± 2.02 bc 
Note: Genotypes with less than 2% of the total lactations are not shown. For details of GH2-N and GH2-Z genotype codes see Table IV-13. 
N = number of lactations. 
a, b, c, d, e – values in the same column with different letters are significantly different (P<0.05). 
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Table IV-15. GH2-N, GH2-Z and associated GH2-N+GH2-Z phenotypes, their respective frequencies (%) and deviation of milk yield (l/150 d), fat 
and protein contents (g/kg), and fat, protein and fat+protein yields (kg/150 d) at 150 days of lactation ± standard error for the most frequent 
homozygous phenotype. 
 
Freq. 
(%) 
Milk yield 
(L/150 d) 
Fat content 
(g/kg) 
Protein content 
(g/kg) 
Fat yield 
(kg/150 d) 
Protein yield 
(kg/150 d) 
Fat+Protein yield 
(kg/150 d) 
GH2-N phenotype (N=284)       
AAN 69.0 0 0 0 0 c 0 ab 0 
ACN 3.1 -11.8 ± 10.2 -1.77 ± 3.47 -2.38 ± 3.39 -1.35 ± 0.71 a -1.08 ± 0.64 a -2.47 ± 1.42 
ADN 20.4 0.0 ± 4.5 0.55 ± 1.54 -0.26 ± 1.50 -0.19 ± 0.31 b -0.15 ± 0.28 ab -0.32 ± 0.63 
AFN 2.0 9.7 ± 12.0 -3.44 ± 4.10 0.90 ± 4.00 -0.16 ± 0.83 bc 1.05 ± 0.75 b 0.97 ± 1.67 
AIN 2.0 -4 ± 11.9 0.14 ± 4.07 -0.44 ± 3.97 -0.34 ± 0.83 bc 0.03 ± 0.75 ab -0.31 ± 1.66 
GH2-Z phenotype (N=265)       
ABZ 8.2 3.5 ± 6.5 b -1.51 ± 2.22 -0.07 ± 2.16 a -0.20 ± 0.45 b 0.13 ± 0.41 ab -0.04 ± 0.90 bc 
ADZ or BEZ 3.4 -17.3 ± 9.7 ab -1.55 ± 3.33 0.29 ± 3.24 a -1.35 ± 0.68 b -1.02 ± 0.61 ab -2.34 ± 1.36 ab 
AAZ 45.9 0 b 0 0 a 0 b 0 ab 0 b 
ACZ 6.5 3.6 ± 7.7 b -1.25 ± 2.65 0.15 ± 2.59 a 0.21 ± 0.54 b 0.31 ± 0.49 ab 0.54 ± 1.08 bc 
AEZ 19.4 0.0 ± 4.9 b 0.22 ± 1.70 1.08 ± 1.66 a -0.12 ± 0.34 b 0.00 ± 0.31 ab -0.12 ± 0.69 b 
BBZ 4.1 1.7 ± 9.0 b 5.42 ± 3.08 1.08 ± 3.00 a 1.95 ± 0.63 c 0.57 ± 0.57 b 2.55 ± 1.26 c 
AIZ 2.7 -35.4 ± 10.6 a -1.87 ± 3.66 7.51 ± 3.57 b -3.33 ± 0.74 a -1.35 ± 0.67 a -4.68 ± 1.48 a 
GH2-NZ phenotype (N=235)      
AAN+ABZ 6.1 -2.0 ± 7.4 b -2.03 ± 2.52 a -0.80 ± 2.46 a -0.73 ± 0.51 b -0.42 ± 0.46 ab -1.14 ± 1.03 ab 
AAN+AAZ 42.2 0 b 0 a 0 a 0 b 0 ab 0 b 
AAN+ACZ 3.7 5.0 ± 9.8 b -2.69 ± 3.35 a 0.57 ± 3.27 ab 0.25 ± 0.68 b 0.49 ± 0.61 ab 0.74 ± 1.36 bc 
AAN+AEZ 2.0 5.9 ± 12.1 b -4.89 ± 4.14 a 1.54 ± 4.04 ab -0.03 ± 0.84 b 0.67 ± 0.76 ab 0.67 ± 1.70 bc 
AAN+BBZ 2.7 8.5 ± 11.2 b 9.25 ± 3.84 b 1.67 ± 3.75 ab 2.83 ± 0.78 c 0.95 ± 0.70 b 3.81 ± 1.56 c 
AAN+AIZ 2.7 -34.4 ± 10.7 a -1.44 ± 3.69 a 7.80 ± 3.60 b -3.24 ± 0.75 a -1.24 ± 0.67 a -4.46 ± 1.50 a 
ADN+AAZ 2.0 -9.3 ± 12.1 ab -1.07 ± 4.12 a 1.81 ± 4.02 ab -1.23 ± 0.85 ab -0.26 ± 0.77 ab -1.41 ± 1.70 ab 
ADN+ACZ 2.7 -1.7 ± 11.0 b -0.98 ± 3.77 a -1.38 ± 3.67 ab -0.31 ± 0.76 b -0.27 ± 0.69 ab -0.56 ± 1.53 abc 
ADN+AEZ 15.6 2.3 ± 5.6 b 1.33 ± 1.95 a 0.65 ± 1.90 ab 0.10 ± 0.39 b 0.04 ± 0.35 ab 0.17 ± 0.78 b 
Note: Phenotypes with less than 2% of the total lactations are not shown. For details of GH2-N and GH2-Z phenotypes codes see Table IV-5 and Table IV-6. 
N = number of lactations. 
 a, b, c 
– values in the same column with different letters are significantly different (P<0.05). 
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The analysis of GH2-N genotypes revealed that N7, N9 and N12 ewes yielded 
respectively 25.7 ± 10.5 l/150 d, 24.1 ± 10.2 l/150 d and 29.4 ± 11.9 l/150 d more milk than N1 
ewes (P<0.05; Table IV-13). It was also found that the milk of the N8 ewes had significantly 
higher fat content 11.14 ± 4.93 g/kg than the milk of N6 ewes(P<0.05). N2 and N12 ewes 
yielded respectively 2.92 ± 0.66 kg/150 d and 3.39 ± 0.83 kg/150 d more fat than N1 ewes 
(P<0.01). N2 ewes yielded also 2.46 ± 0.85 kg/150 d (P<0.05) more protein and 
5.73 ± 1.89 kg/150 d (P<0.01) more fat+protein than N18 ewes. 
The analysis of GH2-Z genotypes revealed that Z7 ewes yielded 54.2 ± 15.6 l/150 d 
more milk than Z6 ewes (P<0.01), but not than the other ewes. The milk of the Z7 ewes had 
significantly higher fat content (P<0.05) than Z2, Z3, Z6, Z9, Z10 (more 13.60 ± 5.12 g/kg) and 
Z13 ewes, which milks have similar fat contents (P>0.05). The milk of the N6 ewes had 
respectively 8.99 ± 3.86 g/kg and 11.29 ± 5.12 g/kg higher protein content than the milk of Z2 
and Z8 ewes (P<0.05). Z7 ewes yielded also significantly more fat (7.19 ± 1.08 kg/150 d; 
P<0.001), protein (2.82 ± 0.98 kg/150 d; P<0.05) and fat+protein (10.02 ± 2.18 kg/150 d; 
P<0.001) than Z6 ewes (Table IV-13). 
The analysis of associated GH2-N+GH2-Z genotypes revealed that N2+Z7 ewes yielded 
significantly (P<0.001) more milk (76.1 ± 17.4 l/150 d), fat (9.27 ± 1.21 kg/150 d), protein 
(4.39 ± 1.10 kg/150 d) and fat+protein (13.62 ± 2.44 kg/150 d), and their milk had significantly 
higher fat content (12.57 ± 6.00 g/kg; P<0.05) than N1+Z6 ewes and that N2+Z7 and N1+Z6 
ewes had identical protein content (Table IV-14). Furthermore, the milk of N2+Z7 ewes had 
also higher levels of fat content than the milk of N3+Z5, N7+Z10, N6+Z2 and N14+Z3 ewes. It 
was also observed that the milk of N1+Z6 ewes had significantly higher protein content 
(13.27 ± 5.44 kg/150 d; P<0.05) than the milk of N12+Z2 ewes. 
The analysis of GH2-N phenotypes revealed that AFN ewes yielded more milk 
(21.4 ± 15.6 l/150 d; P>0.05), fat (1.19 ± 1.09 kg/150 d; P<0.05), protein (2.13 ± 0.98 kg/150 d; 
P<0.05) and fat+protein (3.44 ± 2.18 kg/150 d; P>0.05) than ACN ewes, and that these phenotypes 
exhibited identical milk fat and protein contents (Table IV-15). It was also observed that AAN 
ewes yielded 1.35 ± 0.71 kg/150 d more fat than ACN ewes (P<0.05). 
The analysis of GH2-Z phenotypes revealed that AAZ, ABZ, ACZ, AEZ and BBZ 
ewes yielded on average 37.2 ± 12.08 l/150 d more milk (P<0.05) than AIZ ewes (Table 
IV-15).  All phenotypes presented identical milk fat contents. The milk of AIZ ewes had on 
average 7.09 ± 4.15 g/kg more protein contents than all the other ewes (P<0.05). The major 
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differences in yield traits were observed between BBZ and AIZ ewes, i.e., BBZ ewes yielded 
more fat (5.28 ± 0.94 kg/150 d; P<0.001), more protein (1.92 ± 0.84 kg/150 d; P<0.05) and 
more fat+protein (7.23 ± 1.88 kg/150 d; P<0.05) than AIZ ewes. This reflects the fact that BBZ 
ewes yield more milk (more 37.1 ± 13.4 l/150 d than AIZ ewes; P<0.05). 
The analysis of the associated GH2-N+GH2-Z phenotypes revealed that AAN+BBZ 
ewes yielded more milk (42.9 ± 14.9 l/150 d; P<0.05), with higher fat content 
(10.69 ± 5.13 kg/150 d; P<0.05) than AAN+AIZ ewes and that these phenotypes have identical 
protein content; thus AAN+BBZ yielded significantly more fat (6.07 ± 1.04 kg/150 d; P<0.001), 
protein (2.19 ± 0.94 kg/150 d; P<0.05) and fat+protein (8.27 ± 2.08 kg/150 d; P<0.01) than 
AAN+AIZ ewes (Table IV-15). 
Generally speaking, genotypes and phenotypes had a huge influence on milk yield traits, 
and only a moderate one on milk fat and protein contents. This is an interesting result as it can 
be expected to improve milk yield potential of the ewes without major detrimental impact on 
their milk quality. Moreover, it was observed simultaneously a higher level of milk yield and 
milk fat content in ewes with some genotypes/phenotypes (e.g. AAN+BBZ ewes). 
 
IV.3 Single nucleotide polymorphisms (SNPs) 
Sequencing of the GH2-N and GH2-Z copies disclosed SNPs (e.g. Figure IV-8) that 
could not be genotyped by PCR-SSCP analysis within the exon 5 of the GH2-Z gene copy 
(E5Z1851). 
Figure IV-8. Partial electropherogram of the PCR product of the GH2-Z copy presenting 
SNPs I4Z1551 (C/T) and I4Z1558 (T/G). 
The red arrows indicate the two polymorphic sites. 
 
SNPs were also found in the 5’-UTR region and in intronic regions. Those SNPs and 
their genotype and allele frequencies for the sequenced animals are listed in Table IV-16 and 
Table IV-17. More than 100 other polymorphic sites were found across the oGH gene copies, 
but only in one strand. Thus SNPs for those sites could not be validated and were not listed. 


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Hardy-Weinberg equilibrium was verified for almost all SNP loci within the GH2-N 
copy. Deviations towards heterozygote deficit were found for 5’N(-125) (P<0.01), for I2N793 
(P<0.05) and for I3N1259 (P<0.05). 
 
Table IV-16. GH1 or GH2-N SNPs and their respective genotype and allele frequencies (%). 
Region Site Genotypesa Allelesb 
5’N(-125) AA 3 (0.15) AG 2 (0.10) GG 15 (0.75) A 8 (0.20) G 32 (0.80) 5' 5’N(-61) CC 0 CT 2 (0.10) TT 18 (0.90) C 2 (0.05) T 38 (0.95) 
I1N381 CC 16 (0.76) CT 4 (0.19) TT 1 (0.05) C 36 (0.86) T 6 (014) 
I1N427 CC 18 (0.90) CT 2 (0.10) TT 0 C 38 (0.95) T 2 (0.05) 
I1N431 CC 0 CT 2 (0.10) TT 18 (0.90) C 2 (0.05) T 38 (0.95) 
I1N437 CC 0 CT 2 (0.10) TT 18 (0.90) C 2 (0.05) T 38 (0.95) 
I1N452 AA 0 AG 2 (0.10) GG 18 (0.90) A 2 (0.05) G 38 (0.95) 
I1N458 AA  A-  --   A 6 - 14 
I1 
I1N480 AA 0 AG 5 (0.25) GG 15 (0.15) A 5 (0.12) G 35 (0.88) 
I2N790 AA   A-   --   A 17 - 3 
I2N793 CC 14 (0.70) CT 3 (0.15) TT 3 (0.15) C 31 (0.78) T 9 (0.22) 
I2N811 CC 1 (0.05) CT 5 (0.25) TT 14 (0.70) C 7 (0.18) T 33 (0.82) 
I2N854 AA 2 (0.10) AG 4 (0.20) GG 14 (0.70) A 8 (0.20) G 32 (0.80) 
I2 
I2N926 AA 1 (0.05) AC 5 (0.25) CC 14 (0.70) A 7 (0.18) C 33 (0.82) 
I3N1254 CC 14 (0.70) CT 5 (0.25) TT 1 (0.05) C 33 (0.82) T 7 (0.18) 
I3N1259 AA 8 (0.40) AC 5 (0.25) CC 7 (0.35) A 21 (0.52) C 19 (0.48) 
I3N1283 AA 13 (0.65) AG 6 (0.30) GG 1 (0.05) A 32 (0.80) G 8 (0.20) I3 
I3N1289 CC 1 (0.05) CG 6 (0.30) GG 13 (0.65) C 8 (0.20) G 32 (0.80) 
I4N1486 AA 11 (0.55) AG 7 (0.35) GG 2 (0.10) A 29 (0.72) G 11 (0.28) 
I4N1509 AA 11 (0.55) AG 7 (0.35) GG 2 (0.10) A 29 (0.72) G 11 (0.28) 
I4N1558 GG 0 GT 6 (0.30) TT 14 (0.14) G 6 (0.15) T 34 (0.85) 
I4N1648 CC 17 (0.85) CT 2 (0.10) TT 1 (0.05) C 36 (0.90) T 4 (0.10) 
I4 
I4N1711 AA 18 (0.90) AG 2 (0.10) GG 0 A 38 (0.95) G 2 (0.05) 
a
 number of animals and genotype frequencies (%) in brackets. 
b
 number of alleles and allele frequencies (%) in brackets. 
Site: U – UTR; E – exon; I – intron; N – GH2-N (or GH1) copy; e.g., 5’N(-125) – 5’-region at GH2-N (or GH1) 
copy, position 125 upstream from the transcription starting site; 5UN381 – 5’-UTR at GH2-N (or GH1) copy, 
position 381 according to the published oGH gene sequence (Orian et al., 1988); GenBank accession no. X12546. 
 
HWE was also verified for some SNP loci within the GH2-Z copy. Deviations towards 
heterozygote deficit were found for 5’Z(-326) (P<0.001), for 5’Z(-282) (P<0.05), for 5’Z(-227) 
(P<0.05), for I1Z438 (P<0.05), for I2Z794 (P<0.05), for I2Z797 (P<0.05), and this tendency was 
also observed for I2N929 (P<0.10). 
Polymorphic sites detected with PCR-SSCP analysis were also analysed individually for 
HWE. Deviations were only observed for E2Z712 and E5Z1852 (significant for heterozygote 
deficit; P<0.05). 
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Table IV-17. GH2-Z SNPs and their respective genotype and allele frequencies (%). 
 
 Gh1/Gh2 Gh2/Gh2 
 Region Site Genotypesa Genotypesa 
Allelesb 
5’Z(-326) A- 1 (0.50) G- 1 (0.50) AA 4 (0.27) AG 2 (0.13) GG 9 (0.60) A 11 (0.34) G 21 (0.66) 
5’Z(-304)    G- 2 (1.00) AA 1 (0.06) AG 3 (0.19) GG 12 (0.75) A 5 (0.15) G 29 (0.85) 
5’Z(-282)    G- 2 (1.00) GG 9 (0.60) GT 3 (0.20) TT 3 (0.20) G 21 (0.66) T 11 (0.34) 
5’Z(-267) C- 2 (1.00)    CC 11 (0.73) CT 3 (0.20) TT 1 (0.07) C 27 (0.84) T 5 (0.16) 
5’Z(-227) A- 1 (0.50) T- 1 (0.50) AA 8 (0.53) AT 4 (0.27) TT 3 (0.20) A 21 (0.66) T 11 (0.34) 
5’Z(-191) C- 1 (0.50) T- 1 (0.50) CC 1 (0.07) CT 5 (0.33) TT 9 (0.60) C 8 (0.25) T 24 (0.75) 
5’ 
5’Z(-107) C- 1 (0.50) G- 1 (0.50) CC 1 (0.07) CG 5 (0.33) GG 9 (0.60) C 8 (0.25) G 24 (0.75) 
5’-UTR 5UZ288    T- 2 (1.00) CC 2 (0.13) CT 4 (0.27) TT 9 (0.60) C 8 (0.25) T 24 (0.75) 
I1Z438 A- 1 (0.50) G- 1 (0.50) AA 6 (0.38) AG 5 (0.31) GG 5 (0.31) A 18 (0.53) G 16 (0.47) I1 I1Z513    G- 2 (1.00) -- 2 (0.13) G- 1 (0.06) GG 13 (0.81) - 5 (0.15) G 29 (0.85) 
I2Z792 A- 1 (0.50) G- 1 (0.50) AA 6 (0.38) AG 3 (0.19) GG 7 (0.44) A 16 (0.47) G 18 (0.53) 
I2Z797 A- 2 (1.00)    AA 13 (0.81) AC 1 (0.06) CC 2 (0.13) A 29 (0.85) C 5 (0.15) 
I2Z801 -- 2 (1.00)    -- 14 (0.88) C- 0 CC 2 (0.12) - 30 (0.88) C 4 (0.12) 
I2Z871 A- 2 (1.00)    AA 12 (0.75) AG 3 (0.19) GG 1 (0.06) A 29 (0.85) G 5 (0.15) 
I2Z926 A- 1 (0.50) C- 1 (0.50) AA 6 (0.38) AC 6 (0.38) CC 4 (0.25) A 19 (0.56) C 15 (0.44) 
I2 
I2Z937 G- 2 (1.00)    GG 8 (0.50) GT 5 (0.31) TT 3 (0.19) G 23 (0.68) T 11 (0.32) 
I3Z1100 A- 1 (0.50) G- 1 (0.50) AA 10 (0.52) AG 6 (0.32) GG 3 (0.16) A 27 (0.68) G 13 (0.33) I3 I3Z1275    G- 2 (1.00) AA 1 (0.06) AG 2 (0.13) GG 13 (0.81) A 4 (0.12) G 30 (0.88) 
I4Z1551 C- 2 (1.00)    CC 12 (0.75) CT 3 (0.19) TT 1 (0.06) C 29 (0.85) T 5 (0.15) 
I4 I4Z1558    T- 2 (1.00) GG 2 (0.13) GT 5 (0.31) TT 9 (0.56) G 9 (0.26) T 25 (0.74) 
E5 E5Z1851 (aa185) C- 2 (1.00)   CC 13 (0.81) CT 2 (0.13) TT 1 (0.06) 
C 
(Tyr) 30 (0.88) 
T 
(Tyr) 4 (0.12) 
a
 number of animals and genotype frequencies (%) in brackets. 
b
 number of alleles and allele frequencies (%) in brackets. 
Site: 5’Z(-326) – 5’-region at GH2-Z copy, position 326 upstream from the transcription starting site; U – UTR; E – exon; I – intron; Z – GH2-Z copy, e.g., 5UZ288 – 
5’-UTR at the GH2-Z copy position 288 according to the published oGH gene sequence (Orian et al., 1988; GenBank accession no. X12546); aa – amino acid 
number of the mature protein (considering N-terminal alanine as amino acid 1 which corresponds to amino acid 27 of the published oGH sequence with GenPept 
accession number CAA31063) (Orian et al., 1988). 
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Table IV-18. Endonucleases1 that discriminate SNPs found by SSCP analysis or DNA 
sequencing along the oGH gene copies. 
Copy Site Base 
substitution 
Endonucleases that recognize new 
restriction site 
E1N301 t→a AluI 
I1N480 g→a SspI 
E2N651 c→t BfaI, MaeI 
E2N666 t→c HpaII, MspI 
E3N973 a→t Eco47III 
E3N1047 a→g HaeIII, HpaII, MspI 
I3N1254 c→t SalI, TaqI 
I3N1254 t→c HaeIII 
I3N1283 a→g BstUI, FnuDII, KspI, MvnI, SacII, ThaI 
E5N1872 a→g AccIII, BseAI, BspEI, HpaII, MspI, MroI 
E5N1938 t→c AluI, PvuII  
3UN2050 c→g DpnI, DpnII, MboI, NdeII, Sau3AI 
GH1 or 
GH2-N 
3UN2069 g→c AluI 
E2Z644 a→g CfoI, HhaI, HinPII, KasI, NarI  
E2Z704 c→g BbrPI, MaeII, PmaCI, PmlI  
E2Z712 a→g AluI, PvuII, 
I2Z793 a→g AosI, AviII, CfoI, FspI, HhaI, HinPII 
I2Z937 t→g PvuII 
E3Z1047 a→g HaeIII, HpaII, MspI 
I4Z1551 t→c BbrPI, MaeII, NlaIII, PmaCI, PmlI 
GH2-Z 
3UZ2030 c→t MseI, Tru9I 
GH1 or GH2-N 
vs. GH2-Z E2N668→E2Z668
2
 
g→(c or t) HaeIII, HpaII, MspI 
1
 Only enzymes with palindromic/non-ambiguous recognition sequences. 
2
 Differences between GH2-N (or GH1) copy and GH2-Z copy (SNP that allows distinguishing Gh1/Gh1 animals 
from Gh1/Gh2 or GH2/Gh2 animals). 
 
PCR-SSCP and sequencing techniques have some limitations for routine SNPs 
genotyping. PCR-SSCP needs a great effort in conditions optimization and can sometimes lead 
to misleading results. Although sequencing has become cheaper in recent years it needs several 
purification steps and results are rather difficult to interpret when DNAs from both 
chromosomes are analysed simultaneously (generated directly from a PCR) and 
insertions/deletions are present in one of them. The use of RFLP analysis for SNPs genotyping 
is an interesting option, because it is easy to apply and allows to genotype exactly the analysed 
animal. Thus, SNPs disclosed by PCR-SSCP (Table IV-4) and sequencing analyses (Table 
IV-15) were examined to find restriction sites that could be recognized by endonucleases useful 
for RFLP analysis. A total of 13 SNPs within GH1 or GH2-N copies, eight SNPs within GH2-Z 
copy and one SNP that allows allows distinguishing GH1 or GH2-N copies from GH2-Z copy 
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are listed in Table IV-18. The remaining SNPs need to be genotyped using alternative 
techniques as allele-specific PCR or SNaPshop.
 
IV.4 Transcription factors binding sites 
The characterization of the 5’-region (1 kb upstream the transcription starting site) of 
the sequences GenBank accession numbers DQ450146 (GH1 copy), DQ461666 (GH2-N copy) 
and DQ461642 (GH2-Z copy) disclosed differences between copies in the putative 
transcription factors binding sites (Figure IV-9; see Appendix 4 for detailed information on 
site positions and sequences). It is evident from the Figure IV-9 that GH1 and GH2-N copies 
have similar putative binding sites and both copies differ considerably from the GH2-Z copy. 
Of particular interest are the different localization of POU1F1 binding sites between the copies; 
the inexistence in the GH2-Z copy of a putative binding site for Zn-15 which is known to 
enhance GH gene expression when in association with POU1F1; the lower number of YY1 
binding sites in GH2-Z copy; and the existence of several putative binding sites for STAT. 
The high divergence found in the regulatory region of the oGH copies concurs to copies 
being expressed in different tissues, i.e., GH1 and GH2-N in pituitary and GH2-Z in placenta 
(Lacroix et al., 1996, 1999; Sartin et al., 1996). 
 
   ♦ ♦ x ♦ ♦ x x ♦  x ♦
   ♦ ♦ x ♦ ♦ x x ♦  x ♦
♦         x     ♦
-1-900 -500-600-700-800 -100-200-300-400
 
Figure IV-9. Putative transcription factors binding sites at the 5’-region at GH1, GH2-N and 
GH2-Z copies. 
 - POU1F1, POU1F1a, POU1F1b and/or POU1F1c (pituitary-specific transcription factor 1);  - Ap-1 (activator 
protein 1);  - AP-2 and NF-1, AP-2alphaA and AP-2alphaB (activator protein 2) and nuclear factor 1;  - GR 
(glucocorticoid receptor); ♦ - T3R and/or T3R-alpha (3,5,3’-triiodothyronine receptor);  - STAT1, STAT5A, 
STAT5B and/or STAT6 (signal transducer and activator of transcription);  - Zn-15 (zinc finger protein); 
x - YY1 (yin and yang factor 1). 
 
GH1 
 
GH2-N 
 
GH2-Z 
bp 
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IV.5 Protein structure prediction 
The protein structure analysis comparison between GH1, GH2-N and GH2-Z was 
performed by using the the PROSITE SCAN package tools (http://us.expasy.org/) from the 
ExPASy Molecular Biology Server. 
All the analysed protein variants have a GH/PRL and related hormones signature 1 
(motif CfSetIpAPtgkneAqqksdleLlrisllLiqSW) and 2 (motif CFRkDLhkTetYlrVmkC) at 
positions 53-86 and 164-181, respectively. Tyrosine kinase phosphorylation site (motif 
Kef.Ert.Y at position 30-36) and luecine zipper pattern (motif LlknyglLscfrkdLhktetyL at 
position 155-176) are present also in all the protein variants analysed. Amino acid substitution 
originate differences in the number of N-myristoylation, protein kinase C phosphorylation, 
casein kinase II phosphorylation and N-glycosylation sites found at each of the oGH copies 
(Table IV-19). All GH2-N protein variants have a N-myristoylation site (motif GLfaNA) at 
positions 9-14, but this site is absent in the GH2-Z protein variants in which G9 is substituted 
by C9 or R9 (Table IV-5).  
 
Table IV-19. Protein motif comparison between several oGH protein variants. 
Location* Motif VNA VN(S32)a VZA VZ(G63)b VZ(G63,N64)c VZ(S160)d 
N-myristoylation site 
9 – 14 GLfaNA x x – – – – 
40 – 45 GQrySI x x x x x x 
63 – 68  GNneAQ – – – – x – 
160 – 165 GLlsCF x x x x x – 
Protein kinase C phosphorylation site 
28 – 30 TfK x x x x x x 
32 – 34 SeR – x – – – – 
62 – 64 TgK x x x x – x 
106 – 108 SdR x x x x x x 
131 – 133 TpR x x x x x x 
Casein kinase II phosphorylation site 
28 – 31 TfkE x x x x x x 
63 – 66 SknE – – x – – x 
71 – 74 SdlE x x x x x x 
ASN_glycosylation site 
158 – 161 NYSL – – – – – x 
a
 - VNH; b – VZD and VZE; c – VZJ; d - VZC, VZG and VZH (see Table IV-6). 
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“The most exciting phrase to hear in science, 
the one that heralds new discoveries, is not 
'Eureka!' (I found it!) but 'That's funny ...'.” 
 
Isaac Asimov (1920 - 1992) 
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V.1 Animals and milk records 
The main objective of the present work was to detect polymorphisms at the oGH gene 
in “Serra da Estrela” animals reared under the “traditional” production system. As each 
shepherd practices his own system according to the genetic potential of his animals, the feed 
availability at the farm at each moment and other management decisions related with individual 
flocks’ constraints at each moment, the present study was extended to seven flocks. All the 
animals present in each flock were sampled for blood regardless whether they were related or 
not. This kind of approach may have limited the level of polymorphism found in this study. 
However this could have been in part overcome by the fact that the analyses were performed in 
seven flocks. Rams from ANCOSE Male Testing Centre were also genotyped. These rams 
came from different flocks spread all over the “Serra da Estrela” region and are sons of the best 
yielding ewes, thus pre-selected as it often happens in studies seeking for genetic markers for 
milk production (Parmentier et al., 1999), not randomly chosen as it is mandatory in genetic 
diversity studies. 
The seven flocks were chosen according to the number of ewes (50 or more), breed 
variety (white or black in a proportion similar to the one of the overall population) and milk 
yield levels (low, medium and high). The mean number of ewes in “Serra da Estrela” flocks is 
low. However flocks with a lower number of animals were not chosen because it would impair 
the statistical analysis. 
Answers to the production system questionnaire suggest that the production system 
changed little since it was thoroughly characterised in 1993 (Gulbenkian et al.). Minor 
differences could perhaps be related with the high number of animals in each flock and with the 
sanitary legislation related to brucellosis control that restricted the use of communitary barren 
lands. 
 
V.2 oGH copy number genotypes 
Duplication of the oGH gene has been described in sheep (Valinsky et al., 1990), in 
goat (Yamano et al., 1991) and in humans (Chen et al., 1989), but not in bovine. Allele Gh1 
(not duplicated) was found to be rare (10%) in “Serra da Estrela” population as it was observed 
also in Assaf, Awassi and Merino (Valinsky et al., 1990), and in “Merino da Beira Baixa” (I.C. 
Santos, personal communication) ovine breeds. Moreover, in ovine breeds, animals carrying 
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the GH2-Z copy (Gh2 allele) represented approximately 90% of the population suggesting that 
it may confer some selective advantage. Moreover, as duplication confers tissue- and 
stage-specific activity to the GH2-Z gene, amino acid divergence between the oGH copies was 
possibly caused by positive Darwinian selection as suggested by Ohta (1993). 
V.2.1 Implications in milk yield 
The number of studies analysing the biological effect of oGH copy number are scarce. 
Nevertheless, it was investigated in ram lambs selected for body composition and GH levels 
(lean and fat lines). Although GH copy number genotypes had no effect on GH secretion 
parameters or body composition, it was observed that they significantly influenced the response 
to GHRH (Gootwine et al., 1998) suggesting that the natural occurring variation in oGH copy 
number influence GH axis response to different nutritional and perhaps physiological status. 
Other studies reported that the effects of the oGH copy number in transgenic animals 
expressing an additional oGH gene copy were an increased growth rate and a decreased body 
fat content (Adams et al., 2002). The effects of the naturally occurring variation in oGH copy 
number have been studied in Awassi dairy sheep (Gootwine and Ofir, 1996). The progeny of 
two GH1/GH2 rams were studied showing that GH1/GH2 daughters of only one of them 
yielded significantly more milk per lactation than their GH2/GH2 half sib (513 l vs 465 l).  
“Serra da Estrela” ewes that received the Gh2 allele from their progenitor yielded 
21.9 ± 7.5 l/150 d more milk than ewes that received the Gh1 allele (model 2; Figure IV-4). 
The higher milk yield observed in ewes with increasing number of Gh2 alleles points to a 
possible dominant effect of Gh2 allele.  
The GH2-N is expressed in anterior pituitary gland somatotrope cells (Warwick et al., 
1989). As the GH2-N and GH2-Z gene copies are regulated differently, GH2-Z is not expressed 
in the pituitary (Gootwine et al., 1996). It is expressed in placenta trophoblasts and syncitium 
between day 30 and 60 of gestation, a period of maximum placental growth (Lacroix et al., 
1996; 1999). Therefore, during early gestation, animals carrying Gh2 allele have two sources of 
circulating GH: the pituitary GH derived from GH2-N copy expression and the placental GH 
derived from GH2-Z copy expression. Hence, it is reasonable to hypothesise that Gh2 carrying 
ewes have higher levels of GH which might influence directly placental and mammary gland 
development in the early gestation, and indirectly mammary cell differentiation in the last 
phase of gestation through higher levels of placental PRL. 
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V.2.2 Transcription factors binding sites and oGH copies regulation 
The analysis of 1 kb fragment upstream from the start of transcription binding site, 
revealed that GH1 and GH2-N copies have identical promoter sequences, divergent from 
GH2-Z promoter (Figure IV-9). Of particular importance in transcription regulation are the 
binding sites located between positions -300 to -1. This region presents at GH1 and GH2-N 
copies four POU1F1 binding sites and a Zn-15 binding site between them; the proximal 
POU1F1 binding site interacting with an YY1 binding site. This group of binding factor sites is 
flanked by two T3R response elements. Putative binding sites for STATs were predicted within 
the -300 to -250 region, flanked proximally by an YY1 putative binding site. The T3R 
proximal element is the only one common to the three GH copies. At GH2-Z copy, one binding 
site for each AP-1, AP-2, STATs, POU1F1 and YY1 transcription factors was predicted. In 
Figure IV-9 and in Appendix 4, only putative binding sites similar to those described in GH, 
PRL and chorionic somatomammotropin genes in human and rat were listed. However a 
considerable higher number of transcription factors binding sites were predicted: among them 
are several GR, Sp1 and nuclear factor-I (NF-1) binding sites. The differences in the 
localisation of the observed putative binding sites are in agreement with the differential 
activation of GH and chorionic somatomammotropin gene expression by Sp1 and T3R (Tansey 
and Catanzaro, 1991). In addition, the presence of an AP-2 binding site at position -64 of the 
GH2-Z copy might mediate GH2-Z copy expression in the placenta in a similar way to the 
AP-2 mediated trophoblast-specific transcription of the oPL gene (Liang et al., 1999). 
To elucidate the effective role played by the predicted binding sites in regulation of 
oGH gene copies, DNase I protection analysis, electrophoretic mobility-shift assays and 
mutational analysis should be performed in the future.
 
V.3 PCR-SSCP polymorphisms at the oGH gene 
The high level of polymorphism detected in each oGH gene copy and between oGH 
gene copies confirms the PCR-SSCP as an efficient technique to detect mutations (Table IV-1 
and Figure IV-5), as it has been shown in other studies in sheep (Bastos et al., 2001; Santos et 
al., 2004), in goats (Malveiro et al., 2001; Marques et al., 2003), in cattle (Lee et al., 1994b; 
Lagziel et al., 1996; Yao et al., 1996; Hines et al., 1998; Lagziel and Soller, 1999) and in pigs 
(Kaminski and Wachek, 2002). Moreover, it is cheaper and faster than other techniques like 
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allele-specific PCR or RFLP. Nevertheless, it has limitations such as the occasional appearance 
of extra bands that may complicate the analysis specially when analysing a duplicated gene. 
Up to seven alleles were discriminated by SSCP in the analysed oGH fragments (Table 
IV-1), some of them present at low frequencies in the studied flocks. Fragments III, IV, VI and 
VII are illustrative of the high variability of the oGH gene in “Serra da Estrela” breed. The high 
number of SSCP patterns found was somehow expected since the analyses were performed 
simultaneously on the two copies of the oGH gene. 
The optimal conditions for the PCR-SSCP analysis, once settled, can be used to 
genotype for known mutations and to screen for new ones simultaneously, being for that 
reason, very popular in cancer research (Berggren et al., 2000; Frayling, 2002; Kringen et al., 
2002) and in monitoring microbial communities (Albuquerque and Costa, 2003; Anderson and 
Cairney, 2004; Etchebehere et al., 2003). The application of PCR-SSCP to detect 
polymorphism in animals has increased in the last years and it probably will continue to 
increase concomitantly with the emergence of alternative ways to perform the SSCP analysis 
(Ganguly, 2002) such as capillary electrophoresis-based SSCP (Andersen et al., 2003; Larsen et 
al., 1999) or fluorescent-SSCP (Scholl et al., 2001) for instance. 
SSCP patterns were found to be present at different frequencies in each flock (Table 
IV-1). In fragments I, II and V, pattern A is largely dominant over the others (frequency higher 
than 90%), namely in the high milk yielding flocks, what suggests that through traditional 
selection, unfavourable alleles were eliminated, thus possibly changing population HWE. 
Results from HWE tests (Table IV-3) showed deviations from the expected values in 
all but fragments IIN and IIIN. It is interesting to notice that for the same fragment in copies 
GH2-N and GH2-Z, the deviation from HWE seems to be due to different causes. In fragments 
IIIN, IVN and VIZ deviation from HWE is mainly due to significant levels of heterozygote 
excess which might indicate the presence of overdominant selection or the occurrence of 
outbreeding. However, in fragments VIIN and IIIZ, IVZ and VIIZ HWE deviation results from a 
homozygote excess what could indicate the occurrence of one or more of the following four 
events: 1) those fragments were under selection; 2) a “null allele” could be present leading to a 
false observation of homozygote excess what is most likely to be the case in GH2-Z fragments; 
3) high levels of inbreeding could have occured; 4) the population could be substructured 
leading to Wahlunds’ effect (Dorak, 2006). Indeed, Gh1/Gh2 animals, if they result from a 
Gh1/Gh1 x Gh1/Gh2 mating, are identical to their Gh1/Gh2 parent at GH2-Z copy and thus 
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their inbreeding coefficient is probably higher increasing artificially the homozygote excess in 
the GH2-Z copy fragments. 
V.3.1 Molecular characterization of the SSCP patterns 
As GH1, GH2-N and GH2-Z sequences are highly homologous it was not possible to 
design specific primers for the exons and the 3’-UTR of each copy. However, the approach 
described in the present study (section IV.2.3) allowed the SSCP patterns to be interpreted and 
GH2-N and GH2-Z copies genotypes attributed. 
Valinsky et al. (1990), Gootwine et al. (1993; 1996) and Ofir and Gootwine (1997) 
reported three PvuII-RFLPs related to the oGH copy number, located at position 712 in exon 2 
(restriction site present only in the GH2-N copy), position 932-937 in the intron 2 (restriction 
site mutated in the GH2-Z copy) and position 1935-1939 in the exon 5 (restriction site present 
both in the GH2-N and GH2-Z copies). The existence of polymorphisms at PvuII restriction 
sites in exons 2 (GH2-N copy) and 5 (GH2-Z copy), identified in the present work, excluded 
the use of PvuII-RFLP to discriminate between oGH copies (Table IV-4); this could be 
achieved using PCR-SSCP analysis of exon 2 as described (section III.4). 
V.3.1.1 oGH gene polymorphisms 
Results presented in Table IV-4 and Table IV-5 revealed copy specific polymorphisms 
(24 at the GH2-N and 14 at the GH2-Z copies) and a common polymorphism at position 1047. 
Alignment of sequences of the GH2-N and GH2-Z predicted mature proteins from all the 
genotyped sheep exhibiting the two oGH gene copies (17 Gh2/Gh2 and two Gh1/Gh2 animals), 
revealed that the protein copies always differ at two amino acids (aa): aa(-7) (P → L; site 624) 
and aa9 (G → R or C; site 668) as reported by Wallis et al. (1998). Aa63 differs also between 
the predicted protein copies (G → S; site 1057) in most animals; however, in some, G63 is 
present in both GH2-Z and GH2-N copies. GH1 protein sequence was found to be identical to 
the GH2-N consensus sequence (Orian et al., 1988) in accordance with the finding by Ofir and 
Gootwine (1997) in Awassi, Romanov and Romney ewes. 
The present (Table IV-1, Table IV-4, Table IV-5 and Figure IV-5) and previous 
results in other Portuguese ovine breeds (Bastos et al., 2001; Santos et al., 2004), as well as in 
Assaf breed (Santos et al., unpublished results), in Israeli breed (Ofir and Gootwine, 1997) and 
in Indian breeds (GenBank accession numbers: DQ166369-74 and DQ176733-47) showed that 
coding regions are much more polymorphic in ovine than in bovine GH gene. In bovine, 
polymorphisms detected by SSCP analysis are present mainly in non-coding regions and in 
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exon 5 (Falaki et al., 1997; Lagziel and Soller, 1999; Ge et al., 2003). The low level of 
polymorphism observed in the 5’-UTR and in exon 1 (fragments I and II, respectively) is in 
agreement with previous findings indicating that these regions are highly conserved in GH1 
and GH2-N genes in ovine (Ofir and Gootwine, 1997). Exon 2 was the most polymorphic one 
in “Serra da Estrela” ewes and also in Merino da Beira Baixa (Santos et al., 2004), but not in 
caprine breeds (Malveiro et al., 2001; Marques et al., 2003). This suggests that those 
polymorphisms arose after species differentiation. In exon 4, no polymorphism was revealed in 
spite of the two observed SSCP patterns, suggesting that DNA modification(s) other than 
nucleotide mutations could be detected by SSCP analysis. Conversely, eight variants were 
described in exon 4 (GenBank accession numbers: DQ176740-47) in Indian ovine breeds, 
mainly within the exon 4-intron 4 junction region, and a high polymorphism level was also 
observed in caprine breeds (Malveiro et al., 2001; Marques et al., 2003). 
Many of the polymorphic sites detected by SSCP analysis were located near to CCC or 
AAA repeated regions suggesting that SSCP analysis might bias SNP detection towards 
repeated sequences with low secondary structure of the single strand DNA being less efficient 
in mutation dectetion within complex local secondary structures as palindromic regions, as 
observed in bovine and humans (Barendse and Armitage, 2001). 
Taking fragment genotypes as a starting point, oGH haplotypes were inferred in both 
copies for some genotypes, but it was not possible to determine the phase for all genotypes, so 
statistical analyses could not be performed involving haplotypes as it has been done in bovine 
by Lagziel et al. (1996). At the time of blood collection many of the ewes’ sires were no longer 
in the flocks, and therefore could not be genotyped. Nevertheless, considering pedigree 
information of 750 animals, a large number of oGH haplotypes was inferred, hence revealing 
considerable genetic diversity at the oGH gene within this breed. Eighty six haplotypes were 
inferred in the GH2-N copy, and 32 in the GH2-Z copy which is much more than the 14 
different haplotypes reported by Lagziel et al. (1996) in Israel Holstein bovine breed. 
V.3.1.2 Predicted protein variants 
The genetic polymorphisms detected in both copies could either involve regulatory 
regions and affect gene transcription rate (Pesole et al., 2000; discussed in section V.2.2), or 
influence the secondary structure of the protein and its post-transcriptional function (Woychik 
et al., 1984), or be linked to a genotype of interest located elsewhere (Sneyers et al., 1994). 
Predicted protein variants are listed in Table IV-6. Considering the predicted amino 
acid changes between GH2-N protein variants, aa(-16) is part of the GH signal peptide, aa3 is 
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near the GH NH2-terminal, amino acids 8, 22, 25 and 32 are in helix 1, with aa8 being involved 
in the second receptor-binding site as defined by Cunningham et al. (1991) for hGH. The 
remaining amino acids involved in variant differentiation are between helices 1 and 2. 
Considering the predicted GH2-Z protein variants, aa(-1) is part of the GH signal 
peptide, aa2 is near the GH NH2-terminal, amino acids 9, 21 and 23 are in helix 1, with aa9 
being part of the second receptor-binding site, amino acids 55, 59, 63 and 64 are between helix 
1 and 2, with aa63 being part of the first receptor-binding site, and aa160 is between helix 3 
and 4. NH2-terminal residues, involved in the GH receptor binding, have a substantial 
galactopoietic activity in cows (Eppard et al., 1992). Hence, polymorphisms found in this 
region could account for the differences observed in the milk yield. 
Several amino acid substitutions found within and/or between GH copies were 
predicted to change the nature/number of protein’s motifs (Table IV-19) that might influence 
protein structure, stability, or activity:  
- The changes at position 9 (G to R in GH2-N or to C in GH2-Z) disrupt the 
N-myristoylation site. The possible link between a fatty acyl group and GH could 
mediate protein-protein interactions or change the structure and activity of the protein to 
which it binds (Voet et al., 1999). S160 GH2-Z variants (VZC, VZG, and VZH) have also 
the N-myristoylation site disrupted, and inversely the VzJ (G63,N64) variant presents an 
extra N-myristoylation site. 
- Several predicted GH variants could be differently regulated as they were found to: 
either have one additional PKC phosphorylation site (S32 in VNH) or lack one (G63,N64 
in
 
VZJ) as compared with VNA and VZA variants, respectively; and/or lack one casein 
kinase II phosphorylation site (VzD and VZJ) with regard to the VZA variant. 
- The occurrence of a putative N-glycosylation site in VZC, VZG, and VZH variants and 
the presence of the appropriate oligosaccharide-processing enzymes could lead to the 
cotranslational N-glycosylation of GH (Voet et al., 1999). It is not known whether it 
affects the biological function of the protein or not. 
Some authors report that GHR processes great conformational plasticity to bond with 
dissimilar sites on GH, thus an amino acid substitution per si possibly does not disrupt 
GH/GHR binding (Sami et al., 1999). However, GH myristoylation, phosphorylation and/or 
glycosylation states might reduce the GH/GHR binding affinity altering GH-signal transduction 
and consequently its biological activity. 
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The present work disclosed new oGH variants coded by both gene copies. To elucidate 
the influence of the underlying amino acid changes on the structure-function of the GH further 
studies are needed. One possible approach could be the heterologous production of functional 
GH variants as suggested by Appa Rao et al. (1997).
 
V.4 Milk yield and composition 
Recent studies performed in goats (Malveiro et al., 2001; Marques et al., 2003) and 
cattle (Lagziel et al., 1996; Lagziel and Soller, 1999; Yao et al., 1996) allowed the 
establishment of associations of GH SSCP patterns with milk traits. 
In the present work significant associations were found between oGH genotypes (Table 
IV-7, Table IV-8 and Table IV-9) or phenotypes (Table IV-10, Table IV-11 and Table 
IV-12) and milk production in “Serra da Estrela” ewes. Some of the alleles uncovered by SSCP 
and sequencing analyses were not found to correspond to homozygous genotypes (and their 
corresponding phenotypes). This limited the statistical analysis to the use of a model where 
only additive genetic effects were considered. 
Considering the overall population, differences of approximately 21 l/150 d (P<0.05) 
were observed between the most and the least productive genotypes either for GH2-N (N7 vs. 
N5; Table IV-7) or GH2-Z copies (Z7 vs. Z2; Table IV-8). However, milk yield differences 
reach 31.4 ± 9.0 l/150 d between the extreme productive GH2-N phenotypes [ABN vs. (AHN 
and /or BEN); Table IV-10], and only 16.6 ± 8.3 l/150 d between the extreme productive GH2-
Z phenotypes [BDZ vs. (ADZ and/or BEZ); Table IV-11]. The results suggest that selecting for 
the highest milk yielding GH2-N phenotype would maximise the selection response. 
At the GH2-N copy, the least (N5) and the most (N7) productive GH2-N genotypes 
code for the same protein variant. Therefore, the observed effect upon milk yield could be due 
to the efficiency of mRNA processing or to the stability of its pre-processed form. 
In the GH2-Z copy, the Z2 genotype codes to a protein variant with the following amino 
acids: F2,R9,L21,S63,K64,G160. It corresponds to the published oGH sequence number Q95205 
(Lacroix et al., 1996) and differs in one amino acid from the one coded by the Z7 genotype that 
has a C in position 9 (C9). The effect of an arginin at position 9 was discussed by Wallis et al. 
(1998) who suggested that a R9 variant can have increased binding affinity to GHR binding site 
2 as it enables a salt bridge formation with E122 and hydrogen bond to S120 of the GHR. 
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Whether the Arg→Cys substitution influences GH binding to its receptor or protein folding 
remains to be elucidated. In any way, the genotypes which code for C9 variant were positively 
(P<0.05) associated with milk yield (Table IV-9). 
The phenotypes ABN vs. (AHN and /or BEN), corresponding to the GH2-N copy, are the 
most and least productive ones respectively; they differ from each other in aa(-16) and aa32. 
The Leu→Pro substitution at aa(-16) introduces probably a kink in the GH signal peptide in 
variants VNE and VNH (both with P-16), which might impair their binding to the signal 
recognition particle and reduce GH secretion rate. As a result, animals carrying the P-16 protein 
variant could have reduced circulating GH level and consequently lower milk yielding aptitude 
as suggested by the present results. Additionally, a Phe→Ser substitution at aa32 located in 
helix 1 creates an additional PKC phosphorylation site that might interfere with VNE and VNH 
protein folding. 
The phenotypes BDZ vs. (ADZ and/or BEZ), corresponding to the GH2-Z copy, are the 
most and least productive ones respectively; they differ from each other in aa9 and aa63. BDZ 
is homozygous for C9, and ADZ and BEZ are heterozygous phenotypes in which variants VZA 
and VZE present an Arg at position 9 and variants VZB and VZD carry a Cys at position 9. The 
putative influence of these amino acid changes were discussed above. The three phenotypes are 
heterozygous for aa63. Aa63 belongs to the binding site 1 in human GH (de Vos et al., 1992). 
Wallis et al. (1998) suggest that the substitution of S63 together with an Arg at position (R9) at 
the GH2-Z copy (VZA) could inhibit GH-GHR binding. The presence of the G63, described for 
the first time in ovine populations in the present work, and its positive effect on milk yield is in 
agreement with that assumption. In nature, although acting at different stages, both oGH copies 
act to control ewes’ metabolism. The GH2-N copy contribute to the homeorhetic control of the 
metabolism throughout life (Bauman and Currie, 1980) and GH2-Z copy is thought to 
influence placental and foetal growth, contributing to successful gestations of twins (Lacroix et 
al., 1999). Whether the GH2-Z copy influences directly milk yield, or not, remains 
controversial. However, significant interactions between GH2-N and GH2-Z were observed 
(Table IV-9 and Table IV-12) indicating that some epistatic effects may occur between GH 
copies, i.e., the effect of one copy depends on the other copy genotype/phenotype. Considering 
both copies simultaneously, the milk yield differential between (N2+Z7) and (N5+Z2) 
genotypes was 39.6 ± 7.5 l/150 d (Table IV-9) and the differential between (AAN+BBZ) and 
[(AHN and/or BEN)+BBZ] phenotypes was only 16.2 ± 8.1 l/150 d (Table IV-12). Thus, the 
apparent joint effect of GH2-N and GH2-Z genotype could improve milk yield in 25% as 
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compared with mean milk yield of the analysed population. Within each flock, the positive 
influence of the combined genotypes on milk yield ranged from 10% in FL2 to approximately 
35% in FL3, FL5 and FL6. 
The effect of genotypes/phenotypes differences in milk yield changes from flock to 
flock. In fact, one genotype/phenotype presenting the highest milk yield within one flock could 
be not the best in other flock. The results suggest that genotype/phenotype x environment 
interaction might influence the expression of milk yield potential in ewes as it was previously 
described in “Serra da Estrela” ewes (Carolino et al., 2003) and in Sarda ewes (Sanna et al., 
2002). Nevertheless, the ranking of genotypes/phenotypes in each flock according to their 
effects on milk yield showed that those which influence milk yield positively within a flock 
have an expected similar effect in the other flocks and the same occurs for the low yielding 
genotypes/phenotypes. However, exceptions can occur as observed in FL5. Thus, it is 
important to test genotypes x environement (i.e., flock) interaction. 
The influence of oGH genotypes/phenotypes were also tested on milk yield composition 
(Table IV-13, Table IV-14 and Table IV-15). Ewes with associated GH2-N+GH2-Z genotype 
N2+Z7 more milk with higher milk fat content and similar protein content than ewes with 
genotype N5+Z2. Moreover, a similar observation was made for AAN+BBZ protein phenotype. 
In general, the oGH genotypes/phenotypes with higher milk yield potential influenced 
positively milk fat and protein content, and milk fat, protein and fat+protein yields. This is an 
interesting result because usually, increasing milk yield results in lower fat and protein 
contents. However further studies should be performed to confirm the present results, because 
only one year of milk composition records was consider. Nevertheless, previous studies 
reported a positive effect of GH polymorphisms in milk fat content (Khatami et al., 2005; Lee 
et al., 1994a). The higher milk fat content observed could result form the enhanced availability 
of milk fat precursors due to GH-induced increase in adipose tissue lipolysis. 
 
V.5 Single nucleotide polymorphisms (SNPs) 
In this work, the oGH copies were sequenced to characterise SSCP alleles. The 
procedure followed adopted, in addition to the detection of polymorphisms not identified by 
SSCP, to screen intronic regions for SNPs. SNPs were found to be more frequent in intron 1 at 
the GH2-N copy, and in the 5’-region and in intron 2 at the GH2-Z copy. It was also found a
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SNP (synonymous mutation) in the exon 5 at the GH2-Z copy not detected by SSCP analysis 
(Table IV-16 and Table IV-17). 
SNPs found in the intronic regions were expected to be in HWE, but some were not. 
Deviation from HWE could be due to selection as well as to other factors discussed in section 
V.3. Deviation of HWE towards homozygote excess suggests that selection could have been 
applied to sites 5’N(-125), I2N793 and I3N1259. Site 5’N(-125) is located at the GH1 and GH2-N 
promoter regions between Sp1 and POU1F1 binding sites (position -125; Figure II-4), within 
an important region for oGH gene transcription regulation where SNPs have been shown to 
affect IGF-1 concentration in cattle (Ge et al., 2003). SNPs in intronic regions of several genes 
from the somatotropic axis have been shown to influence productive traits: e.g., a SNP in 
intron 3 of the GH gene influenced milk fat yield in Holstein cows (Lee et al., 1994a) and a 
SNP in intron 5 of POU1F1 influenced milk and protein yields, fat percentage, body depth, 
angularity, and rear leg set in Italian Holstein-Friesian bulls (Renaville et al., 1997). 
Homozygote excess was also observed for several SNPs at the GH2-Z copy. 
Due to the insufficient number of animals screened, statistical analyses were not 
attempted to search for associations between SNPs and milk production traits. In Table IV-18 
a list of endonucleases is proposed to rapidly identify some of the SNPs found at the oGH in 
“Serra da Estrela” ovine breed through RFLP analysis.
 
V.6 Future perspectives: 
In traditional quantitative genetics, selection is based on phenotypes and parental 
information whereas in molecular genetics, selection could be made directly upon a genotype 
via candidate gene marker approach. 
An ideal dairy system would be the one where: 
- all animals could be correctly identified (e.g., combining traditional identification 
systems with electronic identification such as reticulo-ruminal encapsulated 
chips); 
- parental information is accurate (extensive use of artificial insemination, AI, 
and/or parentage testing) and available for all individuals; and 
- phenotype data records are fully reliable (data normalization and validation). 
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Combining quantitative and molecular genetics (i.e., MAS) in a selection index where 
the best males are selected to sire the next generation should maximise genetic progress. 
However, the “Serra da Estrela” traditional ovine production system is not an ideal one, 
namely because AI application is still limited. An alternative approach to improve the existing 
selection scheme would be to GH genotype solely lamb daughters of the best females within 
the flock and retain only those with the most production-relevant genotypes. Such an approach 
might reduce generation intervals and improve greatly the milk yield response in dairy ewes. 
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One never notices  
what has been done;  
one can only see  
what remains to be done.” 
 
Marie Curie, letter to her brother (1894) 
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In conclusion, the GH2-N and GH2-Z genotypes were shown to significantly affect milk 
yield in the “Serra da Estrela” ewes. The apparent joint effect of GH2-N and GH2-Z genotypes 
could, on average improve milk yield adjusted to 150 d lactation on 25% as compared with 
mean milk yield of the analysed population. 
The high level of polymorphism observed suggests that genetic variability at the GH 
gene in Ovis aries could be exploited to produce genotypes with increased genetic merit. 
In addition the present results suggest that oGH genotypes/phenotypes influence 
significantly milk yield in sheep, without detrimental influence in milk composition. However, 
the use of the oGH gene as a marker for sheep selection requires a previous knowledge of the 
animals’ behaviour within the flock where they are reared. 
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Appendix 1 Questionnaire for dairy sheep farmers 
QUESTIONNAIRE FOR DAIRY SHEEP FARMERS 
Date ____/____/_______ 
FARMER: ________________________________________________________________  
ANCOSE code  __________________________  
Address: ___________________________________________________________________  
Place: __________________________________  
Total area = ________________ ha Owned = ________________ ha 
 Rented = ________________ ha 
 
SHEEP AND SHEEP PRODUCTS 
 
 Ewes Cheese Lambs weaned 
 
Primiparous Multiparous Maximum No. Mouth No. Age Weight 
Sheep        
 
1) FARM HAND-LABOUR 
 
Who does the shepherding? _____________________________________________________  
There are other workers? _______________________________________________________  
When? What they do? _______________________________________________________  
Shepherd _________________________________________________________________  
Person(s) for milking ________________________________________________________  
Person(s) for cheese making __________________________________________________  
Other ____________________________________________________________________  
 
2) PASTURES 
 
Do you have pastures? 
Natural?  Owned  No    Yes    Area = ______ha  
   Rented  No    Yes    Area = ______ha  
Sown?  Owned  No    Yes    Area = ______ha  
   Rented  No    Yes    Area = ______ha  
 
Which crops do you seed? ______________________________________________________  
 
Do you fertilize them? _________________________________________________________  
When? __________________________________________________________________  
With what? ______________________________________________________________  
There is water for irrigation?  Yes   No    Electricity Yes   No   
Do you irrigate the cultures? 
How? __________________________________________________________________  
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Which kind of vegetation do the ewes grass in? ______________________________________  
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
Are they under tree cover pasture?  Natural? No       Yes   
      Sown?  No       Yes   
 
Which are the dominant shrub species? ____________________________________________  
Natural______________________________________________________________________  
Sown _______________________________________________________________________  
 
At which time do the ewes go to the pasture and when do they return? 
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
How much time do the ewes spend till the pasture? __________________________________  
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
Do you have pastures with fences or ewes grass all over the area? 
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
Do the lactating ewes grass separately from the remaining flock? 
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
Do the ewes grass the remains of other crops after harvesting? Which ones? 
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
 
Do the ewes grass in communitary barren lands? Do you practice transhumance? 
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring___________________________________________________________________  
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3) MILKING 
 
In what month do you start milking? ______________________________________________  
In what month do you stop milking? ______________________________________________  
Which is the month with higher milk production?____________________________________  
Who milks the ewes? __________________________________________________________  
How much time does it take? ___________________________________________________  
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring __________________________________________________________________  
At which time are the ewe milked? _______________________________________________  
Autumn _________________________________________________________________  
Winter __________________________________________________________________  
Spring __________________________________________________________________  
 
4) SUPPLEMENTARAY FEED 
 
Do you give any supplementary feed during milking? ___________ (How many? What kind?) 
Autumn _______________________________________________________________  
Winter ________________________________________________________________  
Spring ________________________________________________________________  
 
Do you give any supplementary feed in the pen? 
Hay 
Which kind? ______________________________________________________________  
How much do you give to each ewe? 
Autumn _______________________________________________________________  
Winter ________________________________________________________________  
Spring ________________________________________________________________  
Locally produced or purchased? _______________________________________________  
Straw 
Which kind? ______________________________________________________________  
How much do you give to each ewe? 
Autumn _______________________________________________________________  
Winter ________________________________________________________________  
Spring ________________________________________________________________  
Locally produced or purchased? _______________________________________________  
 
4) MILK AND CHEESE 
 
What do you do with milk? _____________________________________________________  
How many litres are usually necessary to make a cheese? _____________________________  
Autumn _______________________________________________________________  
Winter ________________________________________________________________  
Spring ________________________________________________________________  
How much does a cheese weigh? ________________________________________________  
Autumn _______________________________________________________________  
Winter ________________________________________________________________  
Spring ________________________________________________________________  
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Appendix 2 Flocks’ average milk data records in the lactations of 
the years 95/96 and 96/97 (36 flocks and 2520 ewes) 
Flock No. Ewes 
Lambing 
age 
(month) 
Lambing 
date 
number  
of 
lambings 
Type  
of 
lambing 
Suckled 
milk (l) 
Milked 
milk (l) 
Total 
milk 
yield (l) 
Lactation 
days 
Milk 
yield  
(l/150 d) 
FL1 57 58.7 15-Out 4.9 1.4 28.6 88.9 117.5 224.3 90.0 
FL2 67 47.0 17-Out 4.0 1.4 31.4 160.1 191.4 209.7 152.8 
FL3 84 45.9 02-Nov 3.7 1.5 34.1 203.2 237.3 186.6 210.0 
FL4 79 58.7 16-Out 4.9 1.4 27.9 85.2 113.1 225.5 85.4 
FL5 148 39.4 26-Out 3.3 1.5 21.2 147.6 168.8 184.5 139.5 
FL6 82 47.2 11-Out 4.0 1.5 35.7 179.2 214.9 207.0 179.5 
FL7 48 39.5 11-Out 3.3 1.5 42.3 202.9 245.2 213.9 191.2 
FL8 70 60.0 10-Out 4.9 1.6 35.9 117.6 153.5 214.4 122.2 
FL9 79 58.3 06-Out 4.9 1.5 47.9 173.3 221.2 216.5 167.0 
FL10 103 53.4 23-Set 4.6 1.3 38.5 108.4 146.9 204.7 113.2 
FL11 60 41.6 09-Out 3.5 1.8 29.1 197.2 226.2 191.8 193.2 
FL12 83 54.8 25-Out 4.5 1.3 26.8 101.7 128.5 179.4 111.1 
FL13 31 47.0 13-Out 4.0 1.4 24.1 149.2 173.2 205.7 147.5 
FL14 73 46.2 31-Out 3.8 1.4 30.7 108.5 139.1 182.8 116.7 
FL15 48 48.2 14-Out 3.3 1.4 21.7 156.3 177.9 209.7 141.6 
FL16 19 21.4 13-Nov 3.6 1.9 62.5 169.8 232.3 215.4 201.1 
FL17 34 44.0 28-Set 3.7 1.9 50.0 165.6 215.6 212.7 187.0 
FL18 126 56.6 23-Out 4.6 1.5 27.7 148.1 175.7 186.0 153.5 
FL19 37 41.0 23-Set 3.5 1.9 44.9 181.8 226.7 237.8 172.3 
FL20 36 39.6 03-Out 3.3 1.3 39.0 191.9 230.9 223.6 178.6 
FL21 77 52.1 28-Set 4.4 1.5 53.5 208.2 261.7 234.0 197.0 
FL22 52 41.9 30-Set 3.7 1.6 33.4 183.2 216.5 209.8 179.4 
FL23 84 51.7 20-Out 4.4 1.4 36.2 185.8 221.9 220.7 178.4 
FL24 96 48.2 12-Out 4.1 1.5 35.5 209.1 244.6 227.3 179.6 
FL25 30 45.3 26-Out 3.7 1.7 21.9 155.3 177.2 192.9 147.5 
FL26 34 57.2 25-Out 4.2 1.4 32.9 191.3 224.2 215.2 180.9 
FL27 144 45.4 04-Out 3.9 1.4 21.9 118.9 140.7 185.2 124.5 
FL28 55 39.0 06-Out 3.3 1.4 53.8 209.5 263.3 216.4 196.2 
FL29 58 52.3 27-Out 3.9 1.5 13.0 166.3 179.2 202.0 147.5 
FL30 105 50.8 31-Out 3.8 1.3 13.6 153.6 167.2 174.9 147.3 
FL31 63 41.0 12-Out 3.5 1.6 33.4 135.8 169.2 206.9 139.9 
FL32 81 67.6 09-Nov 5.6 1.5 30.9 85.8 116.7 144.7 112.4 
FL33 32 45.6 28-Set 3.8 1.8 35.6 141.5 177.1 223.3 135.1 
FL34 25 17.5 27-Nov 2.8 1.4 44.1 146.0 190.1 207.9 162.5 
FL35 79 36.4 20-Out 3.1 1.5 21.5 147.3 168.8 213.9 134.8 
FL36 158 48.8 17-Out 4.2 1.4 27.8 80.5 108.3 197.4 92.3 
Mean 70 46.9 06-Nov 3.9 1.5 33.6 154.3 187.8 205.7 153.0 
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Appendix 3 GenBank accession number DQ238053 - the oGH gene 
inter-copy region 
1:  DQ238053. Reports  Ovis aries growth...[gi:79013030]  
LOCUS       DQ238053                4527 bp    DNA     linear   MAM 08-NOV-2005 
DEFINITION  Ovis aries growth hormone (GH) gene, GH2 allele copy GH2-N, exon 5 
            and partial cds; and growth hormone (GH2) gene, GH2 allele copy 
            GH2-Z exons 1, 2, 3 and partial cds. 
ACCESSION   DQ238053 
VERSION     DQ238053.1  GI:79013030 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 4527) 
  AUTHORS   Marques,M.R., Santos,I.C., Carolino,N., Renaville,R. and 
            Cravador,A. 
  TITLE     Effects of genetic polymorphisms at the growth hormone gene on milk 
            yield and composition in Serra da Estrela sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 4527) 
  AUTHORS   Marques,M.R., Santos,I.C., Belo,C.C. and Cravador,A. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (11-OCT-2005) FERN, University of Algarve, FERN - Campus 
            de Gambelas, Faro 8005-139, Portugal 
FEATURES             Location/Qualifiers 
     source          1..4527 
                     /organism="Ovis aries" 
                     /mol_type="genomic DNA" 
                     /db_xref="taxon:9940" 
                     /chromosome="11" 
                     /map="11q25-qter" 
                     /tissue_type="blood" 
                     /note="breed: Serra da Estrela" 
     gene            <1..>201 
                     /gene="GH" 
                     /allele="GH2" 
                     /note="copy GH2-N" 
     mRNA            <1..>201 
                     /gene="GH" 
                     /allele="GH2" 
                     /product="growth hormone" 
     CDS             <1..201 
                     /gene="GH" 
                     /allele="GH2" 
                     /codon_start=1 
                     /product="growth hormone" 
                     /protein_id="ABB51619.1" 
                     /db_xref="GI:79013031" 
                     /translation="ELEDVTPRAGQILKQTYDKFDTNMRSDDALLKNYGLLSCFRKDL 
                     HKTETYLRVMKCRRFGEASCAF" 
     exon            <1..>201 
                     /gene="GH" 
                     /allele="GH2" 
                     /number=5 
     gene            3704..>4527 
                     /gene="GH" 
                     /allele="GH2" 
                     /note="copy GH2-Z" 
     mRNA            join(3704..3774,4023..4183,4410..>4527) 
                     /gene="GH" 
                     /allele="GH2" 
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                     /product="growth hormone" 
     exon            3704..3774 
                     /gene="GH" 
                     /allele="GH2" 
                     /number=1 
     CDS             join(3762..3774,4023..4183,4410..>4527) 
                     /gene="GH" 
                     /allele="GH2" 
                     /codon_start=1 
                     /product="growth hormone" 
                     /protein_id="ABB51620.1" 
                     /db_xref="GI:79013032" 
                     /translation="MMAAGPRTSLLLAFTLLCLLWTQVVGAFPAMSLSRLFANAVLRA 
                     QHLHQLAADTFKEFERTYIPEGQRYSIQNTQVAFCFSETIPAPTSKNEAQQKS" 
     exon            4023..4183 
                     /gene="GH" 
                     /allele="GH2" 
                     /number=2 
     exon            4410..>4527 
                     /gene="GH" 
                     /allele="GH2" 
                     /number=3 
ORIGIN       
        1 gagctggaag atgttacccc ccgggctggg cagatcctca agcagaccta tgacaaattt 
       61 gacacaaaca tgcgcagtga tgatgcgctg ctcaagaact acggtctgct ctcctgcttc 
      121 cggaaggacc tgcacaagac ggagacgtac ctgagggtca tgaagtgtcg ccgcttcggg 
      181 gaggccagct gcgccttcta gttgccagcc atctgttgtt acccctcccc gtgccttcct 
      241 agaccctgga aggtgccact ccagtgccca ctgtcctttc ctaataaagc gaggaaattg 
      301 catcacattg tctgagtagg tgtcattcta ttctaggggg tggggtcagg caggacagcg 
      361 agggggagga ttgggaagac aatagcaggg gtgctgtggg ctctatgggt acccaggtgc 
      421 tgaataattg gcccggttcc tcctgggcca gaaagaagca ggcacatccc cttctctgtg 
      481 acacacccgg tcctcgcccc tggtccttag ttccaacccc actcatagga cactcacagc 
      541 tcaggagggc tctgccttca gtcccacccg ctaaggtgct tggagcggtt tctccttccc 
      601 tcatcagccc accaaaccga acctagcctc caagagtggg aagaaattta agcaagacag 
      661 gctatgaagt acagagggag agaaaatgcc tccaacatgt gaggaagtga tgagagaaag 
      721 cgtagaatta gttttgtgca gaaattttaa ggtgactaca cacttggccc aactaccctt 
      781 gggaaatgtg tgtgtgttag tcactcagct gtgtccagct ctttgtgacc ccacggactg 
      841 tggcctgcca ggctcctctg tccatgggat tctccaggca agaatactgg agggggttgc 
      901 cattccccag gggatcttcc caacccaagg atcaaacccg agtttcctgc attgcaggca 
      961 gattctttac tctctgagcc atcagggaag ccctgtggga aatgggaacc atgcaaaaat 
     1021 ggctttggga ccaattgaac cagaatgttt gggatctgaa ctgggtcaag agatgtggaa 
     1081 gagagattct aaatgcatgt gttcatgcta agttgcttca gtcgtgtccg actatttgca 
     1141 accccatgga ctgcagcccg ccaggctcct ctgtccatgg gattctccat tcaagaatac 
     1201 tggagtgagt ttccattcct cttccagggg atcttccgaa cccaggcatt gaaccagcgt 
     1261 ctcttatatc tcctgcactg acaggcgggt tctttaccac tagcgccacc tgggacccag 
     1321 ttctaagtga ggggttgcaa attcagtgcc aacaggtgcc aggcaggtta tatacataag 
     1381 tggcaagggc tgcatgtgaa gggagaaata gcaaccagcc cttagcctgc ttgtgaagga 
     1441 catagcacag aggggtagga accagggcag cctaaagtct caggccccag ctaaggatgc 
     1501 agcccaccta gccctgttac attgccttat cctgcattca ggactgcagg aggactttcc 
     1561 tggtggtcca gtggctgaga atccacatac caatgcaggg gacacgggtt caatccctga 
     1621 tctggaaaga ttccacatgc ctcagggcaa ctaagcctgt atatcacgac taccaaagcc 
     1681 ctcacaccca cagcctgtgc tgtgctacaa gagaagcccc tcagtgagaa gcctgctcac 
     1741 cacaactaga aagtagagta gcccctgctc gctgcaacta gagaaagccc tcttgcagca 
     1801 accaacccag cacagccaaa actaattaaa agacctcagg ggacttccct ggtggttcag 
     1861 catataaggc tctgtgcttc caatggaggg ggcccaggtt caacccctgg ttggagaact 
     1921 agatccctca tgctgaaatt aaagatccca agtgccacaa cctgactcag ccaaataaat 
     1981 aaattaaaaa aaaaacaaaa ctcagatgca gggctgccag accttctgac tcttcaagac 
     2041 agacagggta tccacacttt catgtaaaat caaatgttta aacattggca actaattcat 
     2101 attgaaacat tttaagggca aattttaacc caaacacatt tgctcttcaa gcagtcagtg 
     2161 agcaatctgt tattagagga atggattggg ataacttgga acaagggaaa gaatcagaaa 
     2221 gacctagact tgaacttgtg ctcaggaaga aattacttaa cctccccagg acccagtttg 
     2281 ctcacctaca aaatagagat aataatgtat tgccttataa ggcttgggtg aggagtaaat 
     2341 gaaatgaggt ctctaaagtg attgacacat tacggcaggt aagaagcttc agctattttt 
     2401 gcattgaact gtggagtgct ctgtgttttt ccaaaggaat tgaatcacat tctgcttccc 
     2461 taatggcagc ctgaatgttc tttctaaata cacttcaaag ggcagtttta aagttgtttt 
     2521 tagtcaccca agcaccttgg ctaagtaacc agtgatcgat aaattaatgc ttagatgttc 
     2581 aaagtaactc tattgtctgc taagttttgc tcataacttt attatttcta ctttactact 
     2641 cactttaaat tttcttcttt aaaagcctct attctttaag tggattttta gattactaac 
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     2701 tttagagctt tactctttac aaatataaga tttaaaagta tggttcagtt cagttcagtt 
     2761 cagttcagtt gctcagtcat gtctgactct ttgcgacccc atgaatcgca gtgtaccagg 
     2821 cctccctgtc catcgccaac tcccgcagtt cactcagact cacgtccatc aagtcagtga 
     2881 tgccatctag ccatctcatc ctctgttgtc cccttctcct cctgccccca atccctccca 
     2941 gcatcagagt cttttccaat gagtcaaccc tttacatgag gtggccaaag tactggaatt 
     3001 tcagctttag catcattcct tccaaagaaa tcccagggct gatctccttc agaatggatt 
     3061 ggttggatct cctggcagtc ccagggactc tcgagagtct tctccaacac cgcagttcaa 
     3121 acgcatcaat tcttcggcgt tcagccttct tcacagtcca gctctcagac tccgtacatg 
     3181 accacagtag tagacatatt tgtcatctga attaaattca cccattccag tccgtttttc 
     3241 tctgatatct gtgttgatgt caatgttcac tgttgccatc tcctgtttga ccacttccaa 
     3301 tttaccttga ttcatggacc taacattcca ggttcctatg caatattgtt ctttacagcg 
     3361 tcagacttta cttccatcac caatcgtatc tataagtggg taccattttc actttggcta 
     3421 cacctcttcc tgctttctgg agttatttct ccactgagct cctgtagcat attgggcacc 
     3481 taccgacctg gggagttcat tgttcagtgt catatctttt tgaattttca tactgttcat 
     3541 gggattctca aggcaagaat acagaagtgg tttaccattg ccttctccag tggaccacgt 
     3601 tttgtcagaa ctctcctcca tgactcatcg gtcttggatg gccctacaca gcacgggtca 
     3661 tagtttcact gagttagaca agggcccagc agggaccaat tccaggatcc caggacccag 
     3721 ttcaccagat gactcagggt cctgctgaca gctcaccagc tatgatggct gcaggtaagc 
     3781 tcacgaaaat cccctccatt agcgtgtcct aagggggtga tgcggggggc cctgccgatg 
     3841 gatgtgtcca cagctttggg ttttagggtt tccgaatgcg aacataggta tctacaccca 
     3901 gacatttggc ccaagtttga aatgttctca gtccctggag ggaagggcag gcggggctgg 
     3961 caggagatca ggcgtctagc tctctgggcc cctccgtcgc ggccctcctg gtctctccct 
     4021 aggcccccgg acctccctgc tcctggcttt caccctgctc tgcctgctct ggactcaggt 
     4081 ggtgggcgcc ttcccagcca tgtccttgtc ccgcctgttt gccaacgctg tgctccgggc 
     4141 tcagcacctg catcaactgg ctgctgacac cttcaaagag tttgtaagct ccccagagat 
     4201 gtgtcccaga ggtggggagg caggaaggga tgaatccgca accctccaca caatgggagg 
     4261 gaactgagga cctcagtggt attttatcca agtaaggatg tggtcagggg agtagaaatg 
     4321 ggggtgtgtg gggtggggag ggttccgaat aaggcagtga ggggaaccac gcaccagctt 
     4381 agacctaggt gggtgtgttc tccccccagg agcgcaccta catcccggag ggacagagat 
     4441 actccatcca gaacacccag gttgccttct gcttctctga aaccatccca gcccccacga 
     4501 gcaagaatga ggcccagcag aaatcag 
// 
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Appendix 4 Putative transcription factors binding sites at the 5’ 
region of oGH gene  
Copy Binding 
Factor   
Position Strand 
GH1 GH2-N GH2-Z 
Sequence 
 (Search Pattern) 
 
Score Identifier 
T3R -880 (-)    AGGGAG 100 HS$CS1_04   
STATa -766 (-)    CTGGGA 100 RAT$AMGL_02  
POU1F1a -730 (-)    ATGAATA 100 HS$PL_05 
AP-2b, NF-1 -720 (+)    TGGCC 100 HS$GRH_01 
AP-2b, NF-1 -686 (+)    TGGCC 100 HS$GRH_01 
STATa 
-671 (-) 
   CTGGGA 100 RAT$AMGL_02  
STATa 
-640 (+)    CTGGGA 100 RAT$AMGL_02  
STATa 
-623 (-) 
   CTGGGA 100 RAT$AMGL_02  
T3R -529 (+) ♦ ♦  AGGGAG 100 HS$CS1_04   
T3R-alpha  -498 (-) ♦ ♦  CTTGGG 100 RAT$GRH_18 
POU1F1a -496 (-)    AATTCAG 100 HS$PL_04 
POU1F1a -490 (+)    TAAAT 100 HS$GRH_03 
MAPF2, YY1 -436 (-) x x  GGAGC 100 RAT$MLC_04 
GR -429 (+)    TGTCCT 100 HS$GRH_07 
T3R-alpha -425 (+) ♦ ♦  CTTGGG 100 RAT$GRH_18 
POU1F1a -403 (-)    TAAAT 100 HS$GRH_03 
POU1F1a -366 (-)    TTGCATA 100 HS$PL_01 
T3R -363 (-) ♦ ♦  GGGTCA 100 HS$CS1_04 
YY1 -334 (+) x x  CATTT 100 HS$GMCSF_03 
STATa -301 (+)    CTGGGA 100 RAT$AMGL_02  
delta factor, 
STAT5 -292 (+)    CCATTT 100 RAT$BCAS_09 
YY1 -291 (+) x x  CATTT 100 HS$GMCSF_03 
MAPF2, YY1 -245 (-)   x GGAGC 100 RAT$MLC_04 
POU1F1a -178 (-)    ATGAAAA 100 HS$PL_10 
T3R -165 (-) ♦ ♦  GGGTCA 100 HS$CS1_04 
POU1F1a -120 (+)    TAAATTATCCAT 100 RAT$GRH_16, HS$GRH_03 
 POU1F1c -116 (+)    TTATCCAT 100 HS$GRH_05 
STAT5B -101 (-)    TTCTGAGAA 88.13 HS$P21WAF1_10 
Zn-15 -99 (+)    CTGTCAGTGG 89.44 RAT$GRH_24 
POU1F1a -86 (+)    TTGCATA 100 HS$PL_01 
AP-1 -83 (+)    ATGAATCATC 89.44 HS$PL_06 
POU1F1a -81 (+)    TAAAT 100 HS$GRH_03 
YY1 -80 (-) x x  CATTT 100 HS$GMCSF_03 
AP-2b, NF-1 -64 (-)    GGCCA 100 HS$GRH_01   
T3R -51 (+) ♦ ♦  AGGGAG 100 HS$CS1_04   
T3R -48 (+)   ♦ GGGTCA 100 HS$CS1_04   
a
 - IL-6 RE-BP, STAT1, STAT5A, STAT5B, STAT6; b - AP-2, AP-2alphaA, AP-2alphaB; c - POU1F1, POU1F1a, 
POU1F1b, POU1F1c 
 - POU1F1, POU1F1a, POU1F1b and/or POU1F1c (pituitary-specific transcription factor 1);  - Ap-1 (activator 
protein 1);  - AP-2 and NF-1, AP-2alphaA and AP-2alphaB (activator protein 2) and nuclear factor 1;  - GR 
(glucocorticoid receptor); ♦ - T3R and/or T3R-alpha (3,5,3’-triiodothyronine receptor);  - STAT1, STAT5A, 
STAT5B and/or STAT6 (signal transducer and activator of transcription);  - Zn-15 (zinc finger protein); x - YY1 
(yin and yang factor 1). 
 
 
 
